CURRICULUM VITAE

of

Professor Dédée F. MURRELL

M.A. (Cantab), B.M.B.Ch. (Oxon),

F.A.A.D.(USA) MD (UNSW), F.A.C.D.

1
 Contents
Page
PERSONAL DETAILS

QUALIFICATIONS

PROFESSIONAL TRAINING & APPOINTMENTS

SCHOLARSHIPS AND PRIZES

PROFESSIONAL ORGANIZATIONS

2
 7

LICENSURE

ADMINISTRATION AND TEACHING

POSITIONS OF RESPONSIBILITY/MANAGEMENT

9
RESEARCH GRANTS

10
CLINICAL TRIALS MANAGED

12
CONSULTANCIES

3
 13
EDITOR

52
REVIEWER

53
CONFERENCES CONVENED

53
TEACHING EXPERIENCE/INITIATIVES

63-66
RESEARCH SUPERVISION

4
 66
CLINICAL INITIATIVES

67
VISITING PROFESSORS ARRANGED

68
COMMUNITY ACTIVITIES

70
INVITED LECTURES

56-63
PRESENTATIONS AT SCIENTIFIC MEETINGS

5
 14-24

PUBLICATIONS
Papers - peer
reviewed

25-31
Papers – non-peer reviewed

31-34
Book Chapters

34

Abstracts 36-
51
Tape Recordings/CD/TV 54

6
7
 PERSONAL DETAILS

Name: Deirdre (Dédée) Frances MURRELL (née Blackburn)

Born: 1st March 1963, Bradford, West Yorkshire, England

Citizenship: British (by birth) and Australian (naturalized 1998)

Current Position: Professor and Head, Department of Dermatology,

The St George Hospital Clinical School,
University of New South Wales,
Kogarah, SYDNEY, N.S.W. 2217
Australia. T +61-2- 9113-2543; F 9113-2906

Director, Premier Specialists & Dermatology Trials Australia

The Church, 17 Kensington St,
Kogarah, SYDNEY, NSW 2217
Australia T +61-2-9598-5800, F 9598-5801

Home address: 57, Bundarra Rd, Bellevue Hill, Sydney, NSW 2023, Australia.
Tel 61-2-9327-3455; Fax 61-2-9327-3499

QUALIFICATIONS

1984 B.A.(MA 88) King's College, Cambridge University, England. Graduated B.A.with 2:1.

1986 F.M.G.E.M.S. Foreign Medical Graduates Examination in Medical Sciences, USA.

1987 BM BCh Oxford University Medical School and New College, Oxford, England.

1990 FLEX- Federal Licensing Examination, USA.

1991 Certificate in Human and Mammalian Genome Analysis, UNC-Chapel Hill.

1993 Diplomate, American Board of Dermatology.

1994 F.A.A.D. Fellowship of the American Academy of Dermatology.

2001 Board Recertification Examination, American Board of Dermatology.

2007 MD (Doctorate of Medicine) by published works “Studies in Blistering Disorders”

University of NSW, Sydney.

2009 F.A.C.D. Australasian College of Dermatologists.

8
 PROFESSIONAL APPOINTMENTS

1981-87 Universities of Cambridge (81-84) and Oxford Medical Schools (84-87),

England

1987-89 General Professional Training in National Health Service, U.K.

8/87-1/88 House Officer in Medicine, King Edward VII Hospital, Windsor
2/88-8/88 House Officer in Surgery at John Radcliffe Hospital, Oxford
8/88-2/89 Senior House Officer, Emergency Medicine, Addenbrooke's
Hospital,
2/89-6/89 Senior House Officer, Physician Training Scheme, Addenbrooke's
Hospital, Cambridge.

1989-90 Department of Medicine, Duke University Medical Center, Durham, North

Carolina U.S.A.
7/89-2/90 Research Associate, Division of Dermatology
3/90-7/90 Resident in Internal Medicine (Cardiology/CCU/Electrophysiology,
Emergency Medicine, General Medicine)

1990-93 Dermatology Residency Training Program, University of North Carolina at

Chapel Hill, North Carolina, USA
1992-3: Chief Resident

1993 Instructor, Department of Dermatology, New York University Medical

Center

1994 Assistant Professor, Attending Physician, Department of Dermatology, New York

University Medical Center.

1995 Clinical Scholar and Director of Epidermolysis Bullosa Registry, Department of

Dermatology, Rockefeller University, New York.

1996 Staff Specialist and Conjoint Lecturer in Dermatology, St George Hospital,

University of New South Wales, Sydney, Australia.

1998- Dermatologist for Epidermolysis Bullosa Clinic, Sydney Children’s Hospital.

2000 Conjoint Senior Lecturer, University of New South Wales.

2002 Senior Staff Specialist, Department of Dermatology, St George Hospital,

Sydney

2003- Conjoint Associate Professor, Faculty of Medicine, University of New

South Wales.

2004- Head, Department of Dermatology, St George Hospital, Sydney.

9
2008- Conjoint Professor, Faculty of Medicine, University of New South Wales

10
 SCHOLARSHIPS AND PRIZES

1977 Duke of Edinburgh Bronze (1977), Silver (1978) & Gold (1980) Awards

1978 Young Person's Literary Prize, Yorkshire

1980 Valedictorian (Dux), St Joseph's College, Bradford, U.K.

1980 English Speaking Union Scholarship

1981 Cum Laude Society, Loomis Chaffee School, Windsor, CT.

1983 Elizabeth Kolb Trust Award, Cambridge University

1984 Lady Mabel Florence Harriet Smith Award, Yorkshire Education Council

1985 Provost's Prize, Royal College of General Practitioners

1986 Oxford Medical School Elective Grant

1986 Elective Sponsorship from Organon Ltd, Stuart & Merck, Sharp & Dohme

1986 British Medical Students' Trust Elective Award

1986 George Drexler Ofrex Foundation Award

1987 Renwick Vickers Prize in Dermatology, Oxford Medical School

1992 Upjohn Young Investigator Award for Excellence in Dermatology Research

1993 Howard Hughes Postdoctoral Research Fellowship for Physicians

1994 N.I.H. Physician Scientist Award (K-11); 1994-1999

1995 Everett C. Fox Award, American Academy of Dermatology

1995 Bill Reed Travelling Fellowship, American Academy of Dermatology, to ESDR

1999 St George Hospital Annual Medical Competition, First Prize (equal)

2000 St George Hospital Annual Medical Competition, Best Basic Science Poster

2002 Mentor for Women’s Dermatology Society Elective Travel Awardee, Dr Eric Hanson

2002 Supervisor for University of NSW Postgraduate PhD Scholarship Awardee, Matthew
Kemp.

11
2002 Best Poster Prize, Cutaneous Biology and Endocrinology Workshop, Australasian Hair
& Wool Society, Melbourne (Senior author and supervisor of Matthew Kemp)

2002 Best Poster Prize, St George Hospital Annual Symposium, (Senior author and
supervisor of Matthew Kemp).

2002 Mentor for Women’s Dermatology Society Travel Awardee Dr Natasha Cook, for a
young dermatologist to attend the American Academy of Dermatology Meeting in San
Francisco.

2003 Supervisor for American Academy of Dermatology Travel Awardee Dr Niken

Trisnowati, for a dermatology resident or fellow from the Third World to present their
research at the International Society of Dermatology meeting in Miami, USA, May
2003.

2003 Supervisor for Japanese Society of Dermatology Travel Awardee Matt Kemp, to present
his research at the International Society of Dermatology Meeting in Miami, May 2003

2003 Women’s Dermatologic Society Career Development Award

2003 Best Poster Prize, St George Hospital Annual Symposium, (Senior author and
supervisor of Dr Niken Trisnowati).

2004 Skin and Cancer Foundation Prize for the best clinical case presentation, Australasian
College of Dermatologists’ Annual Scientific Meeting (Senior author and supervisor of
Dr Gilberto Moreno).

2005 F&E Bauer Prize, Australasian College of Dermatologists, for the best presentation
each year, awarded for paper on Fabry’s disease at Annual Scientific Meeting in Perth
(Senior author and supervisor of Dr Linda Martin).

2005 Mentor for Women’s Dermatologic Society Career Development Awardee, Dr Vangee
Handog, from Manila, Philippines.

2006 Brenan Prize, Australasian Society for Dermatopathology, for the best research paper
presented at the annual meeting, Sydney, (Senior author and supervisor of Dr Eleni
Yiasemides).

2006 American Academy of Dermatology, Leadership Circle for Volunteerism, Silver Award.

2006 Supervisor for Finalist, Dr Ningning Dang, St George Hospital Annual Symposium
Clinical Research presentations

2006 University Post graduate award, UNSW, to PhD student Hellen Yan

2007 Certificate of Appreciation, International Pemphigus & Pemphigoid Society, for

consensus definitions for pemphigus.

12
2007 Inaugural Young Investigator Award for Medical Student Research, St George
Hospital Annual Symposium, to John Frew, 3rd year ILP student under my supervision,
for Quality of Life measure specific for EB.

2008 Canadian Dermatology Foundation Bursary to Dr Susan Poelman of McGill University,

to spend a month’s elective with DM , Feb-March 2008.

2008 Japanese Society for Investigative Dermatology Travel Scholarship, to Hellen Yan, PhD
student under my supervision, to present SCC in EB project at the International Society
for Investigative Dermatology meeting in Kyoto, May 2008.

2008 American Dermatological Association – Honorary International Membership

2008 Sarkany Scholarship for Mary Alice Nading, an intern at Memorial Sloan Kettering
Cancer Ctr, to present a paper on a project completed with me at the EADV, Paris 08.

2008 Maria Duran Lectureship, International Society for Dermatology. (one awarded
per year)

2008 European Academy of Dermatovenereology International Committee – to 2012

2008 Young Investigator Award for Medical Student Research, St George Hospital
Annual Symposium, to Yong Kho, 3rd year ILP student under my supervision, for
Epidemiology of EB from the Australasian EB Registry.

2008 Best Poster Prize, 32nd Philippine Derm Soc/ISD, to Dr Ike Hakim, poster on
ankyloblepharon and EB simplex with me.

2008 Australasian College of Pathologists, travel grant scholarship to Dr Philip Tong to do a

research elective project with me, December 2008.

2008 Chair, Medical Advisory Board, DebRA Australia

2009 Women’s Dermatologic Society Int’l Travel Award to my fellow Dr Liz Intong to
present at the American Academy of Dermatology meeting in San Francisco, March
2009.

2009 Women’s Dermatologic Society Mentorship Award to Dr Stephanie Diamantis, from

UNC-Chapel Hill, for an elective in EB with me, Feb 2010.

2009 UNSW Postgraduate Award for Dr Supriya Venugopal, to do her PhD with my
supervision

2009 Hurwitz Lecturership, Society for Pediatric Dermatology

2009 Australasian College of Dermatologists’ Award for the best research publication by a

13
 registrar, awarded to Dr Linda Martin, for the Interventions for Pemphigus Cochrane
Review.

2009 St George Hospital Annual Symposium, Clinical Investigator Award, for the best
clinical research project presented by a junior doctor, to Dr Supriya Venugopal,
research fellow, for RCT of allogeneic cultured fibroblasts vs placebo for recessive
dystrophic EB

2009 Chair, Federal Government Clinical Advisory Committee, Epidermolysis Bullosa

Dressings Scheme.

2010 America-Australia Foundation, Sir Keith Murdoch Fellowship to Heather Cohn,

MD-PhD candidate, Jefferson Medical College, Philadelphia, to conduct research
project under my supervision on Epidermolysis Bullosa and Genetic risk factors for skin
cancer.

2010 Women’s Dermatologic Society Mentorship grants to Johnny Gurgen and Mercedes
Gonzales to spend one month in Sydney under my supervision.

2010 ESDR Collegiality Award and SID Travel Grant to MDPhD student Heather Cohn, to
present our RCT of cell therapy in the Plenary Session at the ESDR, Helsinki, Finland
(top 26 of 600 abstracts).

2010 Board Member, Australasian Society for Dermatological Research.

2010 Australasian Society for Dermatopathology 2010 Brenan Prize to Supriya Venugopal
for the best research presentation on our RCT for cell therapy in EB, Sydney.

2010 Young Investigator Award for Medical Student Research, St George Hospital
Annual Symposium, to Ann-Marie Hanna, for a project entitled Development of the
ABQOL, a quality of life measure specific for auto-immune blistering diseases, ILP
research student under my supervision.

2010 Young Investigator Runner Up Award for Medical Student Research, St George
Hospital Annual Symposium, to Minhee Kim, for a project on the Epidemiology and
outcomes of Squamous Cell Carcinomas in EB, ILP research student under my
supervision.

2010 Dean’s List Award for Yong C. Kho, final year medical student under my supervision
for his ILP research year. (Awarded to 12 of 200 students).

2010 Dean’s List Award for Deshan Sebaratnam, final year medical student under my
supervision for his ILP research year (Awarded to 6 of 200 students).

2011 Vice Chair, World Congress Fund Task Force, American Academy of Dermatology.

14
 PROFESSIONAL ORGANIZATIONS

1991- American Academy of Dermatology (Fellow since 1994)

1992- Society for Investigative Dermatology (Patron Member since 2005)

1995 European Society for Dermatological Research - 1997

1995- Women’s Dermatology Society, USA

1995- Australian Medical Association

1996- Dystrophic Epidermolysis Bullosa Research Association

1996- International Society for Dermatology

1997- Cochrane Collaboration- Editor of Skin Disease Group

1996 International Pemphigus and Pemphigoid Foundation [Member of Medical Advisory

Board]

2000- Society for Paediatric Dermatology

2001- Medical Dermatology Society (Patron Member from 2007)

2004- Australasian Society of Dermatological Research (Founding Member)

2004- British Association of Dermatologists

2004- Royal Society of Medicine, London

2004- Australasian College of Dermatologists, CPD Programme

2005- European Academy of Dermatovenereology (Full member)

2006 Australasian Society of Dermatopathology

2007 Australasian Wound and Tissue Repair Society

2007 European Society for Dermatological Research (Patron Member)

2008 American Dermatological Association, International Member (invitation only)

2009 Honorary Member, Philippine Dermatological Association

15
2009 Fellow, Australasian College of Dermatologists

LICENSURE

1988 General Medical Council (UK) Full Registration #3243639

1992 North Carolina, USA: Full Licensure #35814

1993 New York State License, USA #194007 - Dermatologist

1995 New South Wales, Australia: License # MPO 316421

1997 Specialist Recognition, Health Insurance Commission, Australia.

2004 Specialist Recognition (Dermatology) Specialist Training Authority, UK.

2010 National Medical Registration, Australia, via APHRA 1174240.

POSITIONS OF RESPONSIBILITY / MANAGEMENT EXPERIENCE

School:

1979-80 Captain of School, St Joseph's College, Bradford, UK (1200 girls).

1980 Expedition Leader, Gold Duke of Edinburgh Award Scheme
1981 Captain, Junior Varsity Swim Team, Loomis Chaffee School, CT, USA.

University:

1982-83 Secretary, Cambridge University Chaplaincy

1984 Loomis Chaffee Reunion Alumni Host, Cambridge University
1984-85 Assistant Secretary, William Osler House, Oxford Medical Students Society
1985&86 Tingewick Pantomime; Oxford University Medical School

Post-Graduate Trainee:

1988 Vice President, John Radcliffe Hospital Doctors' Mess

1989 Study Leave Committee, Addenbrooke's Hospital, Cambridge.
1989 Cambridge Junior Doctors Representative, District Working Party Committee.
1990 Resident in Charge of Cardiac Arrest Team, Duke University Medical Center.
1991 Principal Investigator, PI-initiated Psoriasis Trial, UNC-Chapel Hill
1991 Assistant Secretary, Oxford Society of North Carolina
1992-3 Chief Resident, Department of Dermatology, UNC-Chapel Hill

Faculty:

16
1993 Tutor, Molecular Biology Course for NYU medical and PhD students.
1993 Laboratory Superviser, medical students and technician at NYU.
1994 Director, Bullous Disease Clinic, Bellevue Hospital, New York University.
1995 Dermatologist, National Epidermolysis Bullosa Registry, Rockefeller University.

1995- Director of Investigative Dermatology, Orth. Research Institute, St George Hospital

1997- Editor, Skin Diseases, Cochrane Collaboration (UK)
1997- Staff Specialist Dermatologist for Epidermolysis Bullosa, Sydney Children’s Hospital
1997 Session Co-Director, Gross & Microscopic Symposium, American Academy of
Dermatology (97-2003)
1997- Treasurer, St George Hospital Medical Association & Postgraduate Committee
1998- Member of Medical Advisory Board, International Pemphigus Foundation, USA

2000 Mentor for 4th Year Medical Students, University of NSW.

2001- Clinical Expert, Psoriasis, Biotech Float Prospectus.
2001- Lecturer, Essex-Pharma Dermatology Education Program for General Practitioners
2002 Consultant, Medical Advisory Board, Photodynamic Therapy, Photocure ASA, Norway
2002- Cost Centre Manager, Dermatology Department, St George Hospital
2002- Women’s Dermatologic Society, International Affairs Board Member
2002- Consultant, Medical Advisory Board, Elidel for Atopic Eczema, Novartis.
2002- Medical Observer/MIMS Specialist Panel for Dermatology.
2004.8 American Academy of Dermatology, Skin Cancer Advisory Board
2005.9 International Society of Dermatology, Maria M Duran Award Committee
2005.10 Convening Committee for Dermatology VMO appointments, South/SE Sydney AHS
2005 Medical Dermatology Society, Membership Committee and Mentor
2006 Australasian Blistering Disorders Foundation, President & Co-Founder
2006- SESIAHS Human Ethics Committee
2007- Honorary Consultant Dermatologist, Research Inst Tropical Med, Manila, Philippines
2007-11 American Academy of Dermatology, International Affairs Committee
2007-8 American Academy of Dermatology, Volunteerism & Education Abroad Committee
2007-9 Vice-Chair, Maria Duran Committee, International Society for Dermatology.
2008-11 American Academy of Dermatology, World Congress Fund Raising Task Force.
2008-11 Medical Dermatology Society, Education Committee.
2008-11 Member, Scientific Advisory Board, St George Research Foundation.
2008- Editorial Board, Journal of the American Academy of Dermatology
2008 Faculty of 1000 in Medicine – expert in bullous diseases
2009 Chair, Clinical Advisory Group, DebRA Australia
2009-12 Chair, Maria Duran Committee, International Society for Dermatology
2009-12 Chair, International Affairs Committee, Women’s Dermatologic Society
2009-13 Vice President, International Society for Dermatology
2009 Editorial Board, Croatian Journal of Dermatology
2009 Chair, Clinical Advisory Committee for Federal Government Dressings scheme for EB
2010- Editorial Board, International Journal of Dermatology; Section Editor:
Genodermatoses
2010- Editorial Board, Iranian Journal of Dermatology
2010- Australasian Society of Dermatological Research – Board Member

17
2010 - Vitiligo Australia (patient support charity) – Inaugural Committee Member
2011-13 Executive Vice President, International Society for Dermatology
2011-13 Fundraising Committee, Medical Dermatology Society
2011-15 Chair, World Congress Task Fund, American Academy of Dermatology

ACADEMIC ACTIVITIES

RESEARCH GRANTS

Basic Research:

1991-2 NIH Departmental Training Grant 2T32AR07369-11A1 on "Antigenic Epitope

Mapping of Human Type VII Collagen" at UNC-Chapel Hill, US$33,200.

1993-6 Howard Hughes Postdoctoral Research Fellowship for Physicians, US$231,000.

"Desmoglein Diversity in Cell Adhesion & Pemphigus Foliaceus".

1994-9 N.I.H. Physician Scientist Award, (K-11) US$444,403 over five years.
"Nitric Oxide and Oxygen Free Radicals in Cutaneous Biology".

1996 Ronald Geoffrey Arnott Foundation, New South Wales $2000

"Better Diagnostic Techniques for Patients with Epidermolysis Bullosa"

1996 Dystrophic Epidermolysis Bullosa Research Association of Australia $4506

"Immunofluorescence Mapping and Mutation Analysis in Epidermolysis Bullosa"

2000/1 Dystrophic Epidermolysis Bullosa Research Association of Australia $30,000

"Pathogenesis of Squamous Cell Carcinoma in Epidermolysis Bullosa"

2001/2 Dystrophic Epidermolysis Bullosa Research Association of Australia $30,000

"Mutation Analysis and Gene Transfer in Epidermolysis Bullosa"

2003/4/5 University Post-graduate Award for my PhD student, Matt Kemp, Univ of NSW.
$34,000

2003 Dystrophic Epidermolysis Bullosa Research Association of NSW $10,000.

“Genotype-Phenotype Correlation in EB Simplex”

2003/4 AUSAID Scholarship, MSc student, Dr Niken Trisnowati, to UNSW, $54,000.

2004 Dystrophic Epidermolysis Bullosa Research Association of NSW $20,000.

“Gene Transfer in Epidermolysis Bullosa”

2005 Australasian College of Dermatologists F&E Bauer Grant (Co-investigator) for vitiligo

18
 study at St George Hospital, with Drs Martin, Wittal and LeGuay $1000.

2005-6 Scholarship from Government of China to Dr Ningning Dang for postdoctoral

research $15,000 pa.

2006 Dystrophic Epidermolysis Bullosa Research Association of NSW $10,000

“Genotype-Phenotype Correlation in Junctional EB”

2006 University of NSW – Independent Learning Project – Quality of Life in EB

Medical student John Frew assigned 32 weeks

2006 NIH RFA-AR-06-006 Clinical Trial Outcomes Instrument Development Grant

Program (U01) Measures of Disease Severity and QoL in Pemphigus. Co-Investigator with Dr
VP Werth, US $150,000 (received good ranking but not funded).

2007 Fred Bauer Grant, Australasian College of Dermatology, for post-doc project on
genotype-phenotype in junctional EB – Ningning Dang $1000

2007 Australasian EB Registry – Grant from DebRA Australia $5,000

2007 University of NSW- Independent Learning Project- Quality of Life in Pemphigus.

2007 University of NSW- Independent Learning Project- Epidemiology of Epidermolysis

Bullosa in Australia.

2007 International Pemphigus & Pemphigoid Foundation Grant for Clinical Trial Outcomes
Instrument Development Grant Program Measures of Disease Severity and QoL in
Pemphigus. Co-Investigator with Dr VP Werth, US $25,000.

2007 Pregnancy in Epidermolysis Bullosa – Grants from DebRA Australia & S.A. ($2000)

2008 DebRA Australia – Grant for presentation of Quality of Life Scoring System for EB at
American Academy of Dermatology by medical student, John Frew $3,398.

2008 DebRA NSW – Grant for Cell Therapy for RDEB - $15,000.

2008 Women’s Dermatologic Society Academic Grant (supervisor of Dr Hellen Yan)

$12,000

2008 Japanese Society for Investigative Dermatology – Competitive Travel Grant for
presenting research at International Investigative Dermatology Meeting, Kyoto (to my
PhD student, Hellen Yan) Approx $1000.

2008 Travel grant, DebRA Australia, for my ILP student, Yong Kho, to present our work at
the Aust Wound and Tissue Repair Society Conference in Darwin, NT, May 2008;
$1500

19
2008 University of NSW- Independent Learning Project- Epidemiology and Quality of Life
in Autoimmune Bullous Diseases .

2008 N-RISS Grant for RCT of Allogeneic Cell Therapy in Recessive Dystrophic EB -
$75,000

2008 Co-investigator, Investigation of Fli-1 in wound healing, Channel 7 Fund for

Children’s Hospitals, with A/Prof Allison Cowin, SA. $45,000

2008 DebRA Australia, Funding for EB Registry Project, $10,000

2009 NSW Health – funding for Clinical nurse consultant for adult patients with EB, St
George Hospital $60,000

2009 Co-investigator, NHMRC Project Grant: Investigation of flightless-1 in epidermolysis

bullosa with Allison Cowin, PhD Univ of Adelaide $517,500

2009 N-RISS Grant for Open Label Allogeneic Cell Therapy in Recessive Dystrophic EB -
$24,000

2010 Lord Mayor’s Charitable Foundation, Major Grant, $160,000 for funding of a clinical
nurse consultant for adult patients with epidermolysis bullosa (Foote family award).

Grant for Biologics Clinic, Abbott Pharmaceuticals $15,000

2011 Grant for Biologics Clinic Nurse, Schering Plough Pharmaceuticals, $11,000

Clinical Trials (as PI unless otherwise stated):

1990 Interpro, Inc. "Evaluation of Dermaffin in the Treatment of Psoriasis."US $15,000

(Design, conduct & analysis of RCT comparing dermaffin cream vs 0.1%
triamcinolone cream vs Eucerin Cream vs no treatment in chronic plaque psoriasis)

1998 Schering-Plough Pharmaceuticals $48,000

"A Randomized Trial of Elocon versus Advantan in Psoriasis"

1998 3M Pharmaceuticals $ 41,815 (Co-investigator with Dr S. Shumack)

"Imiquimod for the Treatment of Superficial and Nodular Basal Cell Carcinomas"

1999 Scotia Pharmaceuticals - Tretinoin in Galactobase for Acne $12,000 (With Dr R.

Rosen)

20
2000 Biotech Australia - Principal Investigator: Psoriasis Study $25,000

2000 Photocure (Norway) - PI: Metvix Photodynamic Therapy for Actinic Keratoses
$20,000

2000 Photocure - PI: Metvix Photodynamic Therapy for High Risk Basal Cell Carcinoma
$46,000

2000 A Randomized trial of Treatment Efficacy and Relapse Rates of Acne Vulgaris treated
with Isotretinoin to 120mg/kg/day vs 150mg/kg/day (PI- study driven) Grant from
Roche

2000 Photocure- PI: Metvix Photodynamic Therapy for nodular Basal Cell Carcinoma
$15,000

2001-2 Novartis- PI: SDZ-ASM 981 double-blind placebo controlled multicentre dose-finding
study in chronic plaque psoriasis, $30,000

2001 Randomized double-blind placebo controlled multicentre trial of Dapsone as a steroid-

sparing treatment for Pemphigus Vulgaris. (International study; drug provided by
Jacobis)

2002 Fujisawa. PI: A double bind, multicentre randomized, parallel group study to
demonstrate the equivalence of the response to vaccination of a tacrolimus ointment
regimen to a steroid ointment regimen in children with moderate to severe atopic
dermatitis $45,000

2003 GlaxoSmith Kline; PI: A Randomized, Double-Blind, Placebo Controlled, Parallel

Group Study to Assess the Safety and Efficacy of Three Dose Levels of Rosiglitazone
Maleate in the Treatment of Chronic Plaque Psoriasis. $140,000.

2004 Galderma: A randomized trial of Metvix PDT versus excisional surgery for nodular
basal cell carcinoma.$60,000.

2005 Molynlycke, Sweden: sponsorship of dressings for trial of mepilex and mepilex lite vs
mepitel in epidermolysis bullosa $20,000.

2006 Novartis: A randomized controlled trial of Elidel Cream for Facial Atopic Dermatitis.
$24,000.

2005-8 Clinical Cell Culture, C3, Perth: donation of Recell kits for one arm of RCT of cosmetic
treatments for vitiligo – value $50,000.

2006 Statewide Service Enhancement: 0.5 FTE Clinical Nurse Consultant for Epidermolysis
Bullosa Clinic, Sydney Children’s Hospital.

21
2005 Stiefel Laboratories: Donation towards dermabrader needed for RCT of cosmetic
treatments for chronic stable vitiligo. $1,300.

2005-6 Galderma: RCT of metvix PDT vs excisional surgery for superficial BCCs (lead
recruiter of int’l study) $75,000

2006 Novartis: An open uncontrolled safety study of the use of Pimecrolimus 1% Cream
for seborrhoeic dermatitis $30,000. (study cancelled by Novartis)

2006.7 Galderma: A phase II randomized controlled trial of CD5024 cream for rosacea &
follow-on study $48,000 – completed; lead recruiter for Australia

2008 Galderma: A phase III RCT of CD 5024 cream for rosacea. $32,000 (completed)

2008 Merck-Serono Phase IV trial of efalizumab for palmoplantar psoriasis (completed

recruitment).

2008 Schering-Plough; RCT of a new topical preparation for onychomycosis. (on hold by
company)

2008 Patient familiarization program for Adalimubab for psoriasis (enrolled maximum of 10
patients- ongoing)

2008 Novartis : Validation of QOL scale for psoriasis in Australia $8,000 (completed)

2008 Novartis: Phase II study of AEB for chronic plaque psoriasis – PI for Australia

2009 Schering-Plough: REALITY & DOSE: Phase IIIb & IV RCT of infliximab responders
relapsing before 8 weeks allocated to Methotrexate plus infliximab vs infliximab every 6
weeks

2009 Genentech: Evaluation of oral hedgehog pathway inhibitor for metastatic or unresectable
basal cell carcinoma

2009 Amgen – Phase II RCT of AMG 827 for chronic plaque psoriasis.

2010 Novartis – AEB oral PKC inhibitor for psoriasis extension trial.

2010 Amgen – AMG827 extension trial for psoriasis

2010 Pfizer - Phase 3 trial of oral tazocitinib JAK kinase inhibitor for psoriasis.

22
 CONSULTANCIES

2001 Clinical Expert, Psoriasis, Biotech Float Prospectus

2002 Consultant, Medical Advisory Board, Photodynamic Therapy, Photocure ASA, Norway
2002 3M Pharmaceuticals, Medical Board Meetings in USA
2002 Consultant, Medical Advisory Board, Elidel for Atopic Eczema, Novartis.
2003 FDA Advisory Panel Presentation on behalf of Photocure, Norway, for Metvix-PDT for
Basal Cell Carcinomas.
2004-7 ELITE Global Advisory Board for Elidel for atopic dermatitis, Novartis.
2004-5 Serono, efalizumab patient care program, and medicare application
2005-6 Abbott, adalimubab, advice re psoriasis to rheumatology board
2005- Protalex, Inc. re trial design for pemphigus & pemphigoid
2006-7 Schering-Plough, discussions re infliximab for psoriasis .
2008 Stiefel Pharmaceuticals
2008 Novartis Pharmaceuticals – psoriasis
2009 GenePharm/Pierre Fabre – atopic dermatitis
2009 Novartis Pharmaceuticals – contact dermatitis
2009 Basilea – alitretinoin for chronic hand dermatitis
2010 Ascent/Pierre Fabre – atopic dermatitis
2011 Roche- advisory board for hedgehog inhibitor studies in Basal Cell Carcinoma

PRESENTATIONS AT SCIENTIFIC MEETINGS

1990 American Academy of Dermatology Summer Meeting, Boston.

Paper: Evaluation of a New Barrier Cream in the Prevention of Rhus Dermatitis.

1991 Environmental Threat to the Skin International Conference, Cardiff, U.K.

Paper: A Randomized Double-blind Study of seven Barrier Creams for the

Prevention of Rhus Dermatitis.

23
1992 Sixteenth Hawaii Dermatology Seminar, Maui

Paper: Clinical Trials for the Evaluation of Barrier Creams in the Prevention of
Rhus Dermatitis.

Society for Investigative Dermatology, Baltimore, MD.

Poster: Type VII collagen contains Type III fibronectin repeats at the N terminal
domain.

American Academy of Dermatology, San Francisco, CA.

Paper: Mapping of Type VII Collagen Epitopes Recognized by Autoantibodies

from Patients with Epidermolysis Bullosa Acquisita and Bullous SLE.
(Residents & Fellows Symposium)

Poster: Epitope Mapping of Type VII Collagen in Epidermolysis Bullosa Acquisita

and Bullous Lupus.

1993 American Academy of Dermatology, Washington, DC.

Paper: Systemic Amyloidosis Presenting as Nail Dystrophy.

(Gross & Micro Section).

1994 Society for Investigative Dermatology, Baltimore, MD.

Poster: Distribution of Desmosomal Band 6 Protein

1995 American Academy of Dermatology, New Orleans, LA.

Paper : Overview of Cell Adhesion Molecules

(Focus Session)

Paper: Distribution of Band 6 Protein (Residents & Fellows Symposium;

Winner of Everett C Fox Award for 1995)

Paper: A Severe Case of Livedoid Vasculitis Fails to Respond to Tissue

Plasminogen Activator (Gross & Micro Session)

Australasian Connective Tissue Society, Terrigal, NSW

Paper: Characterization of Plakophilin 1

1996 American Academy of Dermatology, Washington, DC.

24
 Paper: Cell Adhesion Molecules Relevant to Dermatology (Focus Session)

Australasian College of Dermatology, Brisbane, QLD

Paper: A Randomized Double-Blind Placebo-Controlled Trial of Dermaffin in the

Treatment of Chronic Plaque Psoriasis.

Australasian Dermatopathology Society, Sydney, NSW

Paper: Band 6 Protein is Localized in Simple, as well as Complex and Stratified

Epithelia (Brenan Prize runner-up)

1997 American Academy of Dermatology, San Francisco, CA

Faculty: Gross & Microscopic Two-Day Symposium

Paper: Cell Adhesion Molecules (focus session)

1997 19th World Congress of Dermatology, Sydney, Australia

Poster: A Randomized Double-Blind Placebo-Controlled Trial of Dermaffin in the

Treatment of Chronic Plaque Psoriasis.

1998 56th Annual American Academy of Dermatology, Orlando, Florida.

Paper: Cell Adhesion Molecules (Focus Session)

Faculty: Gross and Microscopic Symposium

North American Clinical Dermatologic Society, Sydney, Australia.

Paper: Basement Membrane Disease

1999 57th Annual American Academy of Dermatology, New Orleans, LA.

Paper: Cell Adhesion Molecules (Focus Session)

Faculty: Gross and Microscopic Symposium

Australasian College of Dermatologists, Perth

Paper: Immunofluorescence Mapping in Epidermolysis Bullosa

2000 58th Annual American Academy of Dermatology, San Francisco, CA.

Paper: Dermatology on Three Continents (Focus Session)

Faculty: Gross and Microscopic Symposium

25
2001 59th Annual American Academy of Dermatology, Washington, DC

Paper: Dermatology on Three Continents (Focus Session)

Faculty: Gross and Microscopic Symposium
Poster: Prevalence of Latex Allergy Among Health Care Workers
(Colinet, H & Murrell, DF)

The General Practitioner Conference and Exhibition, Sydney, May 2001

Invited Speaker: Management of Pruritus

Australasian College of Dermatologists Meeting, Adelaide, May 2001

Paper: Koebner Variant of Epidermolysis Bullosa due to a novel keratin 14

mutation: M119V (Senior author).
Paper: A Randomized Study Comparing Photodynamic Therapy Using Metvix
or Placebo Cream to Cryotherapy in Actinic Keratosis (Coauthor).
Paper: Efficacy of Imiquimod 5% Cream for the Treatment of Superficial &
Nodular Basal Cell Carcinomas (Coauthor).

2002 60th Annual American Academy of Dermatology, New Orleans, LA

Paper: Dermatology on Three Continents (Focus Session)

Faculty: Gross and Microscopic Symposium
Photocure Symposium: Summary of Australian Metvix Trial for high risk BCCs.

Australasian College of Dermatologists Annual Meeting, Melbourne

Paper: Evidence-Based Medicine and the Cochrane Skin Group (Contemporary

Dermatology Session)
Paper: Diagnosis of Epidermolysis Bullosa in Newborns (Paediatric Dermatology
Symposium- by invitation)
Poster: Prevalence of Latex Allergy in Health Care Workers.
Poster: A novel mutation causing EB simplex Weber-Cockayne: K14 M272T

The General Practitioner Conference and Exhibition, Sydney, May 2002

Invited Speaker: Kids Skin Diseases

20th World Congress of Dermatology, Paris

Paper: The practice of Dermatology in Australia-

International Women’s Dermatologic Society Meeting
Paper: A novel mutation causing EB simplex Weber-Cockayne: K14 M272T

26
2003 61st Annual American Academy of Dermatology, San Francisco, CA

Paper: Dermatology on Three Continents (Focus Session)

Faculty: Gross and Microscopic Symposium
Photocure Symposium: Summary of Australian Metvix Trial for Nodular BCCs
Poster: Coauthor, RCT of Metvix PDT vs cryotherapy for multiple Actinic
Keratoses

International Society for Dermatology Meeting, Miami Beach, FL

Poster: A novel 15bp deletion in K5 causing EB Simplex (senior author)

Poster: Combined mutations in Keratins 5 and 14 causing EB simplex (senior
author)
Poster: Treatment of severe psoriasis with oral pimecrolimus (RCT) shows dose-
dependent improvement (coathor)
Poster: Safety profile of oral pimecrolimus in atopic eczema and psoriasis: a pooled
analysis from two dose-finding studies. (coauthor).

Indonesian 7th Annual Scientific Meeting of the Indonesian Society of Dermatology and
Venereology, Yogyakarta, Indonesia. July 2003:

Plenary Paper: Evidence-Based Dermatology

Plenary Paper: The pathogenesis of Inherited Bullous Diseases.

First International Symposium on Epidermolysis Bullosa, Institute for Child Health,

London, October 2003

Plenary Paper: Prenatal diagnosis of EB in Australia

Plenary Paper: Photographic Monitoring for Squamous Cell Carcinoma in
Recessive Dystrophic Epidermolysis Bullosa
Plenary Paper: Eyelid nodules in Herlitz Junctional EB

2004
62nd Annual American Academy of Dermatology, Washington, DC

Poster: Coauthor, RCT of Metvix PDT for high risk basal cell carcinomas
Faculty: AAD Skin Cancer Advisory Board
Faculty: Medical Advisory Board, International Pemphigus Foundation

The General Practitioner Conference and Exhibition, Sydney

Invited Speaker: Eczema and Allergies

1st Australasian Society for Dermatological Research, Sydney, May 2004

27
 Plenary Paper: Correlation between IF mapping and EM in the diagnosis of
Epidermolysis Bullosa (Senior author)

Australasian College of Dermatologists Annual Meeting, Sydney, May 2004

Plenary Paper: Evidence-Based Review of Treatments for Bullous Pemphigoid

Plenary Paper: Prenatal Diagnosis of Epidermolysis Bullosa in Australia
Paper: Codominant keratin 5 &14 mutations in EB Simplex (senior author)
Paper: Glomulin mutations in multiple hereditary glomangiomas (senior
author)
Poster: Correlation between IF mapping and EM in the diagnosis of
Epidermolysis Bullosa (Senior author)

2005
63rd Annual American Academy of Dermatology, New Orleans, LA

Paper: Genotype-Phenotype Correlations in Epidermolysis Bullosa (Focus

session) Rated 6.76/7 (mean score 5.92)
Faculty: AAD Skin Cancer Advisory Board
International Pemphigus Foundation, Medical Advisory Board
International Society of Dermatology: Maria Duran Committee

The General Practitioner Conference and Exhibition, Sydney, April 2005

Invited Speaker: Eczema and Allergic Rashes

2nd Australasian Society for Dermatological Research, Perth

Paper: Elevated mutant keratin 5 mRNA expression in a novel deletion

mutation in Dowling-Meara EB Simplex (senior author)
Paper: Novel combined mutations in keratin 5 and 14 genes occurring in a
mother and daughter with different severities of EB simplex (senior
author)
Poster: Late onset Herlitz JEB mimicking laryngo-onycho-cutaneous
syndrome (first author)
Poster: Preparation of dermal and epidermal protein extracts for the
detection of autoimmune bullous disorders using an immunoblotting
technique (coauthor).

Australasian College of Dermatologists Annual Meeting, Perth, May 2005

Plenary paper: Heterozygote for Fabry’s disease presents with hand ischaemia and
painful acroparaesthesia (senior author). [Awarded F&E Bauer
Prize by ACD for the best paper presented at the Annual Meeting]

28
 Australasian College of Dermatologists Spring Meeting, Cairns, Sept 2005

Paper: Is laryngo-onycho-cutaneous syndrome a form of junctional epidermolysis

bullosa? (Senior author & presenter)
Paper: Tropical mycoses – treatment options for chromoblastomycosis (senior
author)

European Academy of Dermato-Venereology, London, October 2005

Papers: Dental abnormalities in heterozygous carriers of the COL17A1:

823delA mutation in a family with non-Herlitz junctional EB.
(Senior author & presenter)

Skin disorders in Aboriginal Australians (invited).

International Pemphigus Foundation Conference, London, October 2005

Paper: Differentiating Pemphigus from Pemphigoid

2006

Seminar in Epidermolysis Bullosa, St George Hospital, February 13th, 2006

Duties: Conference Convenor; & Speaker

Cosmetic Physicians Society First Annual Meeting, Sydney, February 2006

Paper: Photodynamic Therapy for Non-Melanoma Skin Cancer

64th Annual American Academy of Dermatology, San Francisco, CA.

Paper: Outcome Measures in Pemphigus (Pemphigus Definitions Group)

Director of New Forum: Genetic Disorders of Skin Integrity (rated 6.55/7)

Faculty: Skin Cancer Advisory Board

International Pemphigus Foundation Medical
Advisory Board
Women’s Dermatology Society International
Committee
International Society of Dermatology Maria Duran
Committee

Modern Management in Rheumatology, Peppers Salt, Kingscliff, NSW, 11-12

29
 March

Paper: Outcome Measures and Treatment Options for Psoriasis

Australasian Society for Dermatological Research, Melbourne, May 13th

Paper: Dental abnormalities in heterozygous carriers of the COL17A1

823delA mutation in a family with non-Herlitz junctional EB

Posters Gene transfer studies using baculovirus and COL7 cDNA

Differential expression of pyloric atresia in JEB-PA with
ITGB4 identical mutations

Australasian College of Dermatologists Annual Meeting, Melbourne, May 14-17th

Papers: Herlitz vs Non-Herlitz Junctional Epidermolysis Bullosa due to two

novel LAMC2 mutations.(Plenary)

Prenatal diagnosis of junctional EB (Paediatric symposium)

Poster: Dental abnormalities in heterozygous carriers of the

COL17A1:
823delA mutation in a family with non-Herlitz junctional EB

Topical Tacrolimus ointment does not interfere with the host

response to meningitec vaccine in patients with atopic
dermatitis.

Late onset Herlitz JEB mimicking laryngo-onycho-

cutaneous syndrome.

European Society for Dermatological Research, Paris, Sept 6-10th.

Paper: Outcome Measures for Pemphigus (Pemphigus Consensus

Group)
Poster: Lethal GABEB due to novel COL17A1 deletion mutation

17th Regional Conference of Dermatology, Bali, Sept 13-16th

Plenary Speaker: Recent Molecular Advances in Bullous Diseases

European Academy of Dermatovenereology, Rhodes, Greece, October 5th-9th

Papers: A Year in the Life of the Clinical Trialist

Infectious Skin Diseases in Aboriginal Australians

30
Dystrophic Epidermolysis Bullosa Research Association Scientific Meeting, (By
invitation only) Dublin, Ireland, October 10-12th

3 Posters Differential expression of pyloric atresia in JEB with ITGB4

mutations; Novel mutation in LAMA3a in a patient with LOC variant of JEB;

2007
65th Annual American Academy of Dermatology, Washington, DC, Feb 1-5th.
Focus Session Director: Genotype-Phenotype Correlations in EB
Forum: Genetic Disorders of Skin Integrity – topic: Cardiocutaneous
Desmosomal Gene disorders
Satellite Pemphigus Definitions Group- presentation on disease extent tool

University of Santo Tomas, Manila, Annual Postgraduate Dermatology

Conference
4 Plenary lectures – What’s New in Autoimmune Bullous Diseases,
Genotype-phenotype correlation in EB; Desmosome Gene Disorders; Barrier
Defect Genes in Atopic Dermatitis.

Society for Investigative Dermatology, Los Angeles, CA, May 9-12th.

5 posters: See published abstract list, Senior author of 4 on Epidermolysis
Bullosa basic research, first author of RCT of pimecrolimus for atopic
dermatitis and quality of life.
1 talk, satellite meeting of Int’l Pemphigus Definitions Group

European Academy of Dermatovenereology, Vienna, Austria, May 16th-20th

Invited Chair of new session: Hot Topics from the Posters
3 talks- interactive sessions – Measuring the immeasurable, a review of
outcome measures in pemphigus; Differential expression of pyloric atresia in
JEB with ITGB4 mutations; Overlap of LOC syndrome with JEB due to
LAMA3a mutatons.
2 posters- QOL outcomes in RCT of pimecrolimus for Atopic dermatitis;
RCT of metvix PDT vs surgery for superficial BCC.
Invited member of 3rd international EB Consensus meeting.

First EB Professionals Conference, Sydney, Australia, 14th June

Chair of meeting; Genotype to Phenotype in EB

DEBRA Australia Conference, Sydney, Australia, June 2007

What’s New in EB Research

New Zealand Dermatological Society, Auckland

Genotype –Phenotype Correlation of Dystrophic EB with collagen VII
mutations

DEBRA New Zealand Conference, Auckland, August 2007-05-27

31
 Chair, talks on History of EB, Genotype-Phenotype Research in EB in
Australia
Anaemia in EB,
Squamous Cell Carcinomas in EB
Quality of Life Measurement in EB.

European Society for Dermatological Research, Zurich, Switzerland, Sept 5-8th,

2007
Invited Chair, Postgraduate Course
Poster Walk, Genodermatoses (invited)

DEBRA Chile Satellite to World Congress, Sept 27th-29th, Santiago, Chile.

Validation of a Quality of Life Questionnaire specific for EB.

World Congress of Dermatology, Buenos Aires, Argentina, Sept 30th-Oct 5th.

Satellite Meetings:
Women’s Dermatology Society International Retreat
Chair, session on volunteerism in the third world
Endemic Diseases, Jundaio University, Brasil, Sheraton Hotel
Skin disorders in Australian Aborigines (invited)

Genodermatoses (Interactive Session) Tuesday 2ndt Oct:

Differential expression of pyloric atresia in JEB due to
integrin mutations
COL7A1 mutations in DEB in Australia
KRT5 & 14 mutations in EBS in Australia
Splice site mutations in LAMC2 and different expression of
JEB
Interactive Session- Misc; Friday 5th Oct:
How to set up a Clinical Trials Unit
Paediatric & Neonatal Dermatology, Wed 3rd Oct:
How to establish a Multidisciplinary EB Clinic
Pharmacoeconomics, Friday 5th Oct, CN Ellis, Chair.
Pharmacodermatology in Oceania (invited lecture)
Atopic Dermatitis/Eczema Interactive Session, Friday 5th Oct:
RCT of elidel vs vehicle for adults with head & neck atopic
dermatitis
Senior author of 5 additional papers- delivered by fellows Drs Agero &
Martin
Poster: Validation of Quality of Life Score specific for EB

2008

66th Annual American Academy of Dermatology, San Antonio, TX, Jan 30th- Feb

32
 5th
Chair, Focus session: Genotype to phenotype in EB
Speaker, Forum on Genetic Disorders of Skin Integrity
Speaker, Outcome Measures for Pemphigus, Medical Derm Soc
3 Posters

International Society for Dermatology, Kyoto, Japan, May 14-17 2008

Paper & Poster: Quality of Life measurement in EB
Poster: Collagen VII antibody staining and risk of SCC in RDEB

Post-IID Bullous Meeting, Otsu, Japan, May 18-19, 2008

Co-Convenor, Pemphigus Outcome Measures Group
Poster: ABSIS and PDAI in clinical practice.

Australasian College of Dermatologists’ Annual Meeting, May 9-12, 2008

Nine posters (senior author);
Senior author, paper: Transient dermolysis of the newborn case

Australasian Society for Dermatology Research, May 13-14, 2008

Senior author of 4 papers (1 fellow, 3 medical students)

American Dermatological Association, Asheville, NC August 14-17

New member lecture: Laryngo-onycho-cutaneous syndrome – novel
observations

European Academy of Dermatovenereology, Paris, France, Sept 18-23rd.

Co-Chair, Junior Session for the best Resident-Fellow Presentations
Chair, Forum on Epidermolysis Bullosa
Speaker, Symposium on Pemphigus- Definitions
Speaker, Course on Inherited Paediatric Disorders – blistering diseases
Snr author, 1 paper & 2 posters

International Society of Dermatology, Manila, Philippines, Nov 18-22, 2008

Maria Duran Lecturer, 2008 : What’s New in EB
Plenary Session invited speaker: What’s new in autoimmune bullous
diseases

2009
American Academy of Dermatology, San Francisco, March 5-10
Chair, Symposium (3h) on Autoimmune Blistering Diseases
Speaker, Forum on Genodermatoses
2 Poster Discussion Sessions (How to run a ski camp for EB; Australasian
EB Registry)
3 further posters

International Society of Dermatology, Prague, Czech Republic

33
 Chair, Maria Duran Symposium
Chair, Eurasian Dermatology Platform
Speaker: Development of Quality of Life Score for Epidermolysis Bullosa
Speaker: Paediatric Dermatology Symposium, Bullous Genodermatoses

Society for Pediatric Dermatology, Philadelphia, PA July 9-12th

Sidney Hurwitz Lecturer for 2009 (2 lectures):
What’s new in diagnosis and pathogenesis of EB
Update on the management of EB

Epidermolysis Bullosa 2009 (invitation only), Vienna Sept 6-8th

Moderator: Cell therapy for EB – oral presentation
Posters: Quality of life scale for EB; EB Registry ; Cell tx & EB

European Society for Dermatological Research, Budapest, Sept 9-12th

Speaker: RCT of allogeneic fibroblast cell therapy for RDEB*
Co-Chair, International Consensus for Bullous Pemphigoid
Posters: SCC in EB; EBS & ankyloblepharon; EBS-MD
Coauthor presentation: Fli expression in EB subtypes (plenary)*
*highlighted in summing up as major findings

European Academy of Dermatovenereology, Berlin, Germany, Oct 7-10th

Co-Chair, International Consensus for Bullous Pemphigoid
Co-Chair, Junior Session for the best research presentations
Invited Speaker: Outcomes of pregnancy and delivery in EB
Speaker: Systematic Review of Interventions for Pemphigus
Speaker: How to take biopsies for EB (WDS symposium)
Poster: Quality of Life measure for EB.

2010

American Academy of Dermatology, Miami, March 4-9th

Chair: Autoimmune bullous diseases Symposium
Speaker: Quality of Life in AIBD
Speaker: Management of EB – Genodermatoses forum
Senior author – 2 presentations at Residents Fellows Symposium
Senior author – 2 presentations at Medical Dermatology Society
Co-Chair, Int’l Pemphigoid Consensus Group

Australasian Wound and Trauma Research Association, Annual Meeting, Perth,

Mar 22-24th, Perth Convention Centre
RCT of allogeneic cell therapy for wound healing in dystrophic
epidermolysis bullosa (paper);
Flightless expression in EB (coauthor, poster)

New Zealand Dermatological Society, Christchurch, NZ, May 1-4th,

34
 Chair, Genodermatoses session
Papers: cell therapy for EB; Plec1 mutations in EBS with late onset
muscular dystrophy
Senior author of paper- genotype to phenotype in DEB-TDON
Response of 4/4 cases of multiple verrucae to Gardasil
vaccination

Australasian College of Dermatologists Annual Meeting, Darwin, May 15-19th

Senior author of 13 abstracts, including two oral papers
Registrar session – RCT of cell therapy for RDEB
Free paper session – Australasian EB Registry
Satellite meeting – What’s new in atopic dermatitis and medical spa therapy

Australasian Society for Dermatological Research, Cairns, June 2010

Senior author of 3 oral papers

European Society for Dermatological Research, Helsinki, Finland, Sept 2010

Senior author of plenary presentation on cell therapy trial in RDEB

The Malta Meeting, Oct 2-30-Nov 2nd, 2010, Malta (unable to attend due to
health issues)
Invited Co-Chair and speaker, genodermatoses session
What’s new in epidermolysis bullosa?

National Institutes of Health, Bethesda, Pemphigus Meeting, Nov 5-7

Invited speaker – quality of life in pemphigus
Co-Chair, International Consensus meeting on Bullous Pemphigoid

CILAD, Latin American Dermatology Annual Meeting, Cancun, Mexico, Nov

10-14
Co-Chair and Invited speaker, Workshop on Epidermolysis Bullosa
Chair, International Society for Dermatology Session
Co-Chair, Women’s Dermatologic Society Rose Parade of Cases

2011
American Academy of Dermatology, New Orleans, February 3-8th
Chair, Symposium on Autoimmune Blistering Diseases
Speaker, Forum on Autoimmune Diseases.
Co-Chair, Consensus meeting for Bullous Pemphigoid
Vice Chair, AAD World Congress Task Fund meeting
Chair, WDS International Affairs Committee meeting
Chair, ISD Maria Duran Committee meeting

Philippine Dermatologic Society Annual Meeting, Manila, May 2011

Invited speaker:
Atopic dermatitis and psoriasis in teenagers – special considerations in

35
 management
Lupus- considerations for women

World Congress of Dermatology, Seoul, South Korea, May 2011

Invited Co-Chair, Workshop on Epidermolysis Bullosa; speaker on cell
therapy
Invited Co-Chair, Workshop on Databases in Dermatology: speaker on EB
Registries
Invited Speaker, Workshop on Autoimmunity, Speaker on Quality of Life in
AIBD

European Academy of Dermatology, Lisbon, Portugal, October.

Chair, Symposium on Genetic blistering disorders and Genodermatoses.
Invited Speaker, President’s Symposium

PUBLICATIONS

Papers – Peer Reviewed (* highly cited)

1. Resnick SD, Murrell DF, Woosley J. Acne conglobata and a generalized Lichen
Spinulosus-like eruption in an HIV-seropositive man. J Am Acad Dermatol 26:1013-4,
1992. (19 citations)

2. Grevelink S.A., Murrell DF. and Olsen E.A. Effectiveness of various barrier preparations
in preventing and/or ameliorating experimentally produced Toxicodendron dermatitis. J
Am Acad Dermatol 27:182-8, 1992. (21 citations)

3. *Murrell DF. A Radical Proposal for the Pathogenesis of Scleroderma. J Am Acad

Dermatol 28:78-85, 1993. (67 citations)

4. *Gammon WR, Murrell DF, Jenison M, Padilla K, Prisayanh P, Jones DA,Briggaman RA,
Hunt SW . Autoantibodies to Type VII Collagen Recognize Epitopes in a Fibronectin-like
Region of the Noncollagenous (NC1) Domain. J. Invest Dermatol 100:618-622, 1993.
(36 citations)

5. Resnick-SD, Murrell DF, Woosley-JT Pityriasis rubra pilaris, acne conglobata, and
elongated follicular spines: an HIV-associated follicular syndrome? [letter; comment] J
Am Acad Dermatol 29: 283, 1993. (9 citations)

6. Murrell DF. Activated macrophages and radicals in scleroderma (reply to letter) J Am

Acad Dermatol 30:1046-7, 1994.

7. Murrell DF., Jenson J, O'Keefe E Failure of livedoid vasculitis to respond to tissue

plasminogen activator. Arch Dermatol 131:231-2, 1995. (3 citations)

36
8. *Murrell GAC, Szabo C, Hannafin JA, Jang D, Dolan MM, Deng X-H, Murrell DF, &
Warren RF : Modulation of tendon healing by nitric oxide. Inflamm Res 46:19-27, 1997.
(47 citations)

9. Arbiser JL, Fine J-D, Murrell DF, Paller A, Connor S, Keogh K, Marsh E & Folkman J:
Fibroblast growth factor: A missing link between collagen type VII, increased collagenase,
and squamous cell carcinoma in Recessive Dystrophic Epidermolysis Bullosa. Molecular
Medicine 4:191-5, 1998. (15 citations)

10. Williams H, Adetugbo K, Li Wan Po A, Naldi L, Diepgen T & Murrell DF: The Cochrane
Skin Group: Preparing, maintaining and disseminating systematic reviews of clinical
interventions in dermatology. Arch Dermatol 134:1620-1626, 1998. (20 citations)

11. Klingberg S, Mortimore R, Parkes J, Chick JED, Clague AE, Murrell D, Weedon D,
Glass IA: Prenatal diagnosis of dominant dystrophic epidermolysis bullosa by collagen VII
molecular analysis. Prenat Diagn 20(8): 618-622, 2000. (3 citations)

12. See A, Kossard SS, Murrell DF: Dermatofibroma sarcoma protruberans on the back
presenting as an atrophic red plaque. Eur J Derm 11:147-149, 2001.(2 citations)

13. Fang ZM, Lee CS, Sarris M, Murrell D, Lavin MF, Kearsley JH, Clarke RA: Rapid
radiation induction of the ataxia-telangiectasia ATM protein levels in situ. Pathology
33:30-36, 2001. (7 citations)

14. *Nakano A, Pulkkinen L, Murrell D, Rico J, Lucky A, Garzon M, Stevens CA,

Robertson S, Pfender E, Uitto J: Epidermolysis Bullosa with Congenital Pyloric Atresia:
Novel Mutations in the B4 Integrin Gene (ITGB4) and Genotype/Phenotype Correlations.
Pediatric Research 49:618-626, 2001. (35 citations)

15. Wang M-X, Murrell DF, Szabo C, Warren RF, Sarris M & Murrell GAC: Nitric Oxide in
Skeletal Muscle. Inhibition of nitric oxide synthase inhibits walking speed in rats. Nitric
Oxide 49:618-626, 2001. (20 citations)

16. Cummins RE, Klingberg S, Wesley J, Rogers M, Zhao Y, Murrell DF: Keratin 14 point
mutations at codon 119 of helix 1A resulting in different Epidermolysis Bullosa Simplex
phenotypes. J Invest Dermatol 117:1103-1107, 2001. (14 citations)

17. Lim AC, Hart K, Murrell DF: Amlodipine-induced Granuloma Annulare- A Case Report
and Review of Histopathological Classification. Australas J Dermatol 43:28-34, 2002.

18. Premaratne C, Klingberg S, Glass IA, Wright K Murrell DF: Epidermolysis bullosa
simplex Dowling-Meara due to an Arg-Cys substitution in exon 1 of keratin 14. Australas
J Dermatol 43:24-27, 2002.

19. Khumalo NP, Murrell DF, Wojnarowska F, Kirtschig G: A systematic review of

37
 treatments for bullous pemphigoid. Arch Dermatol 138: 385-389, 2002. (20 citations)

20. Kirtschig G, Murrell D, Wojnarowska F, Khumalo N: Interventions for Cicatricial

Pemphigoid and Epidermolysis Bullosa Acquisita. A systematic literature review. Arch
Dermatol 138:380-384, 2002. (19 citations)

21. *Nakano A, Chao S-C, Pulkkinen L, Murrell D, Bruckner-Tuderman L, Pfender E, Uitto

J: Laminin 5 Mutations in Junctional Epidermolysis Bullosa: Molecular Basis of Herlitz vs
Non-Herlitz Phenotypes. Hum Genet 110(1):41-51, 2002. (35 citations)

22. Clarke RA, Fang ZM, Lee CS, Sarris M, Murrell D, Kearsley JH. Multiple sclerosis in a
radiosensitive family with low levels of the ATM protein. Australas Radiol. 46(3): 267-74,
2002 .

23. Kim YJ, Marjoniemi VM, Diamond T, Lim A, Davis G & Murrell DF: Androgenetic
alopecia in a postmenopausal woman due to ovarian hyperthecosis. Australas J Dermatol
44:64-68, 2003.

24. Kirtschig G, Murrell D, Wojnarowska F, Khumalo N: Interventions for Mucous

Membrane Pemphigoid and Epidermolysis Bullosa Acquisita. (Cochrane Review) . In: The
Cochrane Library, Issue 1, 2003. Oxford: Update Software.

25. Khumalo NP, Kirtschig G, Middleton P, Hollis S, Wojnarowska F, Murrell DF:

Interventions for bullous pemphigoid (Cochrane Review) . In: The Cochrane Library,
Issue 3, 2003. Oxford: Update Software.

26. Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P, Thai K-E, Murrell
D, Weightman W, Anderson C, Reid C, Watson A, Foley P: A comparison of
photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle
cryotherapy in patients with actinic keratosis: a prospective, randomized study. J
Dermatolog Treat. Jun;14(2):99-106, 2003.

27. Thai KE, Fergin P, Freeman M, Vinciullo C, Francis D, Spelman L, Murrell D, Anderson
C, Weightman W, Reid C, Watson A, Foley P: A prospective study of the use of
cryosurgery for the treatment of actinic keratoses. Int J Dermatol Sep;43(9):687-92.
2004.(10 citations)

28. Kordjian N, Donaldson A, Murrell D, Krilis S: A case of desquamating rash associated

with methadone use. Med J Aust. Online 5 Dec 2004; 2005; 182(2) 17 Jan 2005. (2
citations)

29. Cronk J, Huynh NT, Whitfeld M, Kossard S & Murrell DF: Multiple firm facial papules.
Arch Dermatol 141(Mar):389-394, 2005.

30. Vinciullo C, Elliott T, Francis D, Gebauer K, Spelman L, Nguyen R, Weightman W, Reid

C, Czarnecki D, Murrell D. Photodynamic therapy with topical methyl aminolevulinate

38
 for difficult to treat basal cell carcinoma. Br J Dermatol 152 (April):765-772, 2005. (23
citations)

31. Kemp MW, Klingberg S, Lloyd L, Molloy TJ, Marr P, Wang Y, Murrell GAC, Murrell
DF: A novel deletion mutation in keratin 5 causing the removal of 5 amino acids and
elevated mutant mRNA levels in Dowling-Meara Epidermolysis Bullosa Simplex. J Invest
Dermatol 124 (May): 1083-1085, 2005.

32. Gottlieb AB, Griffiths C, Dubertret L, Ho VC, Mrowietz U, Murrell DF, Ortonne J-P,
Todd G, Cherill R , Marks I, Emady-Azar S, Paul CF, for the Multi-Centre Investigator
Group. Efficacy and tolerability of oral pimecrolimus in the treatment of moderate to
severe chronic plaque-type psoriasis: A double-blind, multicentre, randomized dose finding
trial. Br J Dermatol 152 (June):1219-1227, 2005. (12 citations)

33. Khumalo N, Kirtschig G, Middleton P, Hollis S, Wojnarowska F, Murrell D. Interventions

for bullous pemphigoid. The Cochrane Database of Systematic Reviews 2005, Issue 3.
Art. No.: CD002292. DOI: 10.1002/14651858.CD002292.pub2.

34. Bieber T, de Prost Y, Cork M, Ellis C, GirolomoniG, Groves R, LangleyR, Luger T,

Meurer M, Murrell D, Orlow S, Paller A, Puig L, Saurat J-H, Schwartz T, Shear N,
Stingl G, Taieb A, Thestrup-Pedersen K. Consensus Statement on Safety Profile of Topical
Calcineurin Inhibitors Dermatology 211(July):77-78, 2005. (12 citations)

35. Yiasemides E, Walton J, Marr P, Villanueva E, Murrell DF: A comparative study of

transmission electron microscopy vs immunofluorescence mapping for the diagnosis of
epidermolysis bullosa. Am J Dermatopath Oct;28(5):387-94 , 2006. (2 citations)

36. Figueira EC, Crotty A, Challinor CJ, Coroneo MT, Murrell DF: Granulation tissue
in the eyelid margin and conjunctiva in junctional epidermolysis bullosa
with features of LOC syndrome. Clin Experiment Ophthalmol Mar;35(2):163-6,
2007.

37. Murrell DF, Pasmooij AMG, Pas HH, Marr P, Klingberg S, Pfendner E, Uitto J,
Sadowski S, Collins F, Widmer R, Jonkman MF. Retrospective Diagnosis of Fatal BP180-
Deficient Non-Herlitz Junctional Epidermolysis Bullosa Suggested by
Immunofluorescence (IF) Antigen-Mapping of Parental Carriers Bearing Enamel Defects.
J Invest Dermatol. 127(7): 1772-5, 2007. Epub 2007 Mar 8.(1 citation)

38. Martin L, Sturgess A, Sillence D, Murrell DF: Fabry disease in a heterozygote presenting
as hand purpura. Australas J Dermatol Feb;48(1):40-2, 2007 .

39. Rubin AI, Moran K, Fine J-D, Wargon O, Murrell DF: Urethral Meatal Stenosis In
Junctional Epidermolysis Bullosa: A Rare Complication Effectively Treated
With A Novel, And Simple Modality. Int J Dermatol (on line early 19 July 2006)
46:1076-1077, 2007. (Oct) doi: 10.1111/j.1365-4632.2006.03065.x

39
40. Hofman T, Cranswick N, Kuna P, Boznanski A, Latos T, Gold M, Murrell DF, Gebauer
K, Behre U, Machera E, Olaffson J, Szalai Z: Tacrolimus Ointment does not Affect the
Immediate Response to Vaccination, the Generation of Immune Memory, or Humoral and
Cell- Mediated Immunity in Children Arch Dis Child 2006 Nov;91(11):905-10. Epub 2006
Jun 23. Erratum in: Arch Dis Child. 2007 Jan;92(1):93. (3 citations)
41. Boyle RJ, Bath-Hextall F, Donath S, Murrell DF, Tang MLK, Taylor J, Varigos G:
Probiotics for Atopic Eczema (protocol). The Cochrane Database of Systematic Reviews,
Issue 2, 2006

42. Dang NN, Klingberg S, Marr P, Murrell DF: Review of Collagen VII sequence variants
found in Australasian patients with dystrophic epidermolysis bullosa reveals 9 novel
COL7A1 variants. J Dermatol Sci 46(3) June:169-178, 2007. Epub 2007 Apr 10. (1
citation)

43. Yiasemides E, Trisnowati N,Su J, Dang NN, Klingberg S, Marr P, Chow CW, Orchard D,
Varigos G, Murrell DF: Clinical heterogeneity in recessive epidermolysis bullosa due to
mutations in the keratin 14 gene, KRT14. Clin Exp Dermatol. Nov 33(6):689-97.2008 doi
10.1111/j.1365-2230.2008.02858.x

44. Martin LK, Agero A, Werth V, Villanueva E, Segall J, Murrell DF: Interventions for
Pemphigus Vulgaris and Pemphigus Foliaceus (protocol). The Cochrane Database of
Systematic Reviews, Issue 3, 2006.

45. Foley P, Freeman M, Menter A, Siller G, El-Azhary RA, Gebauer K, Lowe NJ, Jarratt
MT, Murrell DF, Rich P, Pariser DM, Oseroff AR, Barnetson R, Anderson C, Kossard S,
Gibson LE, Tope WD. Photodynamic therapy with topical methyl aminolevulinate for
primary nodular basal cell carcinoma: results of a randomized study. Int J Derm
48(11):1236-45, 2009.

46. Ostberg A, Kloos M, Moreno G, Su T, Trisnowati N, Marchuk D, Murrell DF: Molecular

Genetic Analysis of Hereditary Glomuvenous Malformations. Australas J Dermatol 48
(3):170-3, 2007.

47. Martin LK, Lawrence R, Kossard S, Murrell DF: Cutaneous Mycobacterium neoaurum
infection causing scarring alopecia in an immunocompetant host. Br J Dermatol (BJD-
2006-01662.R1; epub May 2007; Vol 157 (1) July: 213, 2007.

48. Murrell DF, Calvieri S, Ortonne J-P, Ho VC, Weise-Riccardi S, Barbier N, Paul CF. A
randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with
head and neck atopic dermatitis intolerant of, or dependent on, topical corticosteroids..
Br J Dermatol (accepted May 2007) 157 (Nov) :954-959, 2007. DOI 10.11 11/1.1365-
2133.2007.08.192 x.

49. Dang NN, Klingberg S, Rubin AI, Edwards M, Borelli S, Relic J, Marr P, Tran K Turner
A, Murrell DF: Differential expression of pyloric atresia in junctional epidermolysis

40
 bullosa with novel ITGB4 mutations. Acta Derm Venereol 88(5): 438-448, 2008
(accepted with revisions Mar 08). DOI 10.2340/00015555-0484. Featured with an
accompanying editorial by Leena Bruckner-Tuderman.

50.. Martin LK, Kossard S, Murrell DF: Reticular variant of mid-dermal elastolysis . Am J
Dermatopathol 30 (3) (June) 287-90, 2008.

51. Martin LK, Rubin AI, Theocharous C, Murrell DF: Podophyllin reaction mimicking
Bowen’s Disease in a patient with delusions of verrucosis. Clin Exp Dermatol 33:443-5,
2008 (accepted; in press Oct 2007; on line early Feb 4, 2008; doi: 10.1111/j.1365-
2230.2007.02668.x).

52. Vinciullo C, Elliott T, Francis D, Gebauer K, Spelman L, Nguyen R, Weightman W,

Reid C, Czarnecki D, Murrell DF. Photodynamic therapy with topical methyl
aminolevulinate for “difficult to treat” basal cell carcinoma: 5 year follow-up
data from a prospective trial. Dermatol Surg (submitted).

53. Shipman AR, Agero AL, Cook I, Scolyer RA, Craig P, Pas HH, Wojnarowska F, Murrell
DF: Epidermolysis Bullosa Acquisita Requiring Multiple Oesophageal Dilatations. Clin
Exp Dermatol Nov;33(6):787-9, 2008. Epub 2008 Jul 4. doi 10.1111/j.1365-
2230.2008.02875.x

54. Agero ALC, Lahmar JJ, Martin LK, Holzborn RM, Freckmann ML, Murrell DF:
Naevus of Ota presenting in two generations: a mother and daughter. JEADV 93: 102-4,
2009. DOI: 10.1111/j.1468-3083.2008.02745

55. Martin LK, Murrell DF: Invited editorial to DFM: Treatment of Pemphigus – the need for
better evidence. Arch Dermatol. 144 (1):100-101, 2008. Featured on front cover of
journal.

56. Dang NN, Murrell DF: Mutation analysis and characterization of COL7A1 mutations
with dystrophic epidermolysis bullosa. Exp Dermatol, 17; 553-568., 2008 (Impact factor
2.449; 7/39 derm journals).

57. Murrell DF, Amagai M, Barnadas M, Borradori L, Bystryn JC, Cianchini G, Diaz L,
Fivenson D, Goldsmith L, Hall R, Harman KE, Hashimoto T, Hertl M,
Hunzelmann N, Iranzo P, Joly P, Jonkman MF, Kitajima Y, Korman N,
Martin LK, Mimouni D, Pandya A, Payne A, Rubenstein D, Shimizu H,
Sinha A, Sirois D, Dick S, Werth V: Consensus statement on definitions
of disease endpoints and therapeutic response for pemphigus. J Am Acad Dermatol 58
(June): 1043-6, 2008 (in press Dec 2007; on line early March 11, 2008; doi
10.1016/j.jaad.2008.01.012 )

58. Frew JW, Martin LK, Nijsten T, Murrell DF: Development of a quality of life index
for epidermolysis bullosa (EB) through the development of the QOLEB questionnaire, an
EB-specific quality of life instrument.. Br J Dermatol Dec;161(6):1323-30, 2009. Epub

41
 2009 Jun 11. DOI 10.1111/j.1365-2133.2009.09347.x

59. Shipman AR, Ali L, Murrell DF, Wojnarowska F. Mucous Membrane Pemphigoid:
are Laminin 5 Antibodies a Risk Factor for Laryngeal Involvement?. J Eur
Acad Dermatol Venereol 2009 Feb;23(2):169-70. Epub 2008 Aug 27. DOI:
10.1111/j.1468-3083.2008.02921.x .

60. Szeimies RM, Ibbotson S, Murrell DF, Rubel D, Zillikens D, Kerrouche N. de Berker D,
Dummer R, Villemagne H on behalf of the Excilight Study Group. A clinical study
comparing Methyl Aminolevulinate Photodynamic Therapy (MAL-PDT) and Surgery in
superficial Basal Cell Carcinoma, with a 12-month follow-up.J Eur Acad Dermatol
Venereol Nov;22(11):1302-11, 2008. Epub 2008 Jul 2.

61. Fine J-D, Eady RA, Bauer EA, Bauer J, Bruckner-Tuderman L, Heagerty A, Hintner H,
Hovnanian A, , Jonkman MF, Leigh I, McGrath JA, Mellerio JE, Murrell DF, Shimizu H,
Uitto J, Vahlquist A, Woodley D, Zambruno G, Revised Consensus for Definitions of
Epidermolysis Bullosa. J Am Acad Dermatol 58(June): 931-950, 2008 (in press Dec 2007;
advance on line March 2008. doi:10.1016/j.jaad.2008.02.004) Featured on front cover of
journal.

62. Martin LK, Agero ALC, Werth V, Villanueva E, Segall J, Murrell DF: Interventions for
Pemphigus Vulgaris and Pemphigus Foliaceus. The Cochrane Database of Systematic
Reviews, Review 2009 Jan 21;(1):CD006263

63. Rosenbach M, Murrell DF, Bystryn J-C, Delay S, Dick S, Fakharzadeh S, Hall R,
Korman NJ, Lin J, Okawa J, Pandya AG, Payne AS, Rose M, Rubenstein D, Woodley D,
Vittoria C, Werth BB, Williams EA, Taylor L, Troxel A, Werth VP: Comparison of
reliability and validity between two outcome instruments for pemphigus. J Invest
Dermatol ; 109: 2404-2410, 2009 doi:10.1038/jid.2009.72. Featured on front cover of
journal as ‘outcome instruments for pemphigus’ with two other papers; accompanying
commentary on ‘How to validate instruments for pemphigus’ by S. Bastuji-Garin and E
Sbidian, JID p2328-9.

64. Tassabehji M, Fang ZM, Hilton EN, McGaughran J, Zhao Z, de Bock CE, Howard E,
Malass M, Donnai D, Diwan A, Manson FD, Murrell D, Clarke RA. Mutations in GDF6
are associated with vertebral segmentation defects in Klippel-Feil syndrome. Hum Mutat
Aug;29(8):1017-27, 2008..
65. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang ML.Probiotics for treating
eczema. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006135. Review.

66. Vestergaard ME, Kossard S, Murrell DF: Seborrheic keratoses appearing in sites of
previous psoriasis plaques during responsive treatment with efalizumab. Clin Exp
Dermatol (accepted with revisions Sept 08). Epub June 5th 2009. 34 (8): e564-566. 2009.

67. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang ML.Probiotics for treating

42
 eczema. Clin Exp Allergy 39(8):1117-1127, 2009.

68. Nading MA, Lahmar JJ, Frew JW, Ghionis N, Hanly M, Kemble-Welch A, Murrell DF: A
ski and adventure camp for young patients with severe forms of epidermolysis bullosa. J
Am Acad Dermatol 61(3) 508-511, 2009. DOI 10.1111/j.1365-2133.2009.09347.x69.

69. Foley P, Freeman M, Menter A, Siller G, El-Azhary RA, Gebauer K, Lowe NJ, Jarratt MJ,
Murrell DF, Rich P, Pariser DM, Oseroff AR, Barnetson R, Anderson C, Kossard S.
Gibson LE, Tope WD: Photodynamic therapy with methyl aminolevulinate for primary
nodular basal cell carcinoma: results of two randomized studies. Int J Dermatol 48: 1236-
1245, 2009 DOI: 10.1111/j.1365-4632.2008.04022.x

70. Foley P, Freeman M, Gebauer K, Murrell DF, Shumack S, Tyson C, Varigos G. Long-
term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis:
results from an Australian Expanded Access Programme. Int J Dermatol 48 (12): 1376-
1384, 2009.

71. Lara-Corrales I, Mellerio J, Lucky AW, Azizkhan RG, Murrell DF, Agero ALC, Kantor
P, Pope E. Dilated Cardiomyopathy in Epidermolysis Bullosa, a retrospective, multicenter
study. Pediatr Dermatol 27:238-243, 2010.

72. Venugopal S, Murrell DF: Complete remission of cutaneous warts using the Gardasil
vaccine in a developmentally delayed, thirty one year old Caucasian man. The Cutting
Edge, Arch Dermatol 146: 475-477, 2010.

73. van Geel M, Gattas M, Kesler Y, Tong P, Yan WF, Tran K, Steijlen PM, Murrell DF, van
Steensel MAM: Novel WNT10A nonsense mutations in odonto-onycho-dermal dysplasia.
Br J Dermatol DOI: 10.1111/j.1365-2133.2010.09703.x:162:1403-6, 2010.

74. Wriston CC, Rubin AI, Martin LK, Kossard S, Murrell DF: Plaque-like Cutaneous
Mucinosis: Case Report and Literature Review. Am J Dermpath (in press August 2010)

75. YC Kho, AL Agero, LM Rhodes, S Robertson, J Su, G Varigos, I Robertson, P Hogan, D

Orchard, DF Murrell. Epidemiology of EB in the Antipodes: the Australasian EB Registry
with a focus on Herlitz Junctional EB. Arch Dermatol 146(6): 635-60, 2010 (featured on
the front cover of the journal).

76 Venugopal SS, Intong LRA, Cohn HI, Mather-Hillon J, Murrell DF: Responsiveness of
non-Herlitz junctional epidermolysis bullosa to topical gentian violet. Int J Dermatol 2010
Nov;49(11):1282-5. doi: 10.1111/j.1365-4632.2010.04557.x.

77. Venugopal SS, Murrell DF: Seasonal onychomadesis in an elderly gentleman.

Dermatology Reports Issue 1, Vol 1: e3, 2009.

78. Frew JW & Murrell DF: Quality of Life Measurements in Epidermolysis Bullosa: Tools
for Clinical Research & Patient Care. Dermatol Clin N Am, 28(1):185-190, 2010,

43
79. Cohn HI & Murrell DF: Laryngo-onycho-cutaneous syndrome. Dermatol Clin N Am,
2010, Part I: Epidermolysis Bullosa, 28 (1): 89-93, 2010.

80. Tosti A, Duque-Estrada B, Murrell DF: Alopecia in Epidermolysis Bullosa.  Dermatol

Clin N Am, 28 (1): 165-170, 2010

81. Tosti A, Cadore de Farias D, Murrell DF: Nail involvement in Epidermolysis Bullosa.
Dermatol Clin N Am, 28 (1): 153-158, 2010

82. Figuiera EC, Murrell DF, Coroneo MT: Epidermolysis Bullosa and the Eye. Dermatol
Clin N Am, 28 (1): 143-152, 2010

83. Intong LRA, & Murrell DF: How to Take Skin Biopsies for Epidermolysis Bullosa.
Dermatol Clin N Am, 28 (2): 197-200, 2010.

84. Venugopal SS & Murrell DF: Management of Squamous Cell Carcinoma in

Epidermolysis Bullosa. Dermatol Clin N Am, 28 (2): 283-288, 2010.

85. Yan WF, Murrell DF: Cell therapy for dystrophic epidermolysis bullosa. Dermatol Clin
N Am, 28 (2): 367-370, 2010.
86. Murrell DF: Epidermolysis Bullosa in Australia and New Zealand. Dermatol Clin N Am,
28 2): 433-438, 2010.
87. Sebaratnam DF, Martin LK, Rubin AI, Tran K, Pas HH, Marr PJ, Edmonds J, Murrell
DF: Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests
Toll-like receptor 7 inhibitors may be useful treatments for pemphigus. Clin Exp
Dermatol. Jan;36(1):91-3. doi: 10.1111/j.1365-2230.2010.03918.x. Epub 2010 Sep 1. Jan
2011 (image from article featured on front cover of journal).

88. Martin LK, Werth VP, Villanueva E, Murrell DF: Interventions for Pemphigus Vulgaris
and Pemphigus Foliaceus. J Am Acad Dermatol 2011 May;64(5):903-8. Epub 2011 Feb
25. 10.1016/j.jaad.2010.06.003.

89. Choi SD, Intong LRA, Kho YC, Rhodes LM, Chapman MG, Murrell DF: Outcomes of
11 pregnancies in 3 patients with recessive forms of epidermolysis bullosa. Br J
Dermatol (submitted Mar 2010; accepted with minor revisions July 2010).

90. Intong LR, Choi D, Kho YC, Shipman AR, Rhodes LM, Chapman M, Murrell DF:
Retrospective Evidence of Outcomes of Pregnancy and Childbirth in Epidermolysis
Bullosa in Australia. J Am Acad Dermatol (accepted pending revisions;).

91. Sebaratnam DF, Venugopal SS, Murrell DF: A comparison in real clinical practice of
methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell
carcinoma: 3-year recurrence rates and cosmetic outcomes. JEADV 2011 Jan;25(1):117-8.
doi: 10.1111/j.1468-3083.2010.03697.x.).

44
92. Purdie K, Pourreyron C, Fassihi H, Cepeda R, Volz A, Weissenborn S, Pfister H, Proby C,
Bruckner-Tuderman L, Murrell DF, Salas-Alanis JC, McGrath JA, Leigh IM, Harwood
C, South AP: Squamous cell carcinoma in patients with recessive dystrophic epidermolysis
bullosa are not associated with high risk mucosal human papillomaviruses and do not
exhibit increased infection of beta papillomaviruses. J Invest Dermatol :130(12): 2853-5,
2010. DOI 10.1038/jid2010.243).

93. Fang Z, Kozlov S, McKay MJ Woods R, Birrel G, Sprung CN, Murrell DF, Wangoo K,
Teng L, Kearsley JH, Lavin MF, Graham PH, Clarke RA: Low levels of ATM in breast
cancer patients with clinical radiosensitivity. Genome Integrity 2010, 1:9
doi:10.1186/2041-9414-1-9.

94. Frew JW, Lim S-W, Klausseger A, Chow CW, Tran K, Su J, Orchard D,
Varigos G, Sawamura D, Nishie W, Shimizu H, Murrell DF: Autosomal
Dominant Bullous Dermolysis of the Newborn Associated with a
Heterozygous Mis-sense Mutation p.G1673R in Type VII Collagen.
Australas J Dermatol 2010 Published Online 23/8/10 DOI: 10.1111/j.1440-
0960.2010.00684.

95. Daniel BS and Murrell DF. The actual management of pemphigus. G

Ital Dermatol Venereol. 2010 Oct;145(5):689-702.

96. Kirtschig G, Middleton P, Bennett C, Murrell DF Wojnarowska F,. Khumalo N,

Interventions for bullous pemphigoid. The Cochrane Database of Systematic Reviews
Issue 10, 2010 Oct 6;10:CD002292.

97. Daniel BS and Murrell DF: Chronic urticaria resolving after resection of mucinous breast
cancer. J Clin Exp Dermatol 1:103, 2010. DOI 10.4172/2125.9554.1000103.

98. Yiu EM, Klausegger AK, Waddell LB, Grasern N, Lloyd L, Tran K, North KN, Bauer JW,
McKelvie P, Chow CW, Ryan MM, Murrell DF. Epidermolysis bullosa with late-onset
muscular dystrophy and plectin deficiency. Muscle Nerve (in press Feb 2011).

99. Martin LK, Murrell DF: Pemphigus: Directions for the future. J Am Acad Dermatol.
2011 Feb 24.
100. Murrell DF, Ryan TJ, Bergfeld WF: Advancement of Women in Dermatology. Int J
Dermatol 2011 May;50(5):593-600. doi: 10.1111/j.1365-4632.2011.05075.x. PMID:
21506978

BOOKS/GUEST EDITORSHIPS

45
 Dermatologic Clinics of North America. Guest Editor Epidermolysis Bullosa : Part 1:
Pathogenesis and Clinical Features. Elsevier. January 2010.

Dermatologic Clinics of North America. Guest Editor Epidermolysis Bullosa : Part I1:
Diagnosis and Management. Elsevier. April 2010

Dermatologic Clinics of North America. Guest Editor Autoimmune Blistering Diseases:

Part 1: Diagnosis and Pathogenesis Part II: Management; Elsevier. 2011

Up to date: invited editor for 3 chapters on Epidermolysis Bullosa, 2010

INVITED ARTICLES/EDITORIALS

Martin LK, Murrell DF 2008 Treatment of pemphigus: the need for more evidence. Arch
Dermatol 144:100-101. IF 2.8 Rank in Field 6/41.

Murrell DF, Handog EB 2008 International exchange programs in dermatology: a

prescription for the present, a hope for the future. Dermatol Clin IF 1.4 26:203-219, v-vi.
Sebaratnam DS, Murrell DF 2009: Management of Pemphigus. Expert Review of
Dermatology, Future Science Group, London.

Murrell DF: Life with Epidermolysis Bullosa: Etiology, Diagnosis, Multidisciplinary Care
and Therapy: invited book review. J Am Acad Dermatol: 61(6): 1092-3, 2009.

Murrell DF: Preface to Epidermolysis Bullosa: Part 1- Pathogenesis and Clinical

Features, Dermatol Clin N. Am. 2010 Jan;28(1):xv-xvi.. PMID: 19945610

Daniel BS, Murrell DF: Junctional Epidermal Bullosa Herlitz Variant and the Role of
Prenatal Diagnosis and Palliative Care. Access Dermatology, Prous Science.

Cohn HI, Kim M-H, Murrell DF: Squamous Cell Carcinoma Screening and Management
in Recessive Dystrophic Epidermolysis Bullosa Patients. Access Dermatology, Prous
Science

BOOK CHAPTERS

Murrell D.F., and Olsen E.A. (1992) Ivy Shield: a new barrier cream for the prevention of
Rhus Dermatitis. In: Environmental Threat to the Skin. Ed, R. Marks & G. Plewig.
Martin Dunitz. London. pp 265-8.

Leonard T, Delamere F and Murrell D: The Cochrane Skin Group. In: Evidence-Based
Dermatology. Williams HC, Ed. BMJ Books. pp24-33 (invited contribution) Published

46
 3.4.2003. ISBN: 0727914421.

Sperber BR, Martin LK, Murrell DF & Werth VP: Pemphigus. In: Evidence-Based
Dermatology, 2nd Edition, Williams HC, et al, Eds. Blackwells, pp 581-594, 2008

Leonard T, Delamere F & Murrell DF: The Cochrane Skin Group. In: Evidence-Based
Dermatology, 2nd Edition, Williams HC, et al, Eds. Blackwells, pp 20-28, 2008.

Murrell DF & Handog E: International Exchange Programs in Dermatology: A

Prescription for the Present, A Hope for the Future. Dermatology Clinics of
North America. 26(2): 203-219, 2008.

Venugopal S & Murrell DF: Prevention of Bullous Diseases. In: Prevention of Skin
Disorders. Elsevier. 2008 (in press).

Venugopal S & Murrell DF: A review of cutaneous cancer syndromes. In: Clinics in
Genetics 2008. (in press)
Intong LRA & Murrell DF: Genetics and molecular biology of the sexes. In: Parish LC,
Brenner S, Ramos-e-Silva M, Parish JL, eds. Manual of Gender Dermatology. Sudbury,
Mass: Jones & Bartlett Learning; 2011: 15-23.

Intong LRA, Murrell DF: Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic
Epidermal Necrolysis. Pediatr Dermatol next edition. Irvine A, Ed. Wiley-Blackwells

Sebaratnam D, Murrell DF: What’s New in the Management of Autoimmune Blistering

Diseases. Access Dermatology, Prous Science.

Sebaratnam D, Murrell DF: Treatment of Pemphigus vulgaris and pemphigus foliaceus.

Expert Review of Dermatology, 4(5) 469-481, 2009.

Sebaratnam D, Murrell DF Werth VP: Pemphigus. Evidence-based Dermatology.

Textbook – Howard Maibach, Ed. 2010.

Daniel BS, Murrell DF. Epidermolysis Bullosa. In: Clinical Genomics: Practical
Applications in Adult Patient Care. McGraw Hill and American College of Physicians,
2010.

ABSTRACTS

1. Murrell D.F. and Olsen E.A. (1990) Evaluation of a New Barrier Cream in the Prevention
of Rhus Dermatitis. Proceedings of the American Academy of Dermatology, Boston, MA,
June 1990.

47
2. Murrell D.F., Grevelink S.A. and Olsen E.A. (1991) A Randomized Double-blind Study
of seven Barrier Creams for the Prevention of Rhus Dermatitis. Proceedings of the
Environmental Threat to the Skin Conference, Cardiff, U.K.

3. Murrell D.F., Grevelink S.A. and Olsen E.A. (1992) Clinical Trials for the Evaluation of
Barrier Creams in the Prevention of Rhus Dermatitis. 16th Hawaii Dermatology Seminar
Proceedings.

4. Gammon WR, Hunt S, Jenison M, Murrell DF, Padilla KM, Prisayanh P, Briggaman RA.
(1992) Autoantibodies to Type VII Collagen Recognize Epitopes in a Region Homologous
to Type III Fibronectin Repeats. Proceedings of the Society for Investigative
Dermatology, Baltimore.

5. Murrell D.F. (1992) Mapping of Type VII Collagen Epitopes Recognized by

Autoantibodies from Patients with Epidermolysis Bullosa Acquisita and Bullous SLE.
Proceedings of the American Academy of Dermatology, San Francisco.

6. Jones DA, Murrell DF, Prisayanh P, Briggaman RA & Gammon WR: Type VII Collagen
Autoantibodies Recognize Two Distinct Epitopes Within the Non-Collagenous (NC1)
Domain. J Invest Dermatol 100:531, 1993.

7. Murrell DF: Systemic Amyloidosis Presenting as Nail Dystrophy. Proceedings of the

American Academy of Dermatology, Washington, 1993.

8. Murrell DF & Cowin P (1994): The Desmosomal Plaque Protein, Band 6, Exhibits
Strong Homophilic Binding and Weaker Binding to the Pemphigus Foliaceus Antigen,
Desmoglein I. J Invest Dermatol 102:563, 1994.

9. Murrell GAC, Dolan MM, Murrell DF, Warren RF & Hannafin JA (1994): Nitric Oxide
in Skeletal Muscle: Proceedings of the 4th Annual Symposium on Nitric Oxide,
Washington, DC.

10. Murrell DF & Cowin P: Distribution of Desmosomal Band 6 Protein. Proceedings of the
American Academy of Dermatology, New Orleans, 1995.

11. Murrell DF & Cowin P (1995): Distribution and Interactions of Junctional Band 6
Protein. Immunol Cell Biol 73:A19.

12. Chiritescu ME, Hakimian J, Brauner G, Varghese M & Murrell DF: A Kindred of
Epidermolysis Bullosa Simplex Patients with Dysplastic Epidermal Changes. Proceedings
of the 54th Annual American Academy of Dermatology, Washington, 1996.

13. Hakimian J, Koransky J, Murrell DF: Childhood Epidermolysis Bullosa Acquisita.

Proceedings of the 54th Annual American Academy of Dermatology, Washington, 1996.

14. Murrell DF: Band 6 Protein is localised in desmosomes and adherens junctions in the skin

48
 and extracutaneous tissues. Proceedings of the 17th Annual Australian
Dermatopathology Society, Sydney 1996.

15. Detwiler S, Chiritescu M-E, Forbes M, Leung D, Resnick S and Murrell DF: A
Randomized Double-Blind Placebo-Controlled Trial of Dermaffin in the Treatment of
Chronic Plaque Psoriasis.19th World Congress of Dermatology. Australas J Dermatol
1997.

16. Wang M-X, Murrell DF, Murrell GAC: Nitric Oxide in Skeletal Muscle. Third
International Conference on the Biochemistry and Molecular Biology of Nitric Oxide.
UCLA, 1998. Nitric Oxide. 2(2):135, 1998.

17. MacKenzie-Wood A, Kirkham B, Hart K, Murrell DF: Second Reported Case of Bullous
Pemphigoid-like Eruption Induced by D-Penicillamine. Proceedings of the 57th Annual
American Academy of Dermatology, New Orleans, 1999.

18. Wang M-X, Murrell DF, Murrell GAC: Nitric Oxide in Skeletal Muscle. Proceedings of
the Fifth International Olympic Committee World Congress on Sport Sciences. Sydney,
October 1999.

19. Diwan D, Kruller A, Wei A-Q, Murrell D. Characterization of the Protein Defect in
Inherited Epidermolysis Bullosa by Immunofluorescence Mapping. Australas J Dermatol
May 1999.

20. Nakano A, Pulkkinen L, Murrell D, Rico J, Lucky A, Robertson S, Pfender E, Uitto J:

Novel ITGB4 Mutations in Junctional Epidermolysis Bullosa with Pyloric Atresia:
Genotype/Phenotype Correlations. Poster, 61st Society for Investigative Dermatology,
Chicago, IL May 2000. J. Invest Dermatol 114:869, 2000.

21. Chao SS, Pulkkinen L, Klausegger A, Nakano A, Pfender E, Bauer J, Murrell D, Sybert
V, Hintner H, Uitto J: Mutations in Any of the Three Laminin 5 Subunit Genes (LAMA3,
LAMB3 and LAMC2) Can Result in Non-Herlitz Junctional Epidermolysis Bullosa
Phenotype. Oral Presentation, 61st Society for Investigative Dermatology, Chicago, USA,
May 2000; J Invest Dermatol 114:785, 2000.

22. See A, Cherian M, Murrell DF: Cutaneous Aspergillosis. Australas J Dermatol 41: A17
2000.

23. Fang ZM, Lee CS, Murrell DF, Kearsley JH, Lavin MF, Clarke RA: Regulation of Ataxia
Telangiectasia Mutant (ATM) Induction. St George Hospital Clinical School Annual
Symposium; winner of Best Basic Science Poster Award 2000.

24. Colinet H, Murrell DF: Incidence of Latex Allergy at a Sydney Hospital. Proceedings of
the Am Acad Dermatol 2001.

25. Cummins R, Klingberg S, Wesley J, Rogers M, Murrell D: Koebner Variant of

49
 Epidermolysis Bullosa due to a novel keratin 14 mutation: M119V. Australas J Dermatol
42: A18 2001

26. Foley P, Freeman M, Vinciullo C, Spelman S, Murrell D, Weightman W, Anderson C,

Reid C, Watson A, Fergin P: A Randomized Study Comparing Photodynamic Therapy
(PDT) Using Metvix or Placebo Cream to Cryotherapy in Actinic Keratosis (AK).
Australas J Dermatol 42: A22 2001

27. Marks R, Shumack S & Australasian Multicentre Trial Group: Efficacy of Imiquimod
5% Cream for the Treatment of Superficial & Nodular BCC’s. Australas J Dermatol 42:
A22 2001

28. See A, Shumack, Murrell D: Chinese Herbs & “Spices” – the Secret Recipe for the
Treatment of Skin Diseases? Australas J Dermatol 42: A28 2001

29. Foley P, Freeman M, Vinciullo C, Spelman S, Murrell D, Weightman W, Anderson C,

Reid C, Watson A, Fergin P: A Comparison of Photodynamic Therapy using Metvix with
Cryotherapy in Actinic Keratosis. Proceedings of the European Academy of
DermatoVenereology, Munich, Oct 2001.

30. Klingberg S, Lloyd L, Murrell D, Zhao Y, Clague A: Epidermolysis Bullosa Simplex

Mutation analyis: the Australian Experience. Clin Biochemist Rev 23:80, 2001. (Winner of
best oral research presentation at 39 th Clinical Biochemists Annual Scientific Conference,
Auckland, NZ, October 2001. (Awarded prize for best research presentation).

31. Murrell D, Leonard T, Delamere F, Williams H: Evidence-Based Dermatology and the

Cochrane Skin Group. Australas J Dermatol 43:A24, 2002.

32. Colinet H, Barrett A, Murrell D: Prevalence of Latex Allergy in Health Care Workers.
Australas J Dermatol 43:A31, 2002.

33. Zhao Y, Klingberg S, Wesley J, Wang Y, Lloyd L, Murrell G, Murrell DF: A novel
mutation causing EB simplex Weber-Cockayne: K14 M272T. Proceedings of the 20 th
World Congress of Dermatology, Paris, July 2002 (IC0227).

34. Thai, K.E., Fergin, P., Freeman, M., Vinciullo, C., Francis, D., Spelman, L., Murrell, D.,
Anderson, C., Weightman, W., Reid, C., Watson, A., Foley, P.A prospective study of the
use of cryosurgery for the treatment of actinic keratoses. Proceedings of the 20 th World
Congress of Dermatology, Paris, July 2002 (IC 0890).

35. Kemp MW, Klingberg S, Lloyd L, Marr P, Vonthethoff L, Wang Y, Murrell GAC &
Murrell DF: A Novel deletion mutation in Keratin 5 causing the removal of 5 amino acids
from the highly conserved 2B domain in Weber-Cockayne EB Simplex. The Australasian
Hair and Wool Research Society, Cutaneous Biology and Endocrinology Workshop,
Melbourne, Nov 2002 (oral and poster) .. Winner of Best Poster Prize at meeting. Exp
Dermatol 12:226-7, 2003.

50
36. Foley P, Freeman M, Viniullo C, Spelman L, Murrell D, Weightman W, Anderson C, Reid
C, Watson A, Fergin P: A Comparison of Photodynamic Therapy using Methyl
Aminolevulinate with Cryotherapy in Actinic Keratosis. Proceedings of Poster Abstracts,
American Academy of Dermatology, 2003.

37. Foley P, Freeman M, Viniullo C, Spelman L, Murrell D, Weightman W, Anderson C, Reid

C, Watson A, Fergin P: A Comparison of Photodynamic Therapy using Methyl
Aminolevulinate with Cryotherapy in Actinic Keratosis (Abstracts of posters at Br Asso
ciation of Dermatologists Meeting). Br J Dermatol 149 Suppl 64:46, 2003.

38. P. Foley, M. Freeman, G. Siller, K. Gebauer, D. Murrell, R. Barnetson, C. Anderson, S.

Kossard. A phase III randomized study comparing photodynamic therapy (PDT) using
Metvix or placebo cream in nodular basal cell carcinoma. Australas J Dermatol 44:A5,
2003.

39. M.W. Kemp, S. Klingberg, L.Lloyd, P.Marr, L.Vonthethoff, Y. Wang, G.A.C. Murrell
and.D.F. Murrell: A novel 15 basepair deletion mutation in keratin 5 causes the removal
of 5 amino acids from the highly conserved 2B rod domain in Weber-Cockayne
epidermolysis bullosa simplex. J Invest Dermatol 121: A587, 2003.

40. Trisnowati, N, Klingberg S, Lloyd L, Wang Y, Murrell GAC , Murrell DF: Combined
Mutations in Keratin 5 and Keratin 14 Genes Causing Epidermolysis Bullosa Simplex-
Dowling Meara. J Invest Dermatol 121:A1278, 2003.

41. Griffiths C, Dubertret L, Gottlieb AB, Ho V, Murrell D, Ortonne J-P, Todd G, Marks I,
Cherill R, Paul C, Emady-Azar S and the Multi-Center Investigator Group: Treatment
with Oral Pimecrolimus significantly improves psoriasis with a clear dose-response effect.
J Invest Dermatol 121: A391, 2003.

42. P. Foley, M. Freeman, G. Siller, K. Gebauer, D. Murrell, R. Barnetson, C. Anderson, S.

Kossard. A phase III randomized study comparing photodynamic therapy (PDT) using
Metvix or placebo cream in nodular basal cell carcinoma. JEADV 17 (Suppl 3) P9-14,
231 , 2003.

43. Griffiths C, Dubertret L, Gottlieb AB, Ho V, Murrell D, Ortonne J-P, Todd G, Marks L,
Paul C, Cherill PR and the Multi-Center Investigator Group:. Treatment with Oral
Pimecrolimus significantly improves psoriasis with a clear dose-response effect. JEADV 17
(Suppl 3) P27-82, 383 ,2003.

44. Wolff K, Caro I, Murrell D, Ortonne J-P and the Multi-Center Investigator Group: Safety
profile of oral pimecrolimus in atopic eczema and psoriasis: A pooled analysis from two
dose-finding studies. J Invest Dermatol 121:A1245, 2003.

45. M.T. Kloos, E. Crocker, C. Haisley-Royster, C.L. Hunter, T.P. Leedom, N.C. Nevin, S.J.
Orlow, N. Prose, S.A. Simpson, G.H. Vance, D.F. Murrell, D.A. Marchuk. Molecular

51
 analysis of the glomulin gene in glomulovenous malformation families.American Society
of Human Genetics 2003.

45. Murrell D: Prenatal Diagnosis of EB in Australia. Clinical Management of Children and

Adults with Epidermolysis Bullosa. Proceedings of a Multidisciplinary International
Symposium. Debra (UK) 2004, p30.

46. Murrell D: Eyelid granulomas in late onset Herlitz Junctional EB. Clinical Management of
Children and Adults with Epidermolysis Bullosa. Proceedings of a Multidisciplinary
International Symposium. Debra (UK) 2004, p58.

47. Murrell DF: Genotype-Phenotype Correlations in Epidermolysis Bullosa. Proceedings of

63rd Annual American Academy of Dermatology, http://www.aad.org/aad/abstractsum.htm

48. Murrell DF, Turner A, Moran K, Pfendner E, Uitto J, Lloyd L, Klingberg S: Prenatal
Diagnosis of Epidermolysis Bullosa in Australia. Australas J Dermatol 45:
A15- 16, 2004.

49. Martin L, Lawrence R, Murrell DF. Tropical Mycoses: Treatment Options for
Chromoblastomycosis. Australasian Journal of Dermatology 46 (Suppl2): A39, 2005
Sept. (paper)

50. Martin L, Sturgess A, Murrell DF: Heterozygote for Fabry’s disease presents with hand
ischaemia and painful acroparaesthesia. Aust College of Dermatologists (Plenary paper &
winner of F&E Bauer Award). Australas J Dermatol. 46:A17-18, 2005.
51. Boersma AM, Pas HH, Kloosterhuis G, Kemp MW, Kossard S, Martin L, Murrell DF &
Jonkman MF: Preparation of dermal and epidermal extracts for the detection of
autoimmune bullous disorders using an immunoblotting technique. Aust Soc Derm
Research (poster) J Invest Dermatol 125 (6) A12 2005 Dec.

52 Trisnowati N, Klingberg S, Lloyd L, Vonthethoff L, Marr P, Miyakis S, Wang Y, Murrell

GAC, Murrell DF: Novel combined mutations in keratin 5 and keratin 14 genes occurring
ina mother and daughter with different severities of epidermolysis bullosa simplex . Aust
Soc Derm Research (paper) J Invest Dermatol (in press).

53. Kemp MW, Klingberg S, Lloyd L, Molloy TJ, Wang Y, Murrell GAC, Murrell DF :
Elevated mutant keratin 5 mRNA expression in a novel deletion mutation in Dowling-
Meara epidermolysis bullosa simplex. Aust Soc Derm Research (paper) J Invest Dermatol
(in press)

54. Murrell DF, Hamill K, Pfendner E, Uitto J, Figuiera E, Crotty A, Moran K, Lloyd L,
Klingberg S & McLean WHI: Late Onset Herlitz Junctional Epidermolysis Bullosa
Mimicking Laryngo-Onycho-Cutaneous Syndrome Aust Soc Derm Research (poster). J
Invest Dermatol 125:A10, December 2005.

52
55. Foley P, Freeman M, Vincuillo C, Spelman L, Murrell D, Weightman W, Anderson C,
Reid C, Watson A & Fergin P: Photodynamic therapy using methyl aminolevulinate with
cryotherapy in actinic keratosis: An Australian Study. Bristol Cup Poster, British
Association of Dermatologists Annual Meeting, Glasgow, July 2005. Br J Dermatol
153(Suppl 1):29, 2005.

56. Murrell DF, Hamill K, Pfendner E, Uitto J, Figuiera E, Crotty A, Moran K, Lloyd L,
Klingberg S & McLean WHI: Is Laryngo-Onycho-Cutaneous Syndrome a form of
junctional epidermolysis bullosa? Oral paper, Australasian College of Dermatologists’
Spring Meeting, Cairns, Sept 2005. Australas J Dermatol 46 (Suppl 2): A32-A33, 2005.

57. Pasmooij AMC, Jonkman MF, Pas HH, Klingberg S, Pfendner E, Uitto J, Collins F,
Murrell DF: Dental abnormalities in heterozygous carriers of the COL17A1 823 del A
mutation in a family with non-Herlitz junctional EB. JEADV 19 Suppl 2, FC03.9, p. 12,
Nov 2005..

58. Hofman T & the Tacrolimus Ointment Study Group (DM no 5) Tacrolimus ointment
application does not affect the immediate response to vaccination, the generation of
immune memory, or humoral and cell-mediated immunity in children. JEADV 119 Suppl 2
no 1778, P17.41.

59. Martin L, Lindstrom S, Marjoniemi V, Murrell DF: Disseminated nocardiosis in an

immunosupppressed patient with pemphigus vulgaris. Paper. New Zealand Dermatological
Society Meeting. Waiheke Island, February 2-4, 2006,

60.. Rubin AI, Moran K, Fine J-D, Wargon O, Murrell DF: Urethral meatal stenosis in
Junctional Epidermolysis Bullosa: A rare complication effectively treated with a novel,
and surprisingly simple modality. Paper. New Zealand Dermatological Society Meeting.
Waiheke Island, February 2-4, 2006,

61. Martin L, Hrepka P, Murrell DF: An observational study of Mepilex dressings in

Epidermolysis Bullosa. Poster. Australian Wound Management Conference. Canberra,
March 15-17th, 2006.

62. Murrell DF, Klingberg S, Dang NN, Turner A, Marr P, Tran K, Ozoemena L, Liu
L, McGrath JA, Wessagowit V: Herlitz and non-Herlitz junctional epidermolysis
bullosa resulting from different types of mutation in the LAMC2 gene.
Paper. Australasian College of Dermatologists Annual Meeting,
Melbourne, May 14-17, 2006. Australas J Dermatol. 47 (Suppl 1) A23, May 2006.

63. Murrell DF on behalf of the Tacrolimus Ointment Study Group. Tacrolimus ointment
does not affect the immediate response to vaccination, the generation of immune memory,
or humoral and cell-mediated immunity in children. Poster. Australasian College of
Dermatologists Annual Meeting, Melbourne, May 14-17, 2006. Australas J Dermatol.47
(Suppl 1) 2006 May.

53
64. Martin L, Hrepka P, Murrell DF: An observational study of Mepilex dressings in
Epidermolysis Bullosa. Poster. Australasian College of Dermatologists Annual Meeting,
Melbourne, May 14-17, 2006. Australas J Dermatol. 47(Suppl1): A46 2006 May .
(poster)

65. Martin L, Murrell DF: Measuring the Immeasurable: A Systematic Review of Outcome
Measures in Pemphigus. Paper. Australasian College of Dermatologists Annual Meeting,
Melbourne, May 14-17, 2006. Australas J Dermatol. 47(Suppl1): A32-33 2006 May
(paper).

66. Martin LK, Sachdev R, Murrell DF: Two cases of Bannayan-Riley-Ruvalcaba syndrome
overlapping with Cowden syndrome and Klippel-Trenaunay-Weber and their relationship
to PTEN mutations. Paper. Australasian College of Dermatologists Annual Meeting,
Melbourne, May 14-17, 2006. Australas J Dermatol. 47(Suppl1): A13-14 2006 May
(paper)

67. Yiasemides E, Rubin AI, Murrell DF: A novel way of determining the cause of drug
reactions using a proforma chart. Paper. Australasian College of Dermatologists Annual
Meeting, Melbourne, May 14-17, 2006. Australas J Dermatol. 47(Suppl 1) 2006 May..

68. Rubin AI, Moran K, Fine J-D, Wargon O, Murrell DF: Urethral meatal stenosis in
Junctional Epidermolysis Bullosa: A rare complication effectively treated with a novel,
and surprisingly simple modality. Poster. Australasian College of Dermatologists Annual
Meeting, Melbourne, May 14-17, 2006. Australas J Dermatol. 47 (Suppl 1) 2006 May
(poster).

69. Murrell DF ,Hamill K, Pfendner E, Uitto J, Figueira E, Crotty , A, Moran K, Lloyd L

Klingberg S, McLean WHI. Combined mutations in LAMA3 isoforms causing Herlitz
junctional epidermolysis bullosa with features of laryngo-onycho-cutaneous syndrome.
Poster. Australasian College of Dermatologists Annual Meeting, Melbourne, May 14-17,
2006. Australas J Dermatol. 47 (Suppl 1) 2006 May (poster).

70. Pasmooij AMC, Jonkman MF, Pas HH, Klingberg S, Pfendner E, Uitto J, Collins F,
Murrell DF: Dental abnormalities in heterozygous carriers of the COL17A1 823 del A
mutation in a family with non-Herlitz junctional EB. Australas J Dermatol 47 (Suppl 1)
May :A48, 2006 (poster and oral presentation).

71. Weise-Riccardi S, Calvieri S, Ortonne J-P, Murrell DF, Ho VC, Emady-Azar S, Paul CF:
Randomized vehicle-controlled trial of pimecrolimus cream 1% in adult patients with mild
to moderate head and neck atopic dermatitis intolerant of, or dependent on topical
corticosteroids. Society for Investigative Dermatology, Philadelphia, PA, May 2006. J.
Invest Dermatol.

72. Murrell DF, Ho VC, Ortonne J-P, Paul CF, Weise-Riccardi S. Randomized vehicle-
controlled trial of pimecrolimus cream 1% in adult patients with mild to moderate head
and neck atopic dermatitis intolerant of, or dependent on topical corticosteroids. British

54
 Association of Dermatologists, Manchester, UK, 4-6 July 2006. Br J Dermatol (in press)

73. Yiasemides E, Walton J, Marr P, Villanueva E, Murrell DF: A comparative study of

transmission electron microscopy vs immunofluorescence mapping for the diagnosis of
epidermolysis bullosa. Australasian Society for Dermatopathology, Sydney, August 2006.
Brenan Prize recipient. Australas J Dermatol 47 (4): A59, 2006.

74. Martin L, Rubin A, Tran K, Pas HH, Marr P, Edmonds J, Murrell DF: A complicated
blistering disease case demonstrating the usefulness of immunoblotting and ELISA for the
diagnosis of immunobullous diseases. Shortlisted for Brenan prize, Australasian Society
for Dermatopathology, Sydney, August 2006. Australas J Dermatol. 47(4): A57, Nov
2006.

75. Martin L, Rubin AI, Theocarous C, Murrell DF: Factitial podophyllin reaction mimicking
Bowen’s disease histologically. Paper at Australasian Society for Dermatopathology,
Sydney, August 2006. Australas J Dermatol (in press).

76. Pasmooij AMC, Jonkman MF, Pas HH, Klingberg S, Pfendner E, Uitto J, Collins F,
Murrell DF: Homozygosity for an intragenic deletion in the gene encoding collagen
XVII, COL17A1: 823delA results in lethality in a family with non-Herlitz junctional
epidermolysis bullosa. European Society for Dermatological Research, Paris, Sept 2006
(poster). J Invest Dermatol 126: S38, Poster 212.

77. Murrell DF: Recent advances in Molecular Biology of Blistering Diseases. Opening
Plenary Speaker, ASEAN Regional Dermatology Meeting, Bali, Symposium Proceedings,
Sept 13 –17th , 2006.

78. Marr P, Dang NN, Tran K, Klingberg S, Collins F, Widmer R, Murrell DF: Reduction in
immunofluorescence mapping of the skin with antibodies 1D1 and 1A8C against BP 180
in asymptomatic heterozygous parents of deceased probands with an unknown form of
Epidermolysis Bullosa enables the diagnosis of non-Herlitz junctional EB due to an
intragenic deletion in COL17A1. Paper. ASEAN Regional Dermatology Meeting, Bali,
Symposium Proceedings, Sept 13th – 17th, 2006

79. Trisnowati N, Murrell DF: Case report of junctional epidermolysis bullosa with reduced
expression of integrins A6 and B4. Paper. ASEAN Regional Dermatology Meeting, Bali,
Symposium Proceedings, Sept 13-17th , 2006

80. Murrell DF, Klingberg S, Dang NN, Turner A1, Marr P, Tran K, Ozoemena L, Liu L,
McGrath JA, Wessagowit V: Herlitz and non-Herlitz junctional epidermolysis bullosa
resulting from different types of mutation in the LAMC2 gene. Paper (presented by Dr
Dang), Stradie Cell Biology Meeting, Stradbroke Island, Sept 22nd, 2006.

81. Murrell DF, Ho VC, Ortonne J-P, Paul CF, Weise-Riccardi S. Randomised vehicle-
controlled trial of pimecrolimus cram 1% in adult patients with mild to moderate head and
neck atopic dermatitis intolerant of, or depended on topical corticosteroids.) Poster, 15 th

55
 European Academy of Dermatology , Rhodes, Greece, Oct 3-7, 2006. JEADV (in press).

82. Murrell DF: Infectious Diseases in Aboriginal Australians. Paper, Tropical Dermatology,
15th European Academy of Dermatovenereology, Rhodes, Greece, Oct 3-7, 2006. JEADV
(in press).

83. Dang NN, Klingberg S, Rubin AI, Edwards M, Borelli S, Relic J, Marr P, Tran K, Turner
A, Murrell DF: Differential expression of pyloric atresia in junctional epidermolysis
bullosa with novel ITGB4 mutations. Poster, EB 2006 Invitation only meeting of
international investigators in EB, Dublin, Ireland, Oct 10-12th, 2006.

84. Yiasemides E, Walton J, Marr P, Villanueva E, Murrell DF: A comparative study of

transmission electron microscopy vs immunofluorescence mapping for the diagnosis of
epidermolysis bullosa. Poster EB 2006 Invitation only meeting of international
investigators in EB, Dublin, Ireland, Oct 10-12th, 2006.

85. Ostberg A, Kloos M, Moreno G, Su T, Trisnowati N, Marchuk D, Murrell DF: The

Genetics of Multiple Hereditary Glomangiomas. Poster, ST George Hospital Annual
Symposium, Nov 9th, 2006.

86. Dang NN, Klingberg S, Turner A1, Marr P, Tran K, Ozoemena L, Liu L, McGrath JA,
Wessagowit V, Murrell DF: Herlitz and non-Herlitz junctional epidermolysis bullosa
resulting from different types of mutation in the LAMC2 gene. Finalist for the Young
Investigator, Clinical Research, St George Hospital Annual Symposium, Nov 9th, 2006

87. Martin L, Mangos G, Freiman J, Cheung K, Farnsworth A, DeSousa P, Murrell DF:

Diffuse Hyperpigmentation and Melanuria from Metastatic Melanoma. American
Academy of Dermatology, Washington DC, Gross & Micro section.

88. Murrell DF: Genotype-Phenotype Correlations in Epidermolysis Bullosa. Proceedings of

the 65th Annual American Academy of Dermatology, Washington DC, Feb 1-5th, 2007.
Focus Session. www.aad.org/aad/abstractsum.htm.

89. Murrell DF: Desmosome gene disorders. Paper, Forum on Genetic Disorders of Skin
Integrity. Proceedings of the 65th Annual American Academy of Dermatology, Washington
DC, Feb 1-5th, 2007. Focus Session. www.aad.org/aad/abstractsum.htm.

90. Murrell DF: Desmosome Gene Disorders. Educational Sessions Handouts, 65th Annual
Meeting CD Rom. Omnipress. 2007 AAD

91. Murrell DF: Genotype to Phenotype Correlations in Epidermolysis Bullosa. Educational

Sessions Handouts, 65th Annual Meeting CD Rom. Omnipress. 2007 AAD.

92. Murrell DF, Pasmooij AMG, Pas HH, Klingberg S, Marr P, Pfendner E, Uitto J,
Sadowski S, Collins F, Widmer R, Jonkman MF: Retrospective diagnosis of BP-180
deficient non-Herlitz junctional epidermolysis bullosa suggested by IF antigen mapping of

56
 carriers bearing enamel defects. Poster, Society for Investigative Dermatology, Los
Angeles, May 2007. J Invest Dermatol 127 Suppl S510, April 2007.

93. Dang N, Klingberg S, Rubin AI, Edwards M, Borelli S, Relic J, Marr P, Tran K, Turner A,
Smith N, Murrell DF: Differential expression of pyloric atresia in junctional epidermolysis
bullosa with novel ITGB4 mutations. Poster, Society for Investigative Dermatology, Los
Angeles, May 2007. J Invest Dermatol 127 Suppl S509, April 2007.

94. Yan FW, Klingberg S, Lloyd L, Trisnowati N, Turner A, Murrell DF: Novel and recurrent
mutations in KRT5 and KRT14 in epidermolysis bullosa simplex in Australasia. Poster,
Society for Investigative Dermatology, Los Angeles, May 2007. J Invest Dermatol 127
Suppl S511, April 2007.

95. Hamill K, Uitto J, Figuiera E, Crotty A, Moran K, Lloyd L, Klingberg S, McLean WHI,
Murrell DF: Novel N-terminal mutation in LAMA3a isoform causing late-onset Herlitz
junctional epidermolysis bullosa with features of laryngo-onycho-cutaneous syndrome.
Poster, Society for Investigative Dermatology, Los Angeles, May 2007. J Invest Dermatol
127 Suppl S530, April 2007.

96. Murrell DF, Ho VC, Glendinning A, Paul CF: Randomized controlled trial comparing
pimecrolimus 1% cream and vehicle in patients with head and neck atopic dermatitis who
are intolerant of, or dependent on topical corticosteroids: Quality of life outcomes. Poster,
Society for Investigative Dermatology, Los Angeles, May 2007. J Invest Dermatol 127
Suppl S326, April 2007.

97. Martin LK, Yiasemides E, Trisnowati N, Su J, Dang N, Klingberg S, Marr P, Chow CW,
Orchard D, Varigos G, Murrell DF: A case of recessive Epidermolysis Bullosa Simplex
due to homozygous truncation mutation KRT14-Y204X with basal K6/16 expression.
Paper by LKM, Australasian Society for Dermatological Research, Adelaide, May 12 th
2007. J Invest Dermatol (in press).

98. Dang N, Klingberg S, Turner A, Murrell DF: Review of collagen VII mutations found in
Australian patients with dystrophic epidermolysis bullosa reveals 9 novel COL7A1
mutations. Paper presented by NND, Australasian Society for Dermatological Research,
Adelaide, May 12th 2007. J Invest Dermatol (in press).

99. Yan WF, Klingberg S, Lloyd L, Trisnowati N, Turner A, Murrell DF: Novel and recurrent
mutations in KRT5 and KRT14 in epidermolysis bullosa simplex in Australasia. Paper
presented by WFY, Australasian Society for Dermatological Research, Adelaide, May 12 th
2007. J Invest Dermatol (in press).

100. Martin LK, Yiasemides E, Trisnowati N, Su J, Dang N, Klingberg S, Marr P, Chow CW,
Orchard D, Varigos G, Murrell DF: A case of recessive Epidermolysis Bullosa Simplex
due to homozygous KRT14-Y204X mutation with keratin 6 and 16 expression. Paper by
LKM, Paediatric Dermatology Symposium, Australasian College of Dermatologists
Annual Meeting, Adelaide, May 13-16th, 2007. Australas J Dermatol 48 (Suppl 1) A19.

57
101. Dang N, Klingberg S, Rubin AI, Edwards M, Borelli S, Relic J, Marr P, Tran K, Turner A,
Smith N, Murrell DF: Differential expression of pyloric atresia in junctional epidermolysis
bullosa with novel ITGB4 mutations. Paper presented by NND, Paediatric Dermatology
Symposium, Australasian College of Dermatologists Annual Meeting, Adelaide, May 13-
16th, 2007. Australas J Dermatol 48 (Suppl 1) A20.

102. Dang N, Klingberg S, Turner A, Murrell DF: Review of collagen VII mutations found in
Australian patients with dystrophic epidermolysis bullosa reveals 9 novel COL7A1
mutations. Poster, Australasian College of Dermatologists Annual Meeting, Adelaide, May
13-16th, 2007. Australas J Dermatol 48 (Suppl 1) A37.

103. Agero AL, Martin L, Freckmann M-L, Murrell DF: Naevus of Ota presenting in two
generations- a mother and daughter. Poster, Australasian College of Dermatologists
Annual Meeting, Adelaide, May 13-16th, 2007. Australas J Dermatol 48 (Suppl 1) A39.

104. Frew J, Martin L, Murrell DF: Quality of life evaluation in epidermolysis bullosa. Poster,
Australasian College of Dermatologists Annual Meeting, Adelaide, May 13-16th, 2007.
Australas J Dermatol 48 (Suppl 1) A49.

105. Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N, Sullivan J,
Baker C, Paul CF: Pimecrolimus 1% cream but not vehicle cream significantly improved
skin atrophy in adults with head and neck atopic dermatitis who were intolerant of or
dependent on topical corticosteroids. Poster, Australasian College of Dermatologists
Annual Meeting, Adelaide, May 13-16th, 2007. Australas J Dermatol 48 (Suppl 1) A60.

106. Yan WF, Klingberg S, Lloyd L, Trisnowati N, Turner A, Murrell DF: Novel and recurrent
mutations in KRT5 and KRT14 in epidermolysis bullosa simplex in Australasia. Poster,
Australasian College of Dermatologists Annual Meeting, Adelaide, May 13-16th, 2007.
Australas J Dermatol 48 (Suppl 1) A64.

107. Martin LK, Murrell DF: Measuring the immeasurable: a systematic review of outcome
measures in pemphigus. Paper presented by DFM, Autoimmune Bullous Diseases
Symposium, FC5.1 Abst 318, European Academy of Dermatovenereology, Vienna, May
16-20th, 2007. JEADV (in press).

108. Dang N, Klingberg S, Rubin AI, Edwards M, Borelli S, Relic J, Marr P, Tran K, Turner A,
Smith N, Murrell DF: Differential expression of pyloric atresia in junctional epidermolysis
bullosa with novel ITGB4 mutations. Paper presented by DFM, Genetic Diseases
Symposium, FC8.1 Abst 1146, European Academy of Dermatovenereology, Vienna, May
16-20th, 2007. JEADV (in press).

109. Murrell DF, Hamill K, Uitto J, Figuiera E, Crotty A, Moran K, Lloyd L, Klingberg S,
McLean WHI: Novel N-terminal mutation in LAMA3a isoform causing late-onset Herlitz
junctional epidermolysis bullosa with features of laryngo-onycho-cutaneous syndrome.
Paper presented by DFM, Genetic Diseases Symposium, FC8.3 Abst 1155, European

58
 Academy of Dermatovenereology, Vienna, May 16-20th, 2007. JEADV (in press).

110. Murrell DF, Calvieri S, Ortonne J-P, Ho VC, Weisse-Riccardi S, Glendinning A, Paul CF:
Quality of life outcomes in a randomized controlled trial of pimecrolimus cream 1% in
patients with head and neck atopic dermatitis who are intolerant of, or dependent on
topical corticosteroids. Poster 59, European Academy of Dermatovenereology, Vienna,
May 16-20th, 2007. JEADV (in press).

111.. Szeimes RM, Ibbotson S, Murrell DF, Rubel R, Zillikens D, Villemagne H,

Kerrouche N: RCT of 5 methyl aminolevulinate-Photodynamic therapy (MAL-PDT)
versus simple excision surgery for Superficial Basal Cell Carcinoma. European Academy
of Dermatology, Vienna 2007 (Poster). JEADV (in press). Selected for oral presentation in
the Hot Topics at the Posters Symposium.

112. Murrell DF, Dang NN, Klingberg S, Turner A, Marr P, Tran K, Ozoemana L, Liu
L, Mc Grath JA, Wessagowit V. Splice site mutations in LAMC2 resulting in
lethal or non-lethal forms of junctional EB. (Paper by DM in Genodermatoses session) CD
of abstract proceedings of 21st World Congress of Dermatology, Buenos Aires,
Argentina.

113. Agero AL, Martin LK, Tran K, Marjoniemi V, Lynch J, Kossard S, Murrell DF:
Diverse presentations of carcinoma erysipelatoides. (Paper presented by fellow Dr
Agero) CD of abstract proceedings of 21st World Congress of Dermatology,
Buenos Aires, Argentina.

114. Agero AL, Lahmar JJ, Holzborn R, Martin LK, Freckmann ML, Murrell DF: Rare
presentations of naevus of Ota in two generations. (Paper presented by fellow Dr
Agero) CD of abstract proceedings of 21st World Congress of Dermatology, Buenos
Aires, Argentina.

115, Agero AL, Kho Y, Rhodes LM, Varigos G, Su J, Orchard D, Murrell DF: The
Australasian EB Registry. (Paper presented by fellow Dr Agero) CD of abstract
proceedings of 21st World Congress of Dermatology, Buenos Aires, Argentina.
116. Martin LK, Murrell DF: Measuring the Immeasurable: a systematic
review of outcome measures in pemphigus. (Paper by fellow Dr Martin in
bullous session) , ILDS CD of abstract proceedings of 21st World
Congress of Dermatology, Buenos Aires, Argentina.
117. Martin LK, Agero AL, Rhodes L, Wittal R, Murrell DF, Le Guay J: A
randomized controlled trial of autologous melanocyte transplantation with
Recell vs minigrafting in chronic stable vitiligo. (Paper by fellow Dr
Martin in pigmentary disorders session) , ILDS CD of abstract
proceedings of 21st World Congress of Dermatology, Buenos Aires,
Argentina.
118. Murrell DF: How to establish a clinical trials centre. Paper in

59
 Miscellaneous Interactive Session. ILDS CD of abstract proceedings of
st
21 World Congress of Dermatology, Buenos Aires, Argentina.
119. Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N,
Paul CF: Pimecrolimus 1% cream but not vehicle cream significantly
improved skin atrophy in adults with head and neck atopic dermatitis who
were intolerant of or dependant on topical corticosteroids. Paper by DM
in Atopic Dermatitis Session. ILDS CD of abstract proceedings of 21st
World Congress of Dermatology, Buenos Aires, Argentina.
120. Murrell DF: Use of pharmacoeconomics in Oceania. Invited paper,
Pharmacoeconomics Session. ILDS CD of abstract proceedings of 21st
World Congress of Dermatology, Buenos Aires, Argentina.
121. Murrell DF: How to establish a multi-disciplinary clinic for Epidermolysis
Bullosa. Paper, Pediatric and neonatal dermatology, International League
of Dermatological Societies CD of abstract proceedings of 21st World
Congress of Dermatology, Buenos Aires, Argentina.
122. Murrell DF: Skin diseases of Aboriginal Australians. Invited paper,
Endemic Diseases. Satellite meeting, Sheraton Hotel, 21st World Congress
of Dermatology, Buenos Aires, Argentina.
123. Dang NN, Klingberg S, Turner A, Marr P, Murrell DF. Review of
Collagen VII mutations found in Australian patients with dystrophic
epidermolysis bullosa reveals 9 novel COL7A1 mutations Paper presented
by DM, Bullous session, International League of Dermatological Societies
CD of abstract proceedings of 21st World Congress of Dermatology,
Buenos Aires, Argentina.
124. Dang NN, Klingberg S, Rubin AI, Edwards M, Borelli S, Relic J, Marr P,
Tran K, Turner A, Smith N, Murrell DF. Novel ITGB4 mutations in
patients with junctional epidermolysis bullosa and differential expression
of pyloric atresia. Paper presented by DM, Genodermatoses session, CD of
abstract proceedings of 21st World Congress of Dermatology, Buenos
Aires, Argentina.
126. Yan WF, Klingberg S, Lloyd L, Trisnowati N, Turner A, Murrell DF:
Novel and recurrent mutations in keratins 5 and 14 in Australasian patients
with epidermolysis bullosa simplex. Paper presented by DM,
Genodermatoses session, CD of abstract proceedings of 21st World
Congress of Dermatology, Buenos Aires, Argentina.

127. Agero AL, Rhodes LM, Murrell DF: The Australasian EB Registry. Poster, American
Academy of Dermatology, San Antonio, Texas, 2008.

128. Frew JW, Martin LK, Murrell DF: Development of the Quality of Life Questionnaire for
Epidermolysis Bullosa. Poster 1307, American Academy of Dermatology, San Antonio,

60
 Texas, 2008; JAAD Suppl Feb 2008 AB81.

129. Shipman AR, Agero ALC, Cook I, Scolyer RA, Craig P, Pas HH, Wojnarowska F,
Murrell DF: Epidermolysis Bullosa Acquisita Requiring Multiple Oesophageal
Dilatations.Poster, American Academy of Dermatology, San Antonio, Texas, 2008. JAAD
Suppl Feb 2008.

130. Venugopal S, Chee SN, Frew JW, Martin LK, Rhodes LM, Murrell DF: Using the
Autoimmune Bullous Skin Disorder Index Score and the Pemphigus Disease Activity
Index and Pemphigus Severity Score in Clinical Practice. Proceedings of International
Meeting on Autoimmune Bullous Diseases. Otsu, Shiga, Japan, May 17-19, 2008, p.49.

131. Werth VP, Troxel A, Bystryn J-C, Hall R, Korman N, Pandya A, Payne AS, Rosenbach M,
Rubenstein D, Woodley D, Murrell DF: Comparison of reliability and validity between
two outcome instruments for pemphigus. Proceedings of International Meeting on
Autoimmune Bullous Diseases. Otsu, Shiga, Japan, May 17-19, 2008, p.39.

132. Yan W, Kho Y, Frew JW, Dang N, Marr PJ, Melbourne W, Tran K, South AP, Murrell
DF: Reactivity of LH7-2 and FNC1 antibodies against collagen VII does not predict the
development of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. J
Invest Dermatol 128 (Suppl 1): S27 Abstract 160, 2008.

133. Rosenbach M, Murrell DF, Taylor L, Troxel A and Werth VP. Comparison of reliability
and validity between two outcome instruments for pemphigus. . J Invest Dermatol 128
(Suppl 1): S75 Abstract 449, 2008.

134. Frew JW, Martin LK, Murrell DF: Development of a quality of life instrument for
epidermolysis bullosa. (oral presentation by DM at International Investigative
Dermatology Meeting, Kyoto). . J Invest Dermatol 128 (Suppl 1): S75 Abstract 449,
2008.

135. Kho YC, Robertson S, Robertson I, Agero ALC, Rhodes LM, Varigos G, Su J, Orchard
D, Murrell DF: Clinical outcomes of Herlitz junctional epidermolysis bullosa infants:
Findings from the Australasian epidermolysis bullosa registry. Proceedings of the
Australasian Society for Dermatology Research 5th Annual Scientific Meeting. Sydney,
21-22 May 2008. L23 (paper).

136. Frew JW, Martin LK, Murrell DF: Quality of life evaluation in epidermolysis bullosa:
Development and results of the QOLEB questionnaire. Proceedings of the Australasian
Society for Dermatology Research 5th Annual Scientific Meeting. Sydney, 21-22 May
2008. , L24 (paper).

137. Chee SN, Martin LK, Murrell DF: The development of a quality of life instrument
specific for pemphigus. Proceedings of the Australasian Society for Dermatology
Research 5th Annual Scientific Meeting. Sydney, 21-22 May 2008. L25 (paper).

61
138. Venugopal S, Martin LK, Wittal R, Rhodes L, Agero AL, Murrell DF, Le Guay J: A
randomized controlled trial of autologous melanocyte transplanting with recell vs
minigrafting in chronic stable vitiligo. Proceedings of the Australasian Society for
Dermatology Research 5th Annual Scientific Meeting. Sydney, 21-22 May 2008. Paper,
L30 (paper).

139. Lim SW, Su J, Orchard D, Varigos D, Sawamura D, Nishie W, Shimizu H, Murrell DF:
Transient dermolysis of the newborn – 2 novel amino acid substitutions in COL7A1.
Australas J Dermatol 49 (Suppl 1): A4, 2008. (Paper).

140. Chee SN, Martin LK, Murrell DF: The development of a specific quality of life score for
patients with pemphigus. Australas J Dermatol 49 (Suppl 1): A42, 2008. (Poster)

141. Chee SN, Rhodes LM, Murrell DF: A comparison of dermatology life quality index
(DLQI) scores in a dermatology practice setting. Australas J Dermatol 49 (Suppl 1):
A43, 2008. (Poster).

142. Choi SD, Kho YC, Rhodes LM, Chapman MG, Murrell DF: Outcomes of 10
pregnancies in 3 patients with recessive forms of epidermolysis bullosa. Australas J
Dermatol 49 (Suppl 1): A44, 2008. (Poster).

143. Choi SD, Shipman AR, Kho YC, Rhodes LM, Chapman MG, Murrell DF. Retrospective
evidence on outcomes and experiences of pregnancy and childbirth in Australia. .
Australas J Dermatol 49 (Suppl 1): A44, 2008. (Poster).

144. Frew J, Martin L, Murrell DF: Quality of life evaluation in epidermolysis bullosa:
Development of the QOLEB questionnaire. Australas J Dermatol 49 (Suppl 1): A48,
2008. (Poster).

145. Kho YC, Agero ALC, Rhodes LM, Varigos G, Su J, Orchard D, Murrell DF:
Demographic data from the Australasian epidermolysis bullosa registry. Australas J
Dermatol 49 (Suppl 1): A55, 2008. (Poster).

146. Kho YC, Robertson S, Agero ALC, Rhodes LM, Varigos G, Su J, Murrell DF: Clinical
outcomes of Herlitz junctional epidermolysis bullosa infants: Findings from the
Australasian epidermolysis bullosa registry. Australas J Dermatol 49 (Suppl 1): A56,
2008. (Poster).

147. Venugopal S, Yiasemides E, Rubin AI, Murrell DF: Graphical drug charts: an aid in
identifying the cause of cutaneous drug reactions. Australas J Dermatol 49 (Suppl 1):
A67, 2008. (Poster).

148. Kho YC, Agero ALC, Rhodes LM, Holley S, Murrell DF: Wound data from the
Australasian Epidermolysis Bullosa Registry. Proceedings of the 7th National Conference
of the Australian Wound Management Association. (Paper). p.42., 7-10th May 2008,
Darwin.

62
149. Kho YC, Agero ALC, Rhodes LM, Murrell DF: Epidemiology of Epidermolysis bullosa
in Australia: Findings from the Australasian Epidermolysis Bullosa Registry.(Paper)
Proceedings of the 1st Australasian Wound and Tissue Repair Society Conference, 6-7th
May, 2008, Darwin.

150. Venugopal S, Martin LK, Mangos G, Freiman J, Cheung K, Farnsworth A, De Souza P,

Murrell DF: A Study of rare presentations of metastatic melanoma. Brenan Prize
Presentations. Aust Soc Dermatopathology Meeting, Melbourne, Aug 1st, 2008.

151. Nading MA (Awarded Sarkany Scholarship by EADV to attend and present this paper),
Lahmar JJ, Frew JW, Kemble-Welch A, Murrell DF: How to organize and run a winter
sports camp for teenagers with Epidermolysis Bullosa. Selected for Junior Session (9/106
submissions), European Academy of Dermatovenereology Meeting, Paris, Sept 2008.

152. Venugopal S, Martin LK, Wittal R, Rhodes LM, Agero AL, Le Guay J, Murrell DF: A
randomized controlled trial of autologous melanocyte transplanting with recell vs
minigrafting in chronic stable vitiligo. Selected for Junior Session (9/106 submissions),
European Academy of Dermatovenereology Meeting, Paris, Sept 2008.

153. Choi SD, Kho YC, Rhodes LM, Chapman MG, Murrell DF: Outcomes of 10
pregnancies in 3 patients with recessive forms of epidermolysis bullosa. American
Academy of Dermatology, San Francisco 2009 (Poster). J. Am Acad Dermatol (in press).

154. Kho YC, Agero ALC, Rhodes LM, Varigos G, Su J, Orchard D, Murrell DF: The
Australasian Epidermolysis Bullosa Registry. American Academy of Dermatology, San
Francisco 2009 (Selected for Poster Discussion ). J. Am Acad Dermatol (in press).
155, Chee SN, Rhodes LM, Murrell DF: A comparison of dermatology life quality index
(DLQI) scores in a dermatology practice setting. American Academy of Dermatology, San
Francisco 2009 (Poster). J. Am Acad Dermatol (in press).
156. Vestergaard ME, Kossard S, Murrell DF: Seborrheic keratoses appearing in sites of
previous psoriasis plaques during responsive treatment with efalizumab. American
Academy of Dermatology, San Francisco 2009 (Poster). J. Am Acad Dermatol (in press).

157. Frew JW, Lahmar JJ, Nading MA, Kemble-Welch A, Murrell DF: How to organize a ski
and adventure camp for young patients with Epidermolysis Bullosa American Academy of
Dermatology, San Francisco 2009 (Selected for Poster Discussion ). J. Am Acad
Dermatol (in press).

158. Intong LR, Choi D, Kho YC, Shipman AR, Rhodes LM, Chapman M, Murrell DF:
Retrospective Evidence of Outcomes of Pregnancy and Childbirth in Epidermolysis
Bullosa in Australia. American Academy of Dermatology, San Francisco 2009 (Poster). J.
Am Acad Dermatol (in press).

159. Intong LR, Green J, Sinclair R, Kossard S, Murrell DF: Unusual frontal variant of loose
anagen syndrome. American Academy of Dermatology, San Francisco 2009. Paper, Gross

63
 and Microscopic Symposium.

160. Sebaratnam DS, Chee SN, Venugopal SS, Rhodes LM, Welsh B & Murrell. DF Advances
in the clinical assessment of autoimmune bullous disease: the development of the
Autoimmune Bullous Disease Quality of Life questionnaire [oral presentation].
Australasian Society for Dermatology Research 6th Annual Scientific Meeting, Surfer’s
Paradise, Queensland, Australia. May 20, 2009

161. Frew JW, Martin LK, Nijsten T, Murrell DF: Development of a quality of life scale
specific for EB. Maria Duran Symposium, Int’l Congress of Dermatology, Prague.

162. Sebaratnam DS, Venugopal SS, Murrell DF. Diffuse melanosis cutis: a systematic review
[oral presentation]. Australasian Dermatopathology Society 30th Annual Conference.
Heritage, New Zealand. August 22, 2009

163. Kopecki Z, Arkell R, Ludwig R, Zillikens D, Murrell DF and Cowin A.J:

Cytoskeletal protein Flightless I affects Cellular Adhesion and Blister Formation in
Epidermolysis Bullosa. Plenary session II. ESDR Abstract 470, J Inv Dermatol 129: S79,
2009.

164. Halim I, Yan WF, King–Ismael D, Tran K, Melbourne W, Figueira EC, Chow CW, Lloyd L
Murrell DF A novel keratin 5 splice site mutation in a Filipino family resulting in
epidermolysis bullosa simplex associated with ankyloblepharon. Poster 278, ESDR
Budapest 2009; J Inv Dermatol 129: S47, 2009.

165. Yan WF, Venugopal SS, Frew JW, Tran K, Sturm M, Fogarty J, Marinkovich P. Igawa S,
Ishida-Yamamoto A Murrell DF Investigation of cell therapy for generalized severe
recessive dystrophic epidermolysis bullosa by intradermal allogeneic fibroblasts
randomized against placebo injections. Clinical oral session, ESDR Budapest 2009 #166.
J Invest Dermatol: 129: S28, 2009.

166. Klausseger A, Wadell L, Grasern N, Lloyd L, Tran K, Bauer JW, North K, Murrell DF:
Gradual expression of plectin deficiency in a patient with epidermolysis bullosa simplex
and adult-onset muscular dystrophy. Abstract 306, poster, ESDR Budapest 2009, J Invest
Dermatol 129:S51, 2009/

167. Cole Cl, Pourreyron C, Foerster J, Purdie K, Salas-Alanis JC, Murrell DF, Bruckner-
Tuderman L, McGrath JA, Leigh IM, South AP: SLCO1B3 expression in recessive
dystrophic epidermolysis bullosa associated squamous cell carcinoma is reduced by
recombinant type VII collagen. Abstract 325, poster, ESDR Budapest 2009, J Invest
Dermatol 129: S55, 2009,

168. Venugopal SS, Intong LRA, Cohn HI, Mather-Hillon J, Murrell DF: An intra-patient,
prospective study of topical Gentian Violet for the treatment of chronic ulcers in non-

64
 Herlitz Junctional Epidermolysis Bullosa. Australasian College of Dermatologists’ Spring
Meeting, Hunter Valley, NSW. Poster. Australas J Dermatol, 50 (Suppl 2) A56, 2009. .

169. Sebaratnam D, Venugopal S, Murrell DF. The development of an Excel program to

compare disease-specific instruments for assessing activity and extent of autoimmune
bullous disease [oral presentation]. Australasian College of Dermatology Biennial Spring
Conference 2009. Pokolbin, New South Wales, Australia. October 9, 2009

170. Intong LRA, Choi SD, Shipman AR, Kho YC, Rhodes LM, Chapman MG, Murrell DF:
The mother with Epidermolysis Bullosa - what are the problems? Invited paper.
Proceedings of the European Academy of Dermatovenereology, Berlin, 2009. Published
on CDROM by documediaS GmbH Hannover A-156-0011-00508

171. Murrell DF: How to take skin biopsies in patients with EB. Women’s Dermatologic
Society Satellite meeting, EADV, Berlin 2009 (paper).

172. Boyce AE, McGrath JA, Techanukul T, Tran K, Chow CW, McGregor L, Murrell DF,
Warren L: Ectodermal dysplasia-skin fragility syndrome due to a novel internal deletion
mutation in the plakophilin 1 gene. Poster, World Congress of Pediatric Dermatology,
Bangkok, Thailand, Nov 2009.

173. Sebaratnam D, Venugopal S, Murrell DF. A comparison of photodynamic therapy and

surgery in superficial basal cell carcinoma: 3 year recurrence rates and cosmetic outcome
[oral presentation]. Austraaslian Society for Dermatology Research 7th Annual Scientific
Meeting. Cairns, Queensland, Australia. June 19, 2010.

174. Sebaratnam D, Venugopal S, Murrell DF A clinical study comparing photodynamic

therapy and surgery in superficial basal cell carcinoma: 3-year follow-up investigating
recurrence and cosmetic outcome [poster]. Australasian College of Dermatologists 43rd
Annual Scientific Meeting. Darwin, Northern Territory, Australia. May 16, 2010.

175. Hanna A, Sebaratnam D, Chee SN, Venugopal S, Welsh B & Murrell DF. The
development of a disease-specific quality of life instrument for autoimmune bullous
diseases – the ABQOL [poster]. Medical Dermatology Society Meeting. Miami, Florida,
USA. March 4, 2010.

176. Kho YC, Rhodes LM, Robertson S, Su J, Varigos G, Hogan P, Orchard D, Murrell DF.
(2010).The Australasian Epidermolysis Bullosa Registry – First Orphan Disease Registry
in Australia (Oral Plenary Presentation). Australasian College of Dermatologist’s 43rd
Annual Scientific Meeting, Darwin, NT, Australia.

177. Venugopal SS, Yan H, Tran K, Sturm M, Fogarty J, Nelson J, Frew JW, Melbourne W,
Rhodes LM, Wood F, Marinkovich MP, Igawa S, Ishida-Yamamoto A, Murrell DF.
Investigation of cell therapy for generalized severe recessive dystrophic epidermolysis

65
 bullosa by intradermal allogeneic fibroblasts randomized against placebo injections.
Registrars Oral Presentations (runner up for 1st prize) Australasian College of
Dermatologist’s 43rd Annual Scientific Meeting, Darwin, NT, Australia.

178. Daniel BS, Venugopal SS, Martin LK, Wittal R, Rhodes LM, Le Guay J Murrell DF. A
Randomised Controlled Trial of Minigrafting Vs ReCell in Stable Vitiligo. First Vitiligo
World Congress. Milan, Italy, October 2010. Oral plenary paper.

179. Sebaratnam DS, Venugopal SS, Frew JW, McMillan JR, Murrell DF: A systematic review
of diffuse melanosis cutis as a rare presention of metastatic melanoma. Poster
presentation, World Congress of Melanoma, Sydney, Nov 2010. Pigment Cell and
Melanoma 23(6); 974. A281.

180. Daniel BS, Venugopal SS, Murrell DF. Complete resolution of multiple verrucae vulgaris
treated with quadrivalent human papilloma virus (HPV) vaccine. J Am Acad Dermatol 64:
AB110, P 2511. 69th Annual Meeting, New Orleans, 2011. (latter names missing in
published abstract).

181. Kim M-H, Intong LRA, Kho YC, Murrell DF: Recessive dystrophic epidermolysis
bullosa with squamous cell carcinoma. J Am Acad Dermatol 64: AB84, P 2004. 69th
Annual Meeting, New Orleans, 2011.

182. Intong LRA, Ho K, Konecny P, Bhargava V, Murrell DF: Scedosporium asiospermum

skin infection successfully treated with voriconazole. J Am Acad Dermatol 64: AB104, P
2410. 69th Annual Meeting, New Orleans, 2011.

183. Daniel BS, Murrell DF: Unilateral Darier disease following the lines of Blascko. J Am
Acad Dermatol 64: AB89, P 2025. 69th Annual Meeting, New Orleans, 2011. (Senior
author’s name missing from abstract).

184. Intong LRA, Cohn HI, Dosen A, Hovnanian A, Sprecher E, Murrell DF: A curious case
resembling Netherton Syndrome with normal LEKTI and negative exonic SPINK5
mutations. Cases for Diagnosis (oral paper by Dr Intong). Society of Pediatric
Dermatology Pre- AAD meeting, New Orleans, LA, February 2011. .

PAPERS WITH ACKNOWLEDGED CONTRIBUTIONS:

Robbins PB, Lin Q, Goodnough JB, Tian H, Chen X, Khavari PA: In vivo restoration of laminin 5
B3 expression and function in junctional epidermolysis bullosa. Proc Natl Acad Sci USA 88:5193-
8, 2001. (Providing tissue from H-JEB patients for the study)

Parsi K, Kossard S: Multiple hereditary glomangiomas: Successful treatment with sclerotherapy.

Australas J Dermatol. 43: 43-47, 2002. (Arranging investigations on cultured tissue)

66
Shumack S, Robinson J, Kossard S, Golitz L, Greenway H, Schroeter A, Andres K, Amies M &
Owens M: Efficacy of Topical 5% Imiquimod Cream for the Treatment of Nodular Basal Cell
Carcinoma. Comparison of dosing regimens. Arch Dermatol 138:1165-1171, 2002. (Co-
investigator)

Zuberbier T, Orlow SJ, Paller AS, Taïeb A, Allen BR, Hernanz Hermosa JM, Ocampo J, Cox M,
Langeraar J, Simon JC. Patient perspectives on the management of atopic dermatitis Lancet
(submitted July 2005) (Review of questionnaire)

Mentink LF, Mackenzie M, Tóth GG, Laseur M, Lambert FPG, Veeger NJGM, Cianchini G,
Pavlović MD, Jonkman MF: Randomized controlled trial of adjuvant oral dexamethasone pulse
therapy in pemphigus vulgaris (PEMPULS trial). Arch Dermatol 2006 May;142(5):570-6. (For
editing the English)

Varki R, Sadowski S, Pfender E, Uitto J: Epidermolysis Bullosa. I. Molecular genetics of the

junctional and hemidesmosomal variants. J Med Genet. 43:641-652, 2006 (for referral of cases)

Ellis CN, Barker JN, Haig A, Parker CA, Daly S, Jayawardene DA on behalf of Avandia Study
Group. Placebo Response in Two Long-Term Randomized Psoriasis Studies that were Negative
for Rosiglitazone. Am J Clin Derm 8 (2):93-102, 2007. (DM was PI for this study in Australia).

Papers – non peer reviewed/other

1. Blackburn DF. (1984). Toxic Shock Syndrome. Essays in Comparative Pathology.

Cambridge University Department of Pathology.

2. Blackburn DF. (1985) My General Practice Attachment. The White Rose Revue.
Yorkshire Faculty, The Royal College of General Practitioners. Dec pp 3. Winning essay
for Provost's Prize.

3. Blackburn DF. (1987). The Pathogenesis of Psoriasis. Prize-Winning Essay for the
Renwick-Vickers Dermatology Prize. Oxford University Department of Dermatology.

4. Murrell D, Moorhouse R: Emeritus Professor Timothy GC Murrell AM (Obituary). Med

J Aust 178:33, 2003.

5. Cronk J, Murrell DF: Idiopathic guttate hypomelanosis: a benign pigmentation disorder.

Medical Observer 25.April 2003 :50.

6. Jabbour J, Murrell DF: Pyogenic Granuloma. Occasional Spot dermatology casebook,.

Medical Observer. 9 May 2003: 44.

7. Sinclair R, Cowan P, Marshman G, Howard A, Robertson I, Varigos G, Murrell D:

Efficacy and safety of once daily applications of Mometasone Furoate 0.1% (Elocon)
versus twice daily applications of Methylprednisolone Aceponate 1mg/g (Advantan) for

67
 the treatment of mild-to-severe psoriasis. Cochrane Database of Unpublished Clinical
Trials.

8. Cronk J, Murrell DF: Erythema ab igne. Occasional spot dermatology casebook.

Medical Observer. July 11; 40, 2003.

9. Cronk J, Murrell DF: Piezogenic papules. Occasional spot dermatology casebook.

Medical Observer. July 11;41, 2003.

10. Jabbour J, Murrell DF: Paget’s disease of the nipple. Occasional spot dermatology
casebook. Medical Observer. Feb 2004.

11. Murrell DF: Diffuse pruritus and a rash (Urticarial Bullous Pemphigoid) Medical
Observer June 4, 2004.

12. Murrell DF:An unusual ulcer (Factitial) Medical Observer July 2, 2004

13. Murrell DF: Clues to an unusual disorder (Fabry’s disease) Medical Observer July 30,
2004

14. Yiasemides E & Murrell DF: Managing lichen sclerosus. Medical Observer August 27,
2004.

15. Kwan B & Murrell DF: Palpable Purpura. Medical Observer. October 1st, 2004, p40.

16. Kwan B & Murrell DF: Dermatoses of Pregnancy. Medical Observer. October 29th,
2004, p32.

17. Murrell DF: Treating Superficial BCCs. Medical Observer. November 26, 2004.

18. Magdy A, Murrell D: Looking beyond skin deep. (Insulin resistance and acne) Medical
Observer. Jan 28th 2005, p. 28.

19. Kim YJ, Lin E, Murrell D: Lichen Amyloidosis. Medical Observer. Mar 4, 2005, p. 36.

20. Martin L, Murrell D: Discoid Lupus. Medical Observer. April 1, 2005, p. 29.

21. Dacey M, Murrell DF: An unusual case of clubbing (due to marijuana abuse). Medical
Observer April 29, p 32, 2005.

22. Balck S, Henderson C, Murrell DF: Lepromatous leprosy. Medical Observer 27 May, p
34, 2005.

23. Martin L, Murrell D: Gorlin’s Syndrome. Medical Observer. 24 June, p 30, 2005.

24. Do TT, Arnold C, Murrell D: Li-Fraumeni Syndrome. Medical Observer. 22 July, p 34,

68
 2005.

25. Martin L, Fischer A, Murrell DF: Chondrodermatitis nodularis helicis. Medical Observer.
19 August, p.32, 2005.

26. Martin L, Fischer A, Murrell DF: Disseminated superficial actinic porokeratosis. Medical
Observer. 16 September, p38, 2005.

27. Murrell DF: Pemphigus –Rare but Dangerous. Medical Observer. 21 October, p34, 2005

28 Rubin A, Fischer A, Kossard S, Murrell DF: Bullous Pemphigoid. Medical Observer. 25

November, p 34, 2005.

29. Ansari S, Fischer A, Murrell DF: Pyoderma Gangrenosum. Medical Observer, 20th Jan
2006

30 Choi D, Fischer A, Murrell DF: Naevus Sebaeceous. Medical Observer 17th March 2006

31. Yiasemides E & Murrell DF: Tuberous Sclerosis. Medical Observer. 14 April 2006, p. 33.

32. Daniel D, Tran K, Murrell DF: The case of the puzzling blue toes (cholesterol emboli)
Medical Observer, 12 May 2006.

33. Farvolden D, Murrell DF: Rapidly Progressive Bilateral Eye Pain and Complaint of
Decreased Tear Production: Mucous Membrane Pemphigoid. Medical Observer, 16 th June
2006.

34. Martin L, Murrell DF, Wittal R, Le Guay J: Management of vitiligo.Medical Observer,

July 2006.

35. Woo M, Murrell DF: Controlling rosacea. Medical Observer. 4 Aug 2006, p. 38.

36. Kularatne U, Murrell DF: Perniosis. Medical Observer, Sept 2006.

37. Graham A, Murrell DF: Allergic Contact Dermatitis. Medical Observer, 27 Oct 2006,
p36.

38. Murrell DF: Complex Psoriasis Case Studies. Meet the Expert. READY (Remicade
Academy in Dermatology. Shering-Plough Ltd Australia Ltd, Asutralia, Oct 2006.

39. Frew J, Murrell DF: Patches herald pityriasis rosea. Medical Observer 24 Nov 2006, p33.

40. Murrell DF: Fenella Wojnarowska receives Maria Duran Lectureship. Meetings,
Transactions and Society News
Int J Dermatol: 45 (11), 1397–1401, 2006.

69
41. Agero ALC, Murrell DF: Sweet’s Syndrome. Medical Observer Jan 2007.

42. Yu A, Murrell DF: Finding Nemo fan gets hand rash: mycobacterium marinum. Medical
Observer, Feb 2007.

43. Shipman A, Murrell DF: Rash needing lifestyle modification: porphyria cutanea tarda.
Medical Observer, March 2007 .

44. Frew JW, Murrell DF: Acanthosis nigricans. Medical Observer, April 2007.

44. Shipman A, Murrell DF: Systemic Lupus Erythematosus. Medical Observer 18 May
2007, p36.

45. Badiee S, Murrell DF: Guttate psoriasis. Medical Observer, June 2007.

48. Tiong SY, Murrell DF. Recognising and managing scabies. Medical Observer, July
13th, p 30, 2007.

49. Lam V, Murrell DF: Shingles. Medical Observer, August 10th, p 34, 2007.

50. Lahmar JJ, Murrell DF: Managing Keloids. Medical Observer, Sept 7th, 2007, p. 32.

51. Nading MA, Murrell DF. Identifying tinea incognito. Medical Observer, Oct 6th, 2007, p.
36.

52. Biswas S, Murrell DF: Candida intertrigo. Medical Observer, Nov 2 2007, p.34.

53. Chee SN, Murrell DF: Neurofibromatosis type 1. Medical Observer, Nov 30, p. 34, 2007.

54. Julian M, Murrell DF: Eczema Herpeticum. Medical Observer, Jan 25, p30 2008.

55. Ostberg A, Murrell DF: Erythema Multiforme. Medical Observer, Feb 22nd, p 38, 2008.

56. Ong-Sahara L, Murrell DF: Blistering eruptions in the newborn. Medical Observer,
March 7th, pp27-30, 2008.

56. Murrell DF: Leena Bruckner-Tuderman delivers 2008 Maria Duran Lectureship at
International Society for Dermatology Meeting in Cairo. Meetings, Transactions and
Society News. Int J Dermatol (in press):

57 Drummond J, Murrell DF: Wart vs Corn? Medical Observer, 21 March, p.35, 2008.

58. Murrell DF: "Maria M. Duran Symposium Planned for the X ICD Prague, May 2009".
Int J Dermatol (in press for May 2008).

70
59. Gaitskell K, Murrell DF: New treatment for dermatitis. Medical Observer, 11 April p
34, 2008.

60. Halim S, Murrell DF: Kaposi’s sarcoma. Medical Observer. 16 May p 37, 2008.

61. Paugh H, Murrell DF: Cutaneous mastocytosis. Medical Observer June 2008

62. Vestergaard M, Murrell DF: Pseudoaneurysm. Medical Observer. July 11th 2008

63. Paugh H, Murrell DF: Cutaneous Metastases. Medical Observer, Aug 8th 2008

64. Chow T, Murrell DF: Epidermoid cysts. Medical Observer. Sept 5th 2008 p 32.

65. Sebaratnam D, Murrell DF: Tinea capitis. Medical Observer Oct 3rd 2008

66. Joly C, Murrell DF: Cancerous nodules on the thigh. Medical Observer, Oct 31 2008
p33.

67. Woo M, Intong LRA, Murrell DF: Ichthyosis vulgaris. Medical Observer. Nov 2008

68. Burgraaff K, Murrell DF: Jogger’s nipples. Medical Observer Jan 2009

69. Piels M, Murrell DF: Perioral dermatitis. Medical Observer Feb 20, 2009

70. Surjana D, Venugopal S, Murrell DF. A linear eruption. Medical Observer, Mar 13, 2009
p 31.

71. Kopecki Z, Murrell DF, Cowin AJ (2009) Raising the roof on Epidermolysis Bullosa.
Wound Practice & Research 17: 72-80, 2009.

72. Cohn HI, Murrell DF: Puzzling persistent papules: Darier disease. Medical Observer,
April 17th 2009, p. 32.

73. Mather-Hillon J, Ho SJ, Murrell DF: Purpura in a patient receiving heparin: HITTS.
Medical Observer, May 2009.

74. Sonnergren E, Intong L, Murrell DF: Scalp scratching – head lice. Medical Observer,
June 12th, 2009, p 34.

75. Cannon S, Cohn HI, Uitto J, Murrell DF: Unassuming papules: pseudoxanthoma
elasticum. Medical Observer July 10th, 2009, p. 38.

76. Sensen K, Murrell DF: The stretchy skin syndrome. (Ehler’s Danlos) Medical Observer
August 8th 2009, p. 36.

71
77. Baillie L, Murrell DF: The variations of pityriasis versicolor. Medical Observer, Sept 4 th,
2009, p. 30.

78. Baillie L, Murrell DF: Calciphyllaxis: a rare and severe disorder. Medical Observer Oct
8th, 2009.

79. Morin C, Intong LRA, Murrell DF: Athlete’s Foot. Medical Observer, Nov 6 th, 2009, p.
28.

80. Pawar P, Murrell DF: Opportunistic Infections. Medical Observer, Nov 27th, 2009, p. 29.

81. Kim M-H, Murrell DF: Cutaneous sarcoidosis. Medical Observer, Jan 29th, 2010. p. 25.

82. Daniel B, Murrell DF: Palmoplantar psoriasis – management and biologicals. Medical
Observer, March 3rd 2010, p 32.

83. Muller N, Murrell DF: Steroid-induced acne. Medical Observer, April 2nd 2010

84. Meijers W, Murrell DF: Vitiligo. Medical Observer. April 30th 2010.

85. Hanna AM, Murrell DF: Cutaneous T cell Lymphoma masquerading as tinea corporis.
Medical Observer. May 28th, 2010, p.38.

86. Castro C, Intong LRA, Murrell DF: More than just a birthmark, Medical Observer. June
25th, 2010, p 35.

87. Kuijlaars J, Intong LRA, Murrell DF: Small boy’s big skin problem (Netherton
Syndrome) Medical Observer. August 20th, 2010, p. 30.

88. Li MM, Intong LRA, Murrell DF. Axillary papules (Fox Fordyce disease). Medical
Observer. September 17, p. 35, 2010..

89. Daniel BS, Murrell DF. Lichen amyloidosis. Medical Observer, Oct 15, p. 29, 2010.

90. Gurgen J, Murrell DF. Nodules of unusual origin (Leishmaniasis). Medical Observer, Nov
12, p.12, 2010.

91. Hwang S, Daniel B, Murrell DF: Drug related Skin Reactions. Medical Observer, Feb 4,
p. 25. 2011.

92. Tjokrowidjaja A, Daniel BS, Murrell DF: Hailey Hailey Disease. Medical Observer (in
press).

93. Dermawan A, Daniel BS, Murrell DF: Pityriasis Rubra Pilaris. Medical Observer (in
press).

72
 EDITOR

The Cochrane Collaboration Skin Disease Group, 1997-

Coauthor, two published reviews on interventions for Bullous Pemphigoid (see above, 2003 &
revised 2005) and Mucous Membrane Pemphigoid and Epidermolysis Bullosa Acquisita (2002) .

Lead Editor for Several Cochrane Systematic Reviews/protocols:

eg Treatment of Basal Cell Carcinomas; Fumaric acid esters for psoriasis; CTCL; Rosacea;
lipid lowering drugs for melanoma; oral retinoids for psoriasis; PDT for SCCs; prevention
and treatment of cold sores; .Tx of Androgenetic Alopecia; Chemoimmunotherapy vs
chemotherapy for Melanoma; Interventions for actinic keratoses.

Senior author, Cochrane review, Interventions for Pemphigus (title submitted June 2005,
published 4th quarter 2006). Review submitted Feb 2008.

Co-author, Cochrane review, Probiotics for Atopic Dermatitis (title registered July 2005)

Eurasian Dermatology Platform On line Journal 2007-

Editorial Board, Faculty of 1000 Medicine, Dermatology Section (Blistering Disorders) 2008-
Sebaratnam, D. & Murrell, D.F. The role of nitric oxide synthases in
pemphigus vulgaris in a mouse model. The Faculty of 1000. Oct 2008

Sebaratnam, D. & Murrell DF. A pilot quality-of-life instrument for pruritus.

The Faculty of 1000 Medicine. Aug 2008

Editorial Board, Journal of the American Academy of Dermatology 2008-

(Top 5% in Science Citations Index; 6/39 derm journals)

Guest Editor, Dermatology Clinics of North America – two issues on Epidermolysis Bullosa –
published March and September 2010. Book review published in J. Am Acad Dermatol March
2011; mentioned in What’s New in Dermatology Treatment, AAD 2011.

Editorial Board, Acta Dermatologica Croatica, 2009-

Editorial Board, International Journal of Dermatology – for Genodermatoses 2010-

REVIEWER

1995- Journal of Investigative Dermatology (Impact factor 5; 1/39 derm journals)

1997- Journal of the American Academy of Dermatology (IF 2.553) Editorial board 2008-
Clinical and Experimental Dermatology (IF 1.295)

73
 Archives of Dermatology (IF 2.851)
Australasian Journal of Dermatology
Lancet (IF 7.76)
2005- British Journal of Dermatology (IF 3.334; 2/39 derm journals)
2007- Journal of Dermatological Science (IF 2.636)
2008- Internal Medicine Journal (IF 1.4)
American Journal of Clinical Dermatology (IF 2.2)
Dermatologic Therapy
Archives of Diseases of Childhood (IF 2.06)
American Journal of Pathology
Acta Dermatologica Venereologica
Gene Reviews
J Pediatr
Int Med J

2009-
JEADV
Drugs and Aging
Trends in Mol Med
Pediatr Dermatol
Eur J Dermatol
Human Mutation
International Journal of Dermatology
Dermatologic Therapy

2010-
Obstetric Medicine
Pediatrics
Expert Opinion in Pharmacotherapy

PhD & MSc Thesis Reviewer

Sydney University (1 PhD, 1 MSc)

University of Melbourne (M Med, M Nursing)
Quaid-i-Azam University, Islamabad ( Two PhDs on genetic disorders of teeth, nail, hair)

GRANT REVIEWER

European Foundation for Rare Diseases, E-Rare. 2007.

British Skin Foundation 2007-
Fondecyt, Chile 2008

74
Irish Health Research Board (HRB)/Medical Research Charities Group (MRCG)
Austrian Science Fund 2009
Ludwig Boltzmann Gesellschaft, Austria
St George Hospital Medical Research Foundation 2008, 2009, 2010-
National Health and Medical Research Council 2010-

CONFERENCES/SYMPOSIA CONVENED

2006 Seminar on Epidermolysis Bullosa, Feb 13th, 2006, St George Hospital, Sydney

2006,7,8 Forum on Genodermatoses, American Academy of Dermatology Annual Mtgs

2006 Australasian Blistering Diseases Foundation, Inaugural Patient-Doctor

Meeting, Dec 8th, 2006, St George Hospital, Sydney; Invited Speaker: Prof Sara
Brenner, Israel.

2007 First Australian EB Professionals Conference, June 14th, 2007, St

George Hospital, Sydney
Invited Speakers: Prof Michele De Luca, Rome (Gene Therapist)
Jacqui Denyer & Lesley Haynes, Great Ormond St Hospital

2009 Maria Duran Symposium, International Congress of Dermatology,

Prague, May 21, Speakers from 8 countries and awards presented to Professor
Rafael Falabella as Maria Duran Lecturer.

2008,9,10 Symposium on Autoimmune Blistering Diseases, American Academy of

Dermatology. Speakers from multiple countries, speakers and topics changed each
year

2010 Sister Society meeting for the International Society of Dermatology at

CILAD, Cancun, Mexico; Cochair: Dr Tania Cestari.

2010 Sister Society meeting for the Women’s Dermatologic Society, Rose
Parade of Cases, at CILAD, Cancun, Mexico. Co-chair Tania Cestari \

2011 International Leadership Forum, Women’s Dermatology Society, for

World Congress of Dermatology, Seoul, Korea

2012 Australasian Society for Dermatological Research Annual Meeting, Sydney 2012

TAPE RECORDINGS/CD ROM/TV/MEDIA

Murrell DF: Cell Adhesion Molecules Relevant to Dermatology: 1995 and updated annually in
1996, 1997 and 1998; National Audio Video Inc, Denver, CO.

75
Miniconsults in Dermatology, Volume III (1996), Volume IV (1997), Volume V (1998), Volume
VI (1999), Volume VII (2000) CD Roms, Murrell DF (Faculty) American Academy of
Dermatology, Mosby Year Book Inc.

Murrell DF/ Thew M Dialogues in Dermatology: Cell Adhesion Molecules. September 1998
issue. American Academy of Dermatology.

MacKenzie-Wood A, Kirkham B, Hart K, Murrell DF: Second Reported Case of Bullous

Pemphigoid-like Eruption Induced by D-Penicillamine. Mini-Consults in Dermatology Volume VI,
American Academy of Dermatology, Mosby-Year Book Inc, 1999.

Interviewed by Rachel Friend, reporter for A Current Affair, Channel 9 National Network,
Australia (the highest rating current affairs programme in Australia) about Epidermolysis Bullosa;
Broadcast 4/2/00.

Murrell DF & Yiasemides E: Survey of Australian Female Dermatologists, Women’s

Dermatologic Society Newsletter, Vol 6, Issue 3, Sept 2002, p10 &15.

Dermatology in Australia- summary of talk given at Inaugural International Women’s

Dermatologic Society Meeting in Paris, France. Women’s Dermatologic Society Newsletter, Vol
6, Issue 3, Sept 2002, p11-13.

Videotaped interview for Johnson & Johnson re appropriate cleansing regimen –for marketing
products to Coles. December 2002.

Interviewed for article on “Are you too clean?” by Amanda Goff, for “B” Magazine; March 2003
issue p144.

Emerging therapies and gene studies for patients with Epidermolysis Bullosa; Today Tonight,
Channel 7, (Darren Nelson) 22nd May 2003.

Interviewed live on radio TOP FM Darwin (Trevor Scott) for Eczema Awareness Week. Mon 22 nd
Sept, 2003.

Media Training Workshop, Burston-Marsellier, Sydney, February 2004.

Interview for Sun Herald medical article re Epidermolysis Bullosa by Miranda Wood. August 1 st,
2004.

Interview (August 2nd 2004) about the future of gene therapy for Epidermolysis Bullosa. Today
Tonight, Channel 7 (Dr John D’Arcy) broadcast 4th August 2004.

Interview with Michael McCarthy for Video News Release by Novartis re Eczema and Elidel, 16 th
August 2004..

Interview with Megan Peard for article on eczema and new treatments for the Australian Journal

76
of Pharmacy, October 2004 pp 804-808.

Filming of multidisciplinary Epidermolysis Bullosa clinic and care, Sydney Children’s Hospital,
January 2005 for Channel 9 mini-documentary for A Current Affair.

Media Training Workshop, Tony Porter for Burston-Marsellier, St George Hospital.

Interview by Steven Rice for Channel 9 at Research & Education Centre, St George Hospital,
regarding our research on Epidermolysis Bullosa, March & June 2005. Broadcast on Sixty
Minutes Current Affairs on Sunday 11 June 2006. sixtyminutes.ninemsn.com.au/sixtyminutes/

Interview with Sarah Price for Sun Herald via UNSW media office for article on artificial tanning
–pros and cons. August 2005.

Filming for educational DVD on treatment of atopic eczema for GPs by Viva Communications on
behalf of Novartis, June 2006.

Recorded interview with Dr John D’Arcy of Drivetime Radio on A Breakthrough in the

Management of Atopic Dermatitis for GP educational programme. 2006

Interviewed by Channel 9 News re release of Adalimubab for psoriatic arthritis and subsidy
approval by medicare. July 31st, 2006, 6pm news.

Interviewed by journalist Jacqueline Wilson for article on Itching in eczema, Itching to help? For
My Child magazine, Autumn/Winter issue, pp 61-2, 2006.

Interviewed by Dermatology Times, USA, for article on desmosome gene disorders, based on
talk given at AAD in Feb 2007, published May 2007. “Genes provide clues to cardiocutaneous
desmosome disorders. New understanding may yield tools for early diagnosis, future treatment.
Dermatology Times. p 34-38.

UNSW Home page, by Susi Hamilton, media office, Married Professors graduate together with
MDs
April 24th, 25th 2007.

Sun Herald, Sunday 27th January 2008, Article about Elidel trial by Sarah Price, “Cream is up to
Scratch” p 47.

Interview by John D’Arcy for New Idea, Article “The Cotton Wool Girl” Feb 25th, 2008.

St George & Sutherland Shire Leader, April 29th pages 2 & 4: Article & photo re the ‘injection’ of
$120, 000 to the newly launched St George Medical Research Foundation on St George’s Day.

DebRA Australia National Newsletters, April and June 2008.

Dermatology in Australia. Interview translated into Portuguese. Brasilian Dermatology Society

77
Newsletter, June 2008.

Mention of our EB Registry set up at St George in the House of Representatives, 14 th May 2008,
by Tony Zappia, MP for Makin, proposing more federal funding for EB services. Hansard p
2782.

Authored article about International Pemphigus Committee meeting in Otsu, Japan, in the
International Pemphigus and Pemphigoid Newsletter July 2008.

Solaraze media release - Interviewed by 3 national radio channels, 1 live radio interview (ABC, 4th
Sept 2008) and Channel 9 Regional television, 24 Sept 08.

Eczema Awareness week 2008 – interview for article in the St George/Sutherland Shire Leader
newspaper. St George News – Christmas edition.

Dialogs in Dermatology – “Under the EB Umbrella” – interview on the new classification of

epidermolysis bullosa with Dr Stuart Brown recorded at the AAD –Nov 2008 (circulation, one
third of all US dermatologists). Commentary of this interview published by W.Heymann in Dec
2008 JAAD 59(6)(pp 1075-1076)59

Interviewed by Paula Goodyer, Sun Herald, for article on solar keratoses, for Sunday Life Health
section.

DVD on skin barrier, by Viva Communications, for Conference in Hobart on management of

incontinence associated dermatitis.

Interview published in Sun Herald, Sunday 14th June 2009 about adjunctive homeopathic
treatment for adult patients with EB given by Royal podiatrist from the Great Ormond St
Hospital, Dr Tariq Khan.

Recorded presentation & interview of Cell Therapy for EB Trial at DebRA SA conference,
Adelaide, 30 Nov 09 for Channel 7 Today Tonight Adelaide and Adelaide Advertiser. Reporter:
Vassil Milandris.

26th July 2010 for Channel 7 Today Tonight Sydney: Medical Spa therapy for atopic dermatitis.

Channel 7 Sunrise interview with atopic dermatitis patient who went to medical spa in France

8th Oct 2010 for Channel 9 Kerri-Anne Kennerley Morning Program re atopic dermatitis

ABC Radio Tasmania – Elaine Harris

ABC Radio Illawarra – Bonita Brown
ABC Radio Longreach – Tom Harwood
ABC Radio Bega – Tim Holt
6PR Perth – Tim Hood.

78
 INVITED LECTURES

New York University Medical Center, New York:

Dept of Orthopaedic Surgery, April 1994:
Collagen and the Orthopaedic Surgeon
Dept of Dermatology, Nov 1994:
Biology of the Cutaneous Basement Membrane Zone

Stanford University, California:

Dept of Dermatology, May 1994:
Autoimmunity to Cell Adhesion Molecules in Blistering Diseases

Cleveland Clinic Foundation, Ohio:

Depts of Dermatology and Biomedical Engineering, Jan 1995:
Cell Adhesion and Autoimmunity in Bullous Diseases

The University of New South Wales, Sydney, Australia

Medical Grand Rounds, The St George Hospital, May 1995:
The Pathogenesis of Autoimmune Blistering Diseases

The Rockefeller University, New York:

Caspary Auditorium, Health Awareness Lecture Series, May 1995:
Itch and Scratch, Bumps and Zits...Common Skin Problems
and What to Do About Them

The Hospital for Special Surgery, New York:

Department of Rheumatology, Grand Rounds, July 1995
The Pathogenesis of Autoimmune Blistering Diseases

New York Hospital/ Cornell University Medical College, New York:

Department of Dermatology, July 1995
Pemphigus, Bullous Pemphigoid and Epidermolysis Bullosa Acquisita

European Society for Dermatological Research, Vienna, Austria, Sept 1995

Stelwagon Lecturer & Recipient of Bill Reed Travelling Fellowship
Junctional Band 6 Protein

Frontiers in Sports Medicine, St George Hospital, Sydney:

Department of Orthopaedic Surgery, April 1996
Cell Adhesion Molecules and Orthopaedic Surgery

SouthPath 2nd Annual Seminar in Autoimmunity, St George Hospital, Sydney, August 1996
The Subepidermal Autoimmune Bullous Diseases

Royal Australasian College of Obstetricians and Gynaecologists

79
 DRACOG Course, January 1997
Dermatoses of Pregnancy

Dept of Immunology and Infectious Diseases, St George Hospital, Sydney, September 1997
Dermatoses in HIV Positive Patients.

North American Clinical Dermatologic Society, Australian Meeting, Renaissance Hotel, Sydney.
Basement Membrane Diseases.

Dept of Immunology and Infectious Diseases, St George Hospital, Sydney,June 1998

Opportunistic infections in HIV positive patients.

Frontiers in Sports Medicine, St George Hospital, Sydney:

Department of Orthopaedic Surgery, July 1998
Skin Problems in Athletes.

St George Private Hospital, Staff Education Programme, Sydney, Sept 98

Common Skin Problems and How to Treat Them.

GP Education Program, St George Area: Nephrology and Urology; Sept 1998

Dermatological Manifestations of Urogenital Disease.

Dermatology Registrar Training Programme, Adelaide; Oct 1998

Diagnosis of Epidermolysis Bullosa.

Sports Medicine Trainees Education Programme, Sydney, Oct 1998

Diagnosis & Management of Dermatological Problems Encountered in Sports.

Canterbury/Bankstown Medical Association, Sydney, Aug 1999

Management of Acne Vulgaris.

Sydney Children's Hospital Grand Rounds, November 1999

Update on the Pathogenesis of Epidermolysis Bullosa

Essex Pharma Dermatology Privileged Partner Programme for GPs: Sydney, April 2000
Simple Mistakes to Avoid in Dermatology
The Red Scaly Rash

Surgical Grand Rounds, St George Hospital, July 2000

Dermatological Management of Non-Melanoma Skin Cancer

Sydney Children’s Hospital, Genetics Dept, Sept 2000

The Genetics of Epidermolysis Bullosa

Histotechnology Group of NSW, Blackburn Bldg, Sydney University, Oct 2000

Epidermolysis Bullosa – Clinical, Genetic and Pathological Features

80
Essex Pharma Dermatology Privileged Partner Programme for GPs: Sydney, April 2001
Approach to Dermatology I
Advanced Eczema Treatment

General Practitioner Continuing Education Conference, Homebush, Sydney, May 2001

The persistent itch

The Osteoporosis Society, St George Bank Auditorium, Kogarah, June 2001.

The Diagnosis and Management of Common Skin Problems

University of NSW Medical School, Careers Day for Medical Students; Sept 2001
Dermatology as a Career after Medical School.

Essex Pharma Dermatology Privileged Partner Programme for GPs: Noosa, QLD, Sept 2001
Approach to Dermatology I
Advanced Eczema Treatment
Advanced Psoriasis Treatment
Investigation and Management of Hair Loss

Essex Pharma Dermatology Privileged Partner Programme for GPs: Sydney, Sept 2001
Approach to Dermatology II
Advanced Psoriasis

26th Philippine Dermatological Society Annual Convention, Manila, Nov 2001

By invitation: 3 lectures: (My talks delivered in absentia due to Embassy Security Advice)
Evidence-Based Medicine: Dermatology
The Cochrane Skin Group
EBM: Cosmetic Procedures & Cosmeceuticals

St George Hospital Medical Registrar Education Programme, Feb 2002

Dermatological Manifestations of Systemic Diseases

Photocure International Investigators’ Meeting, New Orleans, USA, March 2002

Australian Trial Results of Metvix PDT for “high risk” Basal Cell Carcinomas.

Essex Pharma Dermatology Privileged Partner Programme for GPs: Yeppoon, QLD, April 2002
Advanced Eczema Treatment
Advanced Paediatric Dermatology
Advanced Psoriasis Treatment

East Coast Registrar Training Programme, May 2002

Dermatology in Renal Diseases

Liverpool Hospital Annual Dermatology Meeting & Collegium, May 2002

Trial Results of Metvix Photodynamic Therapy for “high risk” BCC

81
35th Annual Australasian College of Dermatologists’ Meeting, Melbourne, May 2002.
Diagnosis of Epidermolysis Bullosa in Newborns (Paediatric Dermatology Symposium)

General Practitioners’ National Continuing Education Conference, Homebush, Sydney, May

2002
Skin Diseases in Children (150 registrants)

Essex Pharma Dermatology Privileged Partner Programme for GPs: Sydney, August 2002
Diagnosis and Management of Plant Dermatitis

St Vincent’s Hospital Annual Dermatology Meeting, Sydney, Sept 2002

Diagnosis and Management of Mycetoma

Medicine Grand Rounds, St George Hospital, Kogarah, October 2002

Genotype-Phenotype Correlations in Epidermolysis Bullosa

Sydney Genetics Fellows’ Education Programme, Sydney Children’s Hospital, October 2002
Update on the pathogenesis and diagnosis of Epidermolysis Bullosa.

Essex Pharma Dermatology Privileged Partner Programme for GPs: Sydney, November 2002
Diagnosis and Management of Hand Dermatitis

St George Hospital Physicians Training Programme for FRACP, Sydney, February 2003
Dermatological Manifestations of Systemic Disease.

University of NSW Continuing Education Annual Conference for GPs, UNSW, March 2003
Dermatology Workshop: Treatment of Different Types of Acne

Novartis Pharmaceuticals:. Company Representatives Education Program. Sydney, May 2003.

Diagnosis & Management of Atopic Dermatitis

Essex Pharma Dermatology Privileged Partner Programme for GPs: Sydney, May 2003
Actinically Damaged Skin.

Dept of Dermatology, St Vincent’s Hospital, Melbourne & Melbourne Children’s, June 2003
Genotype-Phenotype Correlations in Epidermolysis Bullosa

Indonesian 7th Annual Scientific Meeting of the Indonesian Society of Dermatology and
Venereology, Yogyakarta, Indonesia. July 2003:
Evidence-Based Dermatology (Plenary)
The pathogenesis of Inherited Bullous Diseases. (Plenary)

St Vincent’s Hospital Annual Dermatology Meeting, Sydney, August 2003

Pathogenesis and Management of Erythropoietic Protoporphyria

82
FDA Advisory Panel, Expert for Photocure ASA NDA Application
MAL-PDT in High Risk Basal Cell Carcinoma: Results of two trials in Europe & Australia
Sept 10th, 2003, Maryland, USA.

Parliamentary Briefing on Eczema, Committee Rm 1R1, Parliament House, Canberra

Impact and prevalence of eczema; October 8th, 2003.

University of North Carolina, Chapel Hill, USA, Visiting Prof, Feb12th, 2004.
Genotype-Phenotype Correlation in EB
Dermatology on Three Continents

General Practitioners’ National Continuing Education Conference, Homebush, Sydney, May

2004
The role of allergy in dermatitis (150 registrants)

Update on therapy for skin cancers, Sheraton Mirage, Gold Coast, QLD, May 2004
Non Surgical Therapies for Basal Cell Carcinoma

Rheumatology Training Programme, Sydney, NSW ; Nov 2004

Dermatology in Rheumatology

Genetics Fellow Training Programme, Sydney, NSW; Nov 2004

Genodermatoses

Society of Cosmetic Physicians, Sydney, March 2005:

Non-surgical treatments for Basal Cell Carcinomas.

General Practitioners’ National Continuing Education Conference, Homebush, Sydney, May

2005
Diagnosis and Management of Eczema and Allergy (150 registrants)

The Rockefeller University, New York, July 2005

Unravelling genotype to phenotype in Epidermolysis Bullosa

St Vincent’s Hospital Annual Dermatology Meeting, Sydney, August 2005

Scarring alopecia due to mycobacterium neoaurum mimicking sarcoidosis

Emergency Medicine Training Programme, St George Hospital, Aug 2005

Dermatological Emergencies

NSW Geriatrics Training Scheme Lecture Series, Sutherland Hospital, Sept 2005
Skin Disorders of the Elderly

NSW Osteoporosis Society, St George Leagues Club, October 2005

Sexy, Sixty and Skin Disease?

83
Annual Meeting of the Australian Cosmetic Physicians Society, Sydney Convention Ctr, Feb
2006
Photodynamic Therapy for non-melanoma skin cancer

Pemphigus Definitions Group, American Academy of Dermatology, San Francisco, Mar 3rd, 2006
Outcome Measures in Pemphigus

Modern Management in Rheumatology Conference, Peppars Salt, Kingscliff, NSW, March 11,
2006
Outcome Measures and Treatment Approaches in Psoriasis

Department of Dermatology, Salzburg, Austria, April 24, 2006

Genotype-Phenotype Studies in Epidermolysis Bullosa.

Schering Plough Satellite Meeting on Psoriasis, Melbourne, May 2006

Psoriasis resistant to Efalizumab – what next?
Combining biologicals with traditional systemic therapies for psoriasis.

Department of Aged Care Grand Rounds, St George Hospital, Sydney, May 2006
Common Skin Disorders of the Elderly

The Cutting Edge of Eczema, Seminar for GPs, Shangri-La Hotel, Sydney, Aug 15th, 2006
Chairing lectures by Prof Michael Meurer & Dr Michael Cork.

ASEAN Regional Dermatology Meeting, Bali, Indonesia September 15th 2006

Recent Molecular Advances in Blistering Diseases (Opening Plenary)

European Academy of Dermatovenereology, Rhodes, Greece, October 2006

Tropical Dermatoses in Aboriginal Australians
A year in the life of the Clinical Trialist

Crumlin Children’s Hospital, Dublin, Ireland, October 2006

Genotype to Phenotype Research in EB

Annual Meeting of the Australian Cosmetic Physicians Society, Sydney Convention Ctr, Feb
2006
My Approach to the Treatment of Acne vulgaris

Australasian Society for Medical Geneticists, Sydney, February 2007

Genotype to Phenotype in Epidermolysis Bullosa

University of Santo Tomas, Manila, Philippines, Postgraduate Dermatology Course, March 15-
16th, 2007
Only overseas invited speaker, 4 plenary lectures- What’s New in Autoimmune Bullous
Diseases, Genotype to Phenotype in EB, Desmosome Gene Disorders, Barrier Defect in
Atopic Dermatitis.

84
Research Institute of Tropical Medicine, Manila, March 19th, 2007
Visiting Prof and inaugurated as Honorary Consultant Dermatologist.

International Pemphigus Committee, Society for Investigative Dermatology, Los Angeles, May
2007
Use of pemphigus severity score, PDAI and ABSIS in assessing disease severity and
extent in pemphigus.

Dept of Immunology and Infectious Diseases, St George Hospital, Sydney, June 2007
Skin Manifestations of Systemic Diseases

DebRA Australia National Conference for Patients, Sydney, June 2007

A review of what’s new in Epidermolysis Bullosa research

DebRA New Zealand, in conjunction with the NZ Dermatological Society, Auckland, August
2007
History of EB, Review of Research Conducted in EB in Australia; lectures on clinical
management of EB

World Congress of Dermatology, Buenos Aires, October 2007

Moderator, International Women’s Dermatology Society Satellite Meeting
Pharmacoeconomics of drug approval process in Oceania
Skin Disorders of Aboriginal Australians

Prince of Wales Hospital, Chinese University of Hong Kong, April 13th 2008
Pathogenesis of Squamous Cell Carcinoma in Epidermolysis Bullosa
Invited by Prof Andrew Burd, Chair of Plastic Surgery/ Burns Unit

Visiting Professor, University of Hokkaido, Sapporo, Japan, 19-21 May 2008

Epidermolysis Bullosa Research in Australasia.

Visiting Professor, University of North Carolina, Chapel Hill, USA, August 2008:
Cardiotrichocutaneous disorders

Visiting Professor,Duke University Medical Centre, Durham, North Carolina, USA, August 2008
.From genotype to phenotype in Epidermolysis Bullosa

Australasian College of Dermatologists’ Registrar Education Programme, August 2008

An update on the Diagnosis and Management of EB

European Academy of Dermatovenereology, Paris, September 2008

Epidermolysis bullosa – update on pathogenesis.

Dept of Paediatrics, St George Hospital, October 2008

What’s new in the pathogenesis and treatment of atopic dermatitis

85
Genepharm/Pierre Fabre sponsored lectures for Sydney dermatologists,
Observatory Hotel, Sydney, Nov 3, 2008
The use of topical tazarotene in actinically damaged skin

CSL sponsored lecture for Sydney general practitioners, Fairfield, Sydney, Nov 6, 2008
Solaraze for field treatment of actinic keratoses

International Society of Dermatology, Philippine Dermatogy Society Annual Meeting,

Manila, Nov 2008:
ISD’s Maria Duran 2008 Lectureship: Update on the diagnosis, pathogenesis and
treatment of epidermolysis bullosa
What’s New in Autoimmune Bullous Diseases (plenary)

Novartis Pharmaceuticals, Sir Stamford Hotel, Sydney, December 2008

Systemic treatments for Atopic Dermatitis.

Merck Serono Pharmaceuticals, Intercontinental Hotel, Sydney, January 2009

Diagnosis and Management of Psoriasis

Medical Grand Rounds, St George Hospital, Sydney, May 7th 2009

Pathogenesis and Management of Squamous Cell Carcinoma in EB

International Society for Dermatology, Prague, Czech Republic, May 2009

Paediatric Dermatology Symposium: Bullous Genodermatoses

3rd Epidermolysis Bullosa National Conference, Queensland, June 12-13, 2009

Keynote speaker – Current research in Epidermolysis Bullosa

Society for Pediatric Dermatology, Annual Meeting, Philadelphia, PA, USA, July 9-12, 2009
Sidney Hurwitz Lecturer: What’s New in EB: diagnosis and pathogenesis
What’s New in EB: management.

University of NSW Medical Society

Career obstacles and benefits of dermatology for women
10th Aug 2009

Dept of Dermatology, Zagreb, Croatia, Sept 14th, 2009

Visiting Professor
Novel findings in bullous diseases in Australasia

Dept of Dermatology de Prof Carle Paul, Purpan Hospital, University of Toulouse,

Toulouse, France, 5th October, 2009
Quoi de neuf dans les épidermolyses bulleuses?

European Academy of Dermatology, Berlin, Germany, Oct 2009

86
 The mother with Epidermolysis Bullosa – what are the problems?
In: Symposium on Skin Diseases in Pregnancy

Royal Brisbane Hospital, Dept of Pathology, Oct 2009

Research in Epidermolysis Bullosa from St George Hospital

DebRA South Australia EB Conference, Adelaide, 30th Nov 2009

Cell therapy for recessive dystrophic EB.

Australasian Wound and Tissue Healing Society, Perth, March 2010

Cell therapy trial for recessive dystrophic EB

Dept of Dermatology, Necker Hospital for Children, Paris, France. 9th April 2010
What’s new in epidermolysis bullosa?

New Zealand Dermatologic Society, Christchurch, New Zealand, April 2010

Cell therapy trial for RDEB
Commentary on Clinical Cases, Christchurch Hospital

Inaugural Meeting of the UNSW Dermatology Society, Oct 13th, 2010, Sydney
Dermatology as a Career

*European Academy of Dermatovenereology, Sweden, Oct 2010, President’s Symposium

**Malta Meeting, Nov 2010 – Cochair of Genodermatoses Session & Lecture on Cell Therapy
for EB

**NIH Pemphigus and Pemphigoid 2010 – Cochair of Consensus Session on AIBD – Invited talk
on QOL measures for AIBD

**CILAD 2010 Cancun, Mexico

EB Symposium – cochair & speaker on QOL in EB and Cell Therapies.
* Invited but declined due to prior commitment
** Accepted and organized; unable to travel due to temporary acute health problem

American Academy of Dermatology, New Orleans 2011

What’s New in Autoimmune Blistering Diseases (Forum)

World Congress of Dermatology, Seoul, Korea 2011

CoChair, Symposium on Epidermolysis Bullosa; speaker on Cell Therapy in EB
Chair, Workshop on Databases in Dermatology; speaker on Australasian EB Registry
Speaker, QOL in Blistering Disorders, Workshop on Scoring Systems

Australia and New Zealand Cornea Society Meeting, Sydney, NSW, 17th March 2011
Blistering diseases with Ocular Manifestations.

87
University of Malaya, Kuala Lumpur, Malaysia, Grand Rounds, April 11th, 2011
Autoimmune Blistering Diseases – what’s new?

Hospital of Kuala Lumpur, Malaysia, Dept of Dermatology, April 13th, 2011

Update on new therapies for Epidermolysis Bullosa

Dept of Dermatology, Yale University School of Medicine, New Haven, CT, USA, 8th June 2011
Cell therapies for Epidermolysis Bullosa

TEACHING EXPERIENCE/INITIATIVES

1987-90: Supervision of clinical medical students and interns in medicine & surgery

1989-93: Supervision of medical students in dermatology outpatient clinics

Lectures to dermatology trainees & faculty, Duke Univ & Univ of NC

Biannual Basic Science Lectures
Monthly CPC slide presentations at UNC-Duke conferences
Paediatric Dermatology lectures (to paediatric trainees)
Difficult clinical diagnoses- kodachrome conference- quarterly
Review conference for American Board of Dermatology- bimonthly
Weekly Two Hour Education Programme, UNC (as Chief Resident)

1993-95: Supervision of dermatology registrars in dermatology outpatient clinics

Supervision of dermatology registrars on inpatient dermatology service
Kodachrome diagnosis conference to registrars- bimonthly
Lectures & Journal Clubs for dermatology registrars
Tutorials - undergraduate medical students in cell biology
Clinical & Basic Research teaching to summer students, research fellow

1995-: St George Hospital and University of New South Wales Medical School:

Medical Students:

Establishment of Dermatology Teaching Program for 4th Yr Medical Students

at St George Hospital: weekly lecture series and outpatients over 6 weeks in
blocks of 6 students at a time in during immunology/haematology rotation
(1997-)
Introduction to Dermatology
Common Skin Diseases and How to Treat Them
Skin Manifestations of Systemic Diseases
Drug Reactions

Lectures in dermatology course to 5th year medical students, UNSW (quarterly)

88
 Introduction to Dermatology
Dermatitis – diagnosis and treatment
Psoriasis & Papulosquamous Disorders
Infections of the Skin
Skin Cancers
Skin Manifestations of Systemic Diseases

Teaching clinics, St George Hospital

Examination of final year medical students, UNSW

Bedside teaching of dermatology to medical students, St George Hospital.

Supervision of dermatology elective students (avg 5mo/yr): (also taught in

private rooms)
Udara Kularatne, Cambridge Univ, UK (Recpt of British Association
of Dermatologists Elective Grant), August 2006
Anita Yiu, Harvard University, June 2006
Alexa Shipman, Oxford Univ, Feb-Mar 07
Julien Lahmar, Rouen Univ, Jul-Aug 07
Mary-Alice Nading, Vanderbilt Univ, Aug 07- accepted dermatology
Harvard in match to start 2009
Kezia Gaitskell, Oxford Univ Feb 08;subsequent winner of
British Association of Dermatologists’ 2008 Essay Prize
Holly Paugh, University of Arizona, USA, April 08, accepted Cleveland
2009
Charlotte Joly, St Antoine Hospital, Paris, July-August 08
Keyi Burgraaff, Maastricht Univ, NL, Sept-Oct 08
Marc Piels, Maastricht Univ, NL, Oct-Nov 08
Philip Tong, Perth Med School, Dec 08 (Aust Coll Pathologists Research
grant for this elective)
Kelly Sensen, Maastricht Univ, March 09
Ellen Sonnergren, Univ of Copenhagen, March 09
Jenny O’Nions, Univ of Oxford, April- May 09
Clement Morin, Univ of Paris V St Antoine, July-Aug 09
Elsepeth Rouers, Univ Maastricht, NL, Oct 09
Wouter Meijers, Univ Maastricht, NL, Nov 09
Christian Castro, Univ Maastricht, NL Feb 10
Jennifer Kuijlaars, Univ Maastricht, NL Mar 10
Anne-Sophie Voarick, Univ of Paris V St Antoine, July-Aug 10
Eleni Anthony, Griffith Univ, QLD, Sept-Oct 10
Nader Beshay, UNSW, Nov-Dec 10
Bart Waagemans, Univ Maastricht, NL Jan -Mar 11
Karoline Von Loeper, Tubingen Univ, Germany, Feb-Mar 11
Ingrid Meuwisson, Maastricht Univ, Feb – Mar 11

89
Dermatology teaching in Outpatient clinics at St Vincent's Hospital and Royal
Prince Alfred Hospital, July 96-Dec 97.
Mentor, 4th Year St George students (1999-2000)
New dermatology teaching programme for 5th years; Co-director; 2001-4
Director, 2004-7.
New dermatology education program for medical students from the University
of Maastricht, Netherlands, to send students each year to UNSW-St George.
2008-

Interns, RMOs and non-dermatology registrars/specialists:

Supervision of Dermatology RMO- rotate every 10 weeks
Lecturer on Intern education programme for dermatology "Emergencies in
Dermatology"; 1996-.
Lectures and Case Presentations in dermatology at Medical Grand Rounds
(95,97,98,99,00, 01,02, 04)
Lecture on Skin Manifestations of Systemic Diseases to FRACP candidates.
Lectures (annual) and teaching in weekly outpatient clinic for HIV patients at St
George Hospital

Dermatology Fellows, Registrars and Trainees:

Teaching in dermatology outpatient clinics at St Vincent's Hospital and Royal

Prince Alfred Hospital, July 96-Dec 97.
Case Presentations of live patients at the Skin and Cancer Foundation Monthly
Meetings 1996-
Formal lectures on Identification of Fungi and Epidermolysis Bullosa
Establishment of Dermatology Outpatient Clinic for teaching of Dermatology to
dermatology registrars, St George Hospital, Jan 98.

One year teaching each of dermatology registrars at St George:

Part time:
Michelle Lowes MBBS, PhD,(Asst Prof, Rockefeller Univ, New York)
Simon Lee MBBS (Mohs surgeon)
Diona Damian MBBS PhD (Assoc Prof, Sydney Univ)
Penny Lee MBBS (Psychiatrist and dermatologist)
Paul Chee MBBS
Kate Drummond MBBS FRACGP
Kurosh Parsi MBBS PhD candidate Vascular expert
Natasha Cook MBBS Cosmetic dermatology expert
Li-Chuen Wong MBBS Paediatric Dermatologist
Sophie Bakis MBBS M Med (Clin Epi)
Full time:
Georgia Harris BA MBBS

At EB Clinic, Sydney Children’s Hospital

90
Keng-ee Thai, Keng Chen, Jemima Fisher

Ad-hoc teaching by request to:

Andrew MacKenzie Wood, Kate Drummond, David Cook, Jack Shannon,

Lachlan Warren, Orli Wargon (EB clinic 2000).

Weekly teaching programme for dermatology registrars attending St George

Hospital.
Lectures at National and International Dermatology Conferences (see above)
Supervision of dermatology fellows (FAAD-USA) doing clinical trials
Mentor, Women’s Dermatology Society- Awardee Mentees from USA 2002,4,6

Dermatology Registrar/residents on electives:

Eric Hanson, Chief Resident, UNC-Chapel Hill, USA (6 weeks)
Michael Sullivan, Chief Resident, UNC-Chapel Hill, USA (6 weeks)
Davis Farvolden, U Mass, USA 2006 (6 weeks)
Lydia Ong Sahara, Univ of Minn, USA 2007 (one month)
Susan Poelman, McGill Univ, Montreal, Canada 2008 (one month)
Malene Vestergaard, Copenhagen, Denmark 2007-8- Dermatology Trainee, DK
Sue Yin Ng, Oxford Training Scheme, UK; 2009-1010
Stephanie Diamantis, UNC- Chapel Hill, USA, Feb 2010
Johnny Gurgen, Univ of Florida, May 2010
Mercedes Gonzales, NYU

Medicine Residents:
Laura Baillee, Princess Alexandra Hospital, Brisbane 2009 (one month)
Jessica Mather-Hillon, Oxford University graduate, St George, Jan – Aug 2009

Paediatric Residents Mentees:

Katya Pohli, Monterrey Univ, Mexico, 2008

RESEARCH SUPERVISION

Supervision of Research personnel: Technicians, Masters, PhD students and

post-doctoral research fellows:\
Weekly lab meetings in conjunction with soft tissue research lab of ORI
Teaching of immunofluorescence, DNA extraction and western blotting to
laboratory technicians and post-doctoral research fellows
Dermatology Basic Science teaching to aspiring dermatology researchers.

Supervision/Mentoring of clinical dermatology research fellows:

Board-certified dermatologists: 1-2 year fellowships (funded by me)

91
Dr Rebecca Cummins, (Northwestern Univ, Chicago)-1999-2000 Paediatric
Dermatologist;
Dr Julie Cronk 2001-2 (from Univ of Minnesota) Mohs Surgeon;
Dr Adam Rubin (Columbia Univ) 2005-6–Dermatopathologist, Univ Penn,
Dr Anna Liza Agero (2006-7 from Manila & from Memorial Sloan Kettering).
Dr Lizbeth Intong (2008-10, from Univ of Philippines, then Changi Hosp,
Singapore).
Dr Clarisse G Mendoza (2010-2011, from Dept Derm, RITM, Manila)

Pre-dermatology clinical research fellowships (funded by me):

Drs Adrian Lim 1997-9 (FACD),
Adrian See 1999-2001 (FACD),
Gilberto Moreno 2001-3;
Eleni Yiasemides (dermatology registrar 2007-),
Linda Martin (2005/6; dermatology registrar 2008-),
Supriya Venugopal (2008-9; Dermatology registrar 2010-)
Benjamin Daniel (2010-11)

Supervision of Post-doctoral research fellows:

Yali Zhao PhD, 2000-2001, Beijing University;
Dr Ning-Ning Dang (Dermatologist on Scholarship from Chinese Gov’t, Jinan)
2005-7
Heather Cohn, Jefferson Medical College, Philadelphia 2009-10

Supervision of PhD students, UNSW:

Matt Kemp, 2002-5; Funded by a scholarship established by me and then
awarded a University Post-graduate award for 2 years under competitive
selection. Gene studies in EB (Awarded 2006)
Dr Hellen Yan, 2006-10. Unusual genotypes in EB.
Dr Supriya Venugopal, 2008- Risk factors for AIBD; Cell therapy for RDEB

Supervision of Masters of Science by research student:

Dr Niken Trisnowati, Dermatologist; AUS AID scholar to UNSW, 2002-4;
Winner of Society for Investigative Dermatology Travel Award for scholars
from Third World Countries to present at SID/Tri-Society Meeting in Miami,
FL, May 2003. Thesis submitted March 2004.: “Genotype-Phenotype
Correlation in EB Simplex”. Awarded top rating without revisions by Profs John
McGrath & Rodney Sinclair.

Supervisor, Research Projects/Papers:

Eleni Yiasemides, UNSW med student: Derm Registrar, Perth 2007-
Thy Thy Do MBBS (UNSW); Dermatology Resident, Univ of Michigan 2008
Yung-Jim Kim UNSW med student: Derm Registrar, Queensland 2008-
Deanne Choi MBBS, UNSW
Anna Ostberg UNSW med student – Physician trainee.
Philip Tong, Perth medical student; Inaugural PhD FACD trainee 2011-

92
Co-Supervision of nurse practitioner for Masters Thesis in Public Health, Syd
Univ: Incidence of Latex Allergy amongst Theatre Staff at St George Hospital.
(H.Colinet RN, MPH)

Reviewer for Masters of Medicine Thesis, Sydney University, "Molecular

Biology of Non-Melanoma Skin Cancer: H-ras and p53 gene mutations" by Dr
Robert MacDonald FACD.

Reviewer for Master of Medicine Thesis, Melbourne University “Infectivity of

Molluscum in Children” by Dr Anna Braue.

Supervision of Independent Learning Project (ILP) Students, UNSW:

32 week research projects for medical students in year 3 or 4:

2006: John Frew: Quality of Life in Epidermolysis Bullosa - highest mark in

year & winner of St George research prize; Honours graduate, UNSW, 2009

2007: Shien-Ning Chee (QOL in pemphigus), Yong Kho (Epidemiology of EB

in Australia)- high distinctions; YK winner of St George research prize

2008: Deshan Sebaratnam (QOL in AIBD)– High distinction

2009: Ann-Marie Hanna – ABQOL; Minhee Kim – EB and SCC; Niccolo

Muller- EB and exercise

2010: Minmin Li, Shelley Huang, Angelika Trodjamuto, Andrew Dermawan

2011: Chris Lim (Honours), Jeremy Tan

CLINICAL INITIATIVES

UNC-Chapel Hill, USA –

Initiation & Funding of Clinical Trial of new topical therapy for psoriasis.

New York University, New York: 1994:

Initiation of Bullous Clinic, Bellevue Hospital.

St George Hospital, Kogarah, Sydney

National referral centre for diagnosis of EB by Immunofluorescence
Mapping and Electron Microscopy 1997-
Set up dermatology outpatient teaching clinics 1997-
Dermatology-HIV Clinic 1996-
Clinical Trials Unit in Dermatology Dept 1997-
Dermatology registrar weekly lecture series 1997-

93
 4th year UNSW dermatology teaching series, 1996-
5th year UNSW new dermatology curriculum 2000-
Phototherapy service 1998-
GP Registrar Dermatology Rotations 2005-
Dermatology- Genetics Joint Clinic 2005-
Dermatology RMO 2006- incl Dr Jessica Mather-Hillon, Oxford Univ,
2009
Paediatric Dermatology Clinic 2007-
Adult EB Clinical Nurse Consultant 2009-

Sydney Children’s Hospital, Sydney

Expansion of Multidisciplinary EB Clinic – 1998-
EB Clinical Nurse Consultant 2006-

VISITING PROFESSORS/LECTURES ARRANGED

Prof Bruce Thiers, Univ of South Carolina, Charlottesville,

Editor, Journal of American Academy of Dermatology
“What’s New in Dermatological Therapeutics”
For Annual Dermatology Meeting, Concord Hospital, 1996

Prof Wilma F. Bergfeld, Cleveland Clinic, USA

President, American Academy of Dermatology
“Metabolic Syndrome and Hair Disorders in Women”
Skin and Cancer Foundation, Darlinghurst.

Prof Joseph Jorizzo, Wake Forest Univ, NC, USA

Chairman of Dermatology
Dermatology-Rheumatology Clinical Conference
St George Hospital, Kogarah.

Prof James G Krueger MDPhD, Rockefeller University, NY

Chair of Dermatology
“The dark side of biologicals for psoriasis”
Medicine Grand Rounds, St George Hospital, May 2005

Dr Evangeline Handog, Manila, The Philippines

“Use of vitamins and supplements in dermatology” Nov 2005

Prof Hardyanto Soebono, Dean, Gagjah Mada University Medical School,

Chair of Dermatology, to St George Hospital and
Australasian College of Dermatologists, May 2006

Prof Nancy Thomas MD PhD, Dept of Dermatology

94
 University of North Carolina at Chapel Hill,
“Pigmented lesion clinic and somatic mutations in NRAS & BRAF in
melanoma” June 2006

Dr Joseph Pace, Secretary-General, European Academy of Dermatology

Malta, to St George Hospital Dermatology Dept, Dec 2006
“Acne and Insulin Resistance”

Prof Sarah Brenner, MD, Haifa, Israel

“Drug Induced Pemphigus“ Inaugural Australasian Blistering Diseases
Foundation meeting, St George Hospital, Dec 2006,

Prof Dr Johannes Bauer, MD PhD, Dept Dermatology, Salzburg, Austria

„Trans-splicing and other strategies for treatment of EB”,
St George Hospital Dermatology Dept, 21st July 2007

Prof James McMillan, PhD, Dept Dermatology, Hokkaido Univ, Japan

Studies on plectin and kindlin in variants of Epidermolysis Bullosa.
St George Hospital, October 2007

Dr Francis Palisson, Director of Dermatology, Clinica Alemana, Santiago, Chile

Dermatologist for DebRA Chile & Host of satellite to World Congress in
EB
St George Hospital Dermatology Dept, 12th May 2008

Prof Dra Antonella Tosti, University of Bologna, Italy,

Nail disorders in Children.
Dept Dermatology, St George Hospital, Monday Sept 1st, 2008.

Dr Tariq Khan, Great Ormond St Hospital, London

Complementary Medicine & Podiatry for EB, Sept 8th, 2008.

Prof Martin M. Black and Dr Anne Kobza Black, St John’s Institute of

Dermatology
Skin disorders of pregnancy (MMB)
Management of urticaria (AKB)
March 27th, 2009

Dr CW Chow Dept of Anatomical Pathology, Royal Children’s Hospital,

Melbourne.
Electron Microscopy of Skin Disorders, Dec 7th 2009

Prof Eli Sprecher, Sourasky Dept of Dermatology, Tel Aviv, Israel.

April 28-30th 2010.
Genodermatoses from the Middle East.

95
96
 COMMUNITY ACTIVITIES

General Practitioners:

Royal Australasian College of Obstetricians and Gynaecologists DRACOG

Course, January 1997:Dermatoses of Pregnancy

GP Education Program, St George Area: Nephrology and Urology; Sept

1998Dermatological Manifestations of Urogenital Disease.

Sports Medicine Trainees Education Programme, Sydney, Oct 1998 Diagnosis

& Management of Dermatological Problems Encountered in Sports

Bankstown Area General Practitioners Association: Management of Acne, Oct

1999

Weekly teaching for GP doing Diploma of Dermatology in Cardiff, UK (by

correspondence); passed exam in 2000

Essex Pharma GP Education Course for GPs (9 lectures)

Established Premier Dermatology 10 week GP dermatology training programme

: in practice, accredited for CME by the RACGP (100 CME points)

Annual Lectures for UNSW-run General-Practitioner Continuing Education

Conference (GPCE), Homebush, on dermatology topics 1998-

Teaching programme for GP Registrars in dermatology, St George Hospital,

2005- in dermatology outpatients

GP lectures on Field Therapy for Actinic Keratoses – St George Area, April 30 th

2008; Cronulla 7th May 2008 (sponsored by CSL).

GP nights with patients for dermatology education- at The Church, 17

Kensington St, Kogarah
2010- Focus on atopic dermatitis
2011- Focus on emerging therapies for psoriasis

St George Area
St George Hospital Medical Association: Secretary/Treasurer 1997-2008.
Funds annual research prizes at Annual Symposium
Raises funds to support Annual Hospital Symposium
Supports visiting speakers to Medicine Grand Rounds
Organised closure and donation of remaining $120,000 to St George
Medical Research Foundation, 2008.

97
Patient Support Groups
DEBRA- Australia & New Zealand,
NSW, QLD, SA Branches :

Lectures, newsletter articles, fundraising

Media interviews/TV for raising awareness/fundraising
City to Surf, 2007, 2008, 2009 fundraising with my family for DebRA
Australia
Volunteer, DebRA NZ Adventure Camp for teens with EB, August 2007
(assistance with skiing and dressing changes at camp)
Butterfly Day 2007, 8, 9- Fundraising stalls at St George Hospital
Meetings with Malcolm Turnbull, MP (Leader of Opposition) & Nicola
Roxon, Health Minister’s office (2007/8) re national funding for dressings
for patients with EB and writing of funding application: funding in 2009
federal budget for $16M over 4 years for dressings for EB.

Eczema Association of Australia

Speech to Parliamentary Briefing for Eczema week

International Pemphigus & Pemphigoid Foundation.

Founding Medical Advisory Board Member
Distribution of information to patients in Australia. Web correspondence.

Australasian Blistering Disease Foundation

Cofounder, 2006, with Dr Linda Martin. Monthly support group
meetings at St George Hospital. Website correspondence.
President, 2006-. Fundraising.

International Volunteer Activities

Medical Director, Ski/Adventure Camp for Teens with Epidermolysis Bullosa,

Mt Ruapehu, New Zealand, August 2007.

Visiting Professor & Hon Faculty, Research Institute of Tropical Medicine, Dept
of Dermatology, Manila, Philippines. Mar 2007 & May 2008

Teaching & Visiting Patients with EB & AIBD

- Hong Kong (Prince of Wales Hospital)
- RITM, Manila, Philippines
- HKL, Kuala Lumpur, Malaysia- April 2011
- Ho Chi Min & Hanoi, Vietnam – August 2011

Referees:
Available upon request.

98